<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Parkinson's disease - Wikipedia, the free encyclopedia</title>
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />
<meta name="generator" content="MediaWiki 1.23wmf19" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Parkinson%27s_disease" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/wiki/Parkinson%27s_disease" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.ui.button%7Cskins.common.interface%7Cskins.vector.styles&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>

<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Parkinson's_disease","wgTitle":"Parkinson's disease","wgCurRevisionId":601167669,"wgRevisionId":601167669,"wgArticleId":22228064,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Use dmy dates from March 2014","Wikipedia indefinitely semi-protected pages","Articles with Open Directory Project links","Featured articles","Aging-associated diseases","Geriatrics","Parkinson's disease","Cytoskeletal defects","Psychiatric diagnosis"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Parkinson's_disease","wgIsProbablyEditable":false,"wgRestrictionEdit":["autoconfirmed"],"wgRestrictionMove":["autoconfirmed"],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"templateEditor":false,"templates":false,"preview":false,"previewDialog":false,"publish":false,"toc":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"isPageWatched":false,"magnifyClipIconURL":"//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png","pageLanguageCode":"en","pageLanguageDir":"ltr","svgMaxSize":2048},"wikilove-recipient":"","wikilove-anon":0,"wgGuidedTourHelpGuiderUrl":"Help:Guided tours/guider","wgFlowTermsOfUseEdit":"By saving changes, you agree to our \u003Ca class=\"external text\" href=\"//wikimediafoundation.org/wiki/Terms_of_use\"\u003ETerms of Use\u003C/a\u003E and agree to irrevocably release your text under the \u003Ca rel=\"nofollow\" class=\"external text\" href=\"//creativecommons.org/licenses/by-sa/3.0\"\u003ECC BY-SA 3.0 License\u003C/a\u003E and \u003Ca class=\"external text\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License\"\u003EGFDL\u003C/a\u003E","wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q11085"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function(){mw.user.options.set({"ccmeonemails":0,"cols":80,"date":"default","diffonly":0,"disablemail":0,"editfont":"default","editondblclick":0,"editsectiononrightclick":0,"enotifminoredits":0,"enotifrevealaddr":0,"enotifusertalkpages":1,"enotifwatchlistpages":0,"extendwatchlist":0,"fancysig":0,"forceeditsummary":0,"gender":"unknown","hideminor":0,"hidepatrolled":0,"imagesize":2,"math":0,"minordefault":0,"newpageshidepatrolled":0,"nickname":"","norollbackdiff":0,"numberheadings":0,"previewonfirst":0,"previewontop":1,"rcdays":7,"rclimit":50,"rememberpassword":0,"rows":25,"showhiddencats":false,"shownumberswatching":1,"showtoolbar":1,"skin":"vector","stubthreshold":0,"thumbsize":4,"underline":2,"uselivepreview":0,"usenewrc":0,"watchcreations":1,"watchdefault":0,"watchdeletion":0,"watchlistdays":3,"watchlisthideanons":0,"watchlisthidebots":0,"watchlisthideliu":0,"watchlisthideminor":0,"watchlisthideown":0,"watchlisthidepatrolled":0,"watchmoves":0,
"wllimit":250,"useeditwarning":1,"prefershttps":1,"flaggedrevssimpleui":1,"flaggedrevsstable":0,"flaggedrevseditdiffs":true,"flaggedrevsviewdiffs":false,"usebetatoolbar":1,"usebetatoolbar-cgd":1,"visualeditor-enable":0,"visualeditor-enable-experimental":0,"visualeditor-betatempdisable":0,"wikilove-enabled":1,"echo-subscriptions-web-page-review":true,"echo-subscriptions-email-page-review":false,"ep_showtoplink":false,"ep_bulkdelorgs":false,"ep_bulkdelcourses":true,"ep_showdyk":true,"echo-subscriptions-web-education-program":true,"echo-subscriptions-email-education-program":false,"echo-notify-show-link":true,"echo-show-alert":true,"echo-email-frequency":0,"echo-email-format":"html","echo-subscriptions-email-system":true,"echo-subscriptions-web-system":true,"echo-subscriptions-email-other":false,"echo-subscriptions-web-other":true,"echo-subscriptions-email-edit-user-talk":false,"echo-subscriptions-web-edit-user-talk":true,"echo-subscriptions-email-reverted":false,
"echo-subscriptions-web-reverted":true,"echo-subscriptions-email-article-linked":false,"echo-subscriptions-web-article-linked":false,"echo-subscriptions-email-mention":false,"echo-subscriptions-web-mention":true,"echo-subscriptions-web-edit-thank":true,"echo-subscriptions-email-edit-thank":false,"echo-subscriptions-web-flow-discussion":true,"echo-subscriptions-email-flow-discussion":false,"gettingstarted-task-toolbar-show-intro":true,"uls-preferences":"","language":"en","variant-gan":"gan","variant-iu":"iu","variant-kk":"kk","variant-ku":"ku","variant-shi":"shi","variant-sr":"sr","variant-tg":"tg","variant-uz":"uz","variant-zh":"zh","searchNs0":true,"searchNs1":false,"searchNs2":false,"searchNs3":false,"searchNs4":false,"searchNs5":false,"searchNs6":false,"searchNs7":false,"searchNs8":false,"searchNs9":false,"searchNs10":false,"searchNs11":false,"searchNs12":false,"searchNs13":false,"searchNs14":false,"searchNs15":false,"searchNs100":false,"searchNs101":false,"searchNs108":false,
"searchNs109":false,"searchNs118":false,"searchNs119":false,"searchNs446":false,"searchNs447":false,"searchNs710":false,"searchNs711":false,"searchNs828":false,"searchNs829":false,"gadget-teahouse":1,"gadget-ReferenceTooltips":1,"gadget-DRN-wizard":1,"gadget-charinsert":1,"gadget-mySandbox":1,"variant":"en"});},{},{});mw.loader.implement("user.tokens",function(){mw.user.tokens.set({"editToken":"+\\","patrolToken":false,"watchToken":false});},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:868e43d07ede2616d2d1dc3507cd8145 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","skins.vector.compactPersonalBar.defaultTracking","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","wikibase.client.init","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" /><!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.23wmf19/skins/vector/csshover.min.htc")}</style><![endif]--></head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Parkinson_s_disease skin-vector action-view vector-animateLayout">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>
			<div id="mw-js-message" style="display:none;"></div>
						<div id="siteNotice"><!-- CentralNotice --></div>
						<h1 id="firstHeading" class="firstHeading" lang="en"><span dir="auto">Parkinson's disease</span></h1>
						<div id="bodyContent">
								<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-navigation">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="dablink">"Parkinson's" redirects here. For other uses, see <a href="/wiki/Parkinson%27s_(disambiguation)" title="Parkinson's (disambiguation)">Parkinson's (disambiguation)</a>.</div>
<div class="metadata topicon nopopups" id="protected-icon" style="display:none; right:55px;"><a href="/wiki/Wikipedia:Protection_policy#semi" title="This article is semi-protected indefinitely in response to an ongoing high risk of vandalism."><img alt="Page semi-protected" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Padlock-silver.svg/20px-Padlock-silver.svg.png" width="20" height="20" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Padlock-silver.svg/30px-Padlock-silver.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Padlock-silver.svg/40px-Padlock-silver.svg.png 2x" /></a></div>
<table class="infobox" cellspacing="3" style="border-spacing:3px;width:22em;">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey;">Parkinson's disease</th>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><i>Classification and external resources</i></td>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/File:Paralysis_agitans_(1907,_after_St._Leger).png" class="image" title="Two sketches (one from the front and one from the right side) of a man, with an expressionless face. He is stooped forward and is presumably having difficulty walking."><img alt="Two sketches (one from the front and one from the right side) of a man, with an expressionless face. He is stooped forward and is presumably having difficulty walking." src="//upload.wikimedia.org/wikipedia/en/thumb/5/5d/Paralysis_agitans_%281907%2C_after_St._Leger%29.png/230px-Paralysis_agitans_%281907%2C_after_St._Leger%29.png" width="230" height="242" srcset="//upload.wikimedia.org/wikipedia/en/thumb/5/5d/Paralysis_agitans_%281907%2C_after_St._Leger%29.png/345px-Paralysis_agitans_%281907%2C_after_St._Leger%29.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/5/5d/Paralysis_agitans_%281907%2C_after_St._Leger%29.png/460px-Paralysis_agitans_%281907%2C_after_St._Leger%29.png 2x" /></a><br />
<div>Illustration of Parkinson's disease by <a href="/wiki/William_Richard_Gowers" title="William Richard Gowers" class="mw-redirect">William Richard Gowers</a>, which was first published in <i>A Manual of Diseases of the Nervous System</i> (1886)</div>
</td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_G" title="ICD-10 Chapter G" class="mw-redirect">G</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/G20">20</a>, <a href="/wiki/ICD-10_Chapter_F" title="ICD-10 Chapter F" class="mw-redirect">F</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/F02.3">02.3</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=332">332</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/168600">168600</a> <a rel="nofollow" class="external text" href="http://omim.org/entry/556500">556500</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb9651.htm">9651</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000755.htm">000755</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic304.htm">neuro/304</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic635.htm#">neuro/635</a> in young<br />
<a rel="nofollow" class="external text" href="http://www.emedicine.com/pmr/topic99.htm#">pmr/99</a> rehab</td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></th>
<td class="plainlist">
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK1223/">Parkinson Disease Overview</a></li>
</ul>
</td>
</tr>
</table>
<p><b>Parkinson's disease</b> (<b>PD</b> also known as <b>idiopathic or primary parkinsonism</b>, <b>hypokinetic rigid syndrome/HRS</b>, or <b>paralysis agitans</b>) is a <a href="/wiki/Neurodegeneration" title="Neurodegeneration">degenerative</a> disorder of the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a>. The motor symptoms of Parkinson's disease result from the death of <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>-generating cells in the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a>, a region of the <a href="/wiki/Midbrain" title="Midbrain">midbrain</a>; the cause of this cell death is unknown. Early in the course of the disease, the most obvious symptoms are <a href="/wiki/Motor_skill" title="Motor skill">movement-related</a>; these include <a href="/wiki/Tremor" title="Tremor">shaking</a>, <a href="/wiki/Spasticity" title="Spasticity">rigidity</a>, <a href="/wiki/Bradykinesia" title="Bradykinesia" class="mw-redirect">slowness of movement</a> and difficulty with walking and <a href="/wiki/Gait_(human)" title="Gait (human)">gait</a>. Later, <a href="/wiki/Cognition" title="Cognition">thinking</a> and behavioral problems may arise, with <a href="/wiki/Dementia" title="Dementia">dementia</a> commonly occurring in the advanced stages of the disease, whereas <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a> is the most common psychiatric symptom. Other symptoms include sensory, sleep and emotional problems. Parkinson's disease is more common in older people, with most cases occurring after the age of 50.</p>
<p>The main motor symptoms are collectively called <a href="/wiki/Parkinsonism" title="Parkinsonism">parkinsonism</a>, or a "parkinsonian syndrome". Parkinson's disease is often defined as a parkinsonian syndrome that is <a href="/wiki/Idiopathic" title="Idiopathic">idiopathic</a> (having no known cause), although some atypical cases have a <a href="/wiki/Genetics" title="Genetics">genetic</a> origin. Many risk and protective factors have been investigated: the clearest evidence is for an increased risk of PD in people exposed to certain pesticides and a reduced risk in tobacco smokers. The <a href="/wiki/Pathology" title="Pathology">pathology</a> of the disease is characterized by the accumulation of a protein called <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> into <a href="/wiki/Inclusion_bodies" title="Inclusion bodies">inclusions</a> called <a href="/wiki/Lewy_bodies" title="Lewy bodies" class="mw-redirect">Lewy bodies</a> in neurons, and from insufficient formation and activity of <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> produced in certain <a href="/wiki/Neuron" title="Neuron">neurons</a> within parts of the <a href="/wiki/Midbrain" title="Midbrain">midbrain</a>. Lewy bodies are the pathological hallmark of the idiopathic disorder, and the distribution of the Lewy bodies throughout the Parkinsonian brain varies from one individual to another. The anatomical distribution of the Lewy bodies is often directly related to the expression and degree of the clinical symptoms of each individual. Diagnosis of typical cases is mainly based on symptoms, with tests such as <a href="/wiki/Neuroimaging" title="Neuroimaging">neuroimaging</a> being used for confirmation.</p>
<p>Modern treatments are effective at managing the early motor symptoms of the disease, mainly through the use of <a href="/wiki/Levodopa" title="Levodopa" class="mw-redirect">levodopa</a> and <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonists</a>. As the disease progresses and dopaminergic neurons continue to be lost, these drugs eventually become ineffective at treating the symptoms and at the same time produce a complication called <a href="/wiki/Dyskinesia" title="Dyskinesia">dyskinesia</a>, marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at alleviating symptoms. Surgery and <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">deep brain stimulation</a> have been used to reduce motor symptoms as a last resort in severe cases where drugs are ineffective. Research directions include investigations into new <a href="/wiki/Animal_model" title="Animal model">animal models</a> of the disease and of the potential usefulness of gene therapy, <a href="/wiki/Stem_cell" title="Stem cell">stem cell</a> transplants and <a href="/wiki/Neuroprotective" title="Neuroprotective" class="mw-redirect">neuroprotective</a> agents. Medications to treat non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, also exist.</p>
<p>The disease is named after the English doctor <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a>, who published the first detailed description in <i>An Essay on the Shaking Palsy</i> in 1817. Several major organizations promote research and improvement of quality of life of those with the disease and their families. Public awareness campaigns include Parkinson's disease day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with parkinsonism who have increased the public's awareness include <a href="/wiki/Actor" title="Actor">actor</a> <a href="/wiki/Michael_J._Fox" title="Michael J. Fox">Michael J. Fox</a>, Olympic <a href="/wiki/Cyclist" title="Cyclist" class="mw-redirect">cyclist</a> <a href="/wiki/Davis_Phinney" title="Davis Phinney">Davis Phinney</a> and professional <a href="/wiki/Boxer" title="Boxer" class="mw-redirect">boxer</a> <a href="/wiki/Muhammad_Ali" title="Muhammad Ali">Muhammad Ali</a>.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Motor"><span class="tocnumber">2.1</span> <span class="toctext">Motor</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Neuropsychiatric"><span class="tocnumber">2.2</span> <span class="toctext">Neuropsychiatric</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Other"><span class="tocnumber">2.3</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Causes"><span class="tocnumber">3</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2 tocsection-7"><a href="#Environmental_factors"><span class="tocnumber">3.1</span> <span class="toctext">Environmental factors</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Genetics"><span class="tocnumber">3.2</span> <span class="toctext">Genetics</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-9"><a href="#Pathology"><span class="tocnumber">4</span> <span class="toctext">Pathology</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Anatomical"><span class="tocnumber">4.1</span> <span class="toctext">Anatomical</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Pathophysiology"><span class="tocnumber">4.2</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Brain_cell_death"><span class="tocnumber">4.3</span> <span class="toctext">Brain cell death</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Prevention"><span class="tocnumber">6</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Management"><span class="tocnumber">7</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Levodopa"><span class="tocnumber">7.1</span> <span class="toctext">Levodopa</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Dopamine_agonists"><span class="tocnumber">7.2</span> <span class="toctext">Dopamine agonists</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#MAO-B_inhibitors"><span class="tocnumber">7.3</span> <span class="toctext">MAO-B inhibitors</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Other_drugs"><span class="tocnumber">7.4</span> <span class="toctext">Other drugs</span></a></li>
<li class="toclevel-2 tocsection-20"><a href="#Surgery"><span class="tocnumber">7.5</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Rehabilitation"><span class="tocnumber">7.6</span> <span class="toctext">Rehabilitation</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Palliative_care"><span class="tocnumber">7.7</span> <span class="toctext">Palliative care</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Other_treatments"><span class="tocnumber">7.8</span> <span class="toctext">Other treatments</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-24"><a href="#Prognosis"><span class="tocnumber">8</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-25"><a href="#Epidemiology"><span class="tocnumber">9</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-26"><a href="#History"><span class="tocnumber">10</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-27"><a href="#Society_and_culture"><span class="tocnumber">11</span> <span class="toctext">Society and culture</span></a>
<ul>
<li class="toclevel-2 tocsection-28"><a href="#Cost"><span class="tocnumber">11.1</span> <span class="toctext">Cost</span></a></li>
<li class="toclevel-2 tocsection-29"><a href="#Advocacy"><span class="tocnumber">11.2</span> <span class="toctext">Advocacy</span></a></li>
<li class="toclevel-2 tocsection-30"><a href="#Notable_cases"><span class="tocnumber">11.3</span> <span class="toctext">Notable cases</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-31"><a href="#Research"><span class="tocnumber">12</span> <span class="toctext">Research</span></a>
<ul>
<li class="toclevel-2 tocsection-32"><a href="#Animal_models"><span class="tocnumber">12.1</span> <span class="toctext">Animal models</span></a></li>
<li class="toclevel-2 tocsection-33"><a href="#Gene_therapy"><span class="tocnumber">12.2</span> <span class="toctext">Gene therapy</span></a></li>
<li class="toclevel-2 tocsection-34"><a href="#Neuroprotective_treatments"><span class="tocnumber">12.3</span> <span class="toctext">Neuroprotective treatments</span></a></li>
<li class="toclevel-2 tocsection-35"><a href="#Neural_transplantation"><span class="tocnumber">12.4</span> <span class="toctext">Neural transplantation</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-36"><a href="#References"><span class="tocnumber">13</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-37"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Classification">Classification</span></h2>
<p>The term <a href="/wiki/Parkinsonism" title="Parkinsonism">parkinsonism</a> is used for a motor <a href="/wiki/Syndrome" title="Syndrome">syndrome</a> whose main symptoms are tremor at rest, stiffness, slowing of movement and postural instability. Parkinsonian syndromes can be divided into four subtypes according to their origin: primary or <a href="/wiki/Idiopathic" title="Idiopathic">idiopathic</a>, secondary or acquired, hereditary parkinsonism, and <a href="/wiki/Parkinson_plus_syndrome" title="Parkinson plus syndrome">parkinson plus syndromes</a> or multiple system degeneration.<sup id="cite_ref-Jankovic2008_1-0" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Parkinson's disease is the most common form of parkinsonism and is usually defined as "primary" parkinsonism, meaning parkinsonism with no external identifiable cause.<sup id="cite_ref-pmid15172778_2-0" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Jankovic_book-Epidemiology_3-0" class="reference"><a href="#cite_note-Jankovic_book-Epidemiology-3"><span>[</span>3<span>]</span></a></sup> In recent years several genes that are directly related to some cases of Parkinson's disease have been discovered. As much as this conflicts with the definition of Parkinson's disease as an idiopathic illness, genetic parkinsonism disorders with a similar clinical course to PD are generally included under the Parkinson's disease label. The terms "familial Parkinson's disease" and "sporadic Parkinson's disease" can be used to differentiate genetic from truly idiopathic forms of the disease.<sup id="cite_ref-pmid18398010_4-0" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Usually classified as a <a href="/wiki/Movement_disorder" title="Movement disorder">movement disorder</a>, PD also gives rise to several non-motor types of symptoms such as sensory deficits,<sup id="cite_ref-pmid20206672_5-0" class="reference"><a href="#cite_note-pmid20206672-5"><span>[</span>5<span>]</span></a></sup> cognitive difficulties or sleep problems. <a href="/wiki/Parkinson_plus_syndrome" title="Parkinson plus syndrome">Parkinson plus diseases</a> are primary parkinsonisms which present additional features.<sup id="cite_ref-pmid15172778_2-1" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> They include <a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">multiple system atrophy</a>, <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">progressive supranuclear palsy</a>, <a href="/wiki/Corticobasal_degeneration" title="Corticobasal degeneration">corticobasal degeneration</a> and <a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">dementia with Lewy bodies</a>.<sup id="cite_ref-pmid15172778_2-2" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-pmid20506312_6-0" class="reference"><a href="#cite_note-pmid20506312-6"><span>[</span>6<span>]</span></a></sup></p>
<p>In terms of <a href="/wiki/Pathophysiology" title="Pathophysiology">pathophysiology</a>, PD is considered a <a href="/wiki/Synuclein" title="Synuclein">synucleinopathy</a> due to an abnormal accumulation of <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> protein in the brain in the form of <a href="/wiki/Lewy_body" title="Lewy body">Lewy bodies</a>, as opposed to other diseases such as <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a> where the brain accumulates <a href="/wiki/Tau_protein" title="Tau protein">tau protein</a> in the form of <a href="/wiki/Neurofibrillary_tangle" title="Neurofibrillary tangle">neurofibrillary tangles</a>.<sup id="cite_ref-pmid16489609_7-0" class="reference"><a href="#cite_note-pmid16489609-7"><span>[</span>7<span>]</span></a></sup> Nevertheless, there is clinical and pathological overlap between <a href="/wiki/Tauopathy" title="Tauopathy">tauopathies</a> and synucleinopathies. The most typical symptom of Alzheimer's disease, <a href="/wiki/Dementia" title="Dementia">dementia</a>, occurs in advanced stages of PD, while it is common to find neurofibrillary tangles in brains affected by PD.<sup id="cite_ref-pmid16489609_7-1" class="reference"><a href="#cite_note-pmid16489609-7"><span>[</span>7<span>]</span></a></sup></p>
<p>Dementia with Lewy bodies (DLB) is another synucleinopathy that has similarities with PD, and especially with the subset of PD cases with dementia. However the relationship between PD and DLB is complex and still has to be clarified.<sup id="cite_ref-pmid19173762_8-0" class="reference"><a href="#cite_note-pmid19173762-8"><span>[</span>8<span>]</span></a></sup> They may represent parts of a continuum or they may be separate diseases.<sup id="cite_ref-pmid19173762_8-1" class="reference"><a href="#cite_note-pmid19173762-8"><span>[</span>8<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg" class="image"><img alt="Black and white picture of male with PD stooping forward as he walks. He is viewed from the left side and there is a chair behind him." src="//upload.wikimedia.org/wikipedia/commons/thumb/8/88/Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg/220px-Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg" width="220" height="325" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/88/Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg/330px-Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/88/Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg/440px-Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A man with Parkinson's disease displaying a flexed walking posture pictured in 1892. Photo appeared in <i>Nouvelle Iconographie de la Salpètrière</i>, vol. 5.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Writing_by_a_Parkinson%27s_disease_patient.png" class="image"><img alt="First line of text is &quot;Catherine Metzger&quot; Second line of text is &quot;13 Octobre 1869&quot; (13 October 1869; in French)." src="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Writing_by_a_Parkinson%27s_disease_patient.png/220px-Writing_by_a_Parkinson%27s_disease_patient.png" width="220" height="85" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Writing_by_a_Parkinson%27s_disease_patient.png/330px-Writing_by_a_Parkinson%27s_disease_patient.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/91/Writing_by_a_Parkinson%27s_disease_patient.png/440px-Writing_by_a_Parkinson%27s_disease_patient.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Writing_by_a_Parkinson%27s_disease_patient.png" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Handwriting of a person affected by PD in <i>Lectures on the diseases of the nervous system</i> by Charcot (1879). The original description of the text states "The strokes forming the letters are very irregular and sinuous, whilst the irregularities and sinuosities are of a very limited width. (...) the down-strokes are all, with the exception of the first letter, made with comparative firmness and are, in fact, nearly normal — the finer up-strokes, on the contrary, are all tremulous in appearance (...)."</div>
</div>
</div>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/Signs_and_symptoms_of_Parkinson%27s_disease" title="Signs and symptoms of Parkinson's disease">Signs and symptoms of Parkinson's disease</a></div>
<p>Parkinson's disease affects movement, producing motor symptoms.<sup id="cite_ref-Jankovic2008_1-1" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Non-motor symptoms, which include <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic dysfunction</a>, <a href="/wiki/Neuropsychiatry" title="Neuropsychiatry">neuropsychiatric</a> problems (mood, cognition, behavior or thought alterations), and sensory and sleep difficulties, are also common. Some of these non-motor symptoms are often present at the time of diagnosis and can precede motor symptoms.<sup id="cite_ref-Jankovic2008_1-2" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Motor">Motor</span></h3>
<div class="rellink boilerplate further">Further information: <a href="/wiki/Parkinsonian_gait" title="Parkinsonian gait">Parkinsonian gait</a></div>
<p>Four motor symptoms are considered <a href="/wiki/Cardinal_sign_(pathology)" title="Cardinal sign (pathology)">cardinal</a> in PD: tremor, rigidity, slowness of movement, and postural instability.<sup id="cite_ref-Jankovic2008_1-3" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup></p>
<p><a href="/wiki/Tremor" title="Tremor">Tremor</a> is the most apparent and well-known symptom.<sup id="cite_ref-Jankovic2008_1-4" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> It is the most common; though around 30% of individuals with PD do not have tremor at disease onset, most develop it as the disease progresses.<sup id="cite_ref-Jankovic2008_1-5" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> It is usually a rest tremor: maximal when the limb is at rest and disappearing with voluntary movement and sleep.<sup id="cite_ref-Jankovic2008_1-6" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> It affects to a greater extent the most <a href="/wiki/Anatomical_terms_of_location#Proximal_and_distal" title="Anatomical terms of location">distal</a> part of the limb and at onset typically appears in only a single arm or leg, becoming bilateral later.<sup id="cite_ref-Jankovic2008_1-7" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Frequency of PD tremor is between 4 and 6 <a href="/wiki/Hertz" title="Hertz">hertz</a> (cycles per second). A feature of tremor is <i>pill-rolling</i>, the tendency of the index finger of the hand to get into contact with the thumb and perform together a circular movement.<sup id="cite_ref-Jankovic2008_1-8" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Cooper_9-0" class="reference"><a href="#cite_note-Cooper-9"><span>[</span>9<span>]</span></a></sup> The term derives from the similarity between the movement in people with PD and the earlier pharmaceutical technique of manually making pills.<sup id="cite_ref-Cooper_9-1" class="reference"><a href="#cite_note-Cooper-9"><span>[</span>9<span>]</span></a></sup></p>
<p><a href="/wiki/Bradykinesia" title="Bradykinesia" class="mw-redirect">Bradykinesia</a> (slowness of movement) is another characteristic feature of PD, and is associated with difficulties along the whole course of the movement process, from planning to initiation and finally execution of a movement.<sup id="cite_ref-Jankovic2008_1-9" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Performance of sequential and simultaneous movement is hindered.<sup id="cite_ref-Jankovic2008_1-10" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Bradykinesia is commonly a very disabling symptom in the early stages of the disease.<sup id="cite_ref-pmid15172778_2-3" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> Initial manifestations are problems when performing daily tasks which require fine motor control such as writing, sewing or getting dressed.<sup id="cite_ref-Jankovic2008_1-11" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Clinical evaluation is based in similar tasks such as alternating movements between both hands or both feet.<sup id="cite_ref-pmid15172778_2-4" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> Bradykinesia is not equal for all movements or times. It is modified by the activity or emotional state of the subject, to the point that some people are barely able to walk yet can still ride a bicycle.<sup id="cite_ref-Jankovic2008_1-12" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Generally people with PD have less difficulty when some sort of external cue is provided.<sup id="cite_ref-Jankovic2008_1-13" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid19909911_10-0" class="reference"><a href="#cite_note-pmid19909911-10"><span>[</span>10<span>]</span></a></sup></p>
<p><a href="/wiki/Hypokinesia" title="Hypokinesia">Rigidity</a> is stiffness and resistance to limb movement caused by increased <a href="/wiki/Muscle_tone" title="Muscle tone">muscle tone</a>, an excessive and continuous contraction of muscles.<sup id="cite_ref-Jankovic2008_1-14" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> In parkinsonism the rigidity can be uniform (lead-pipe rigidity) or ratchety (cogwheel rigidity).<sup id="cite_ref-Jankovic2008_1-15" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid15172778_2-5" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Banich_11-0" class="reference"><a href="#cite_note-Banich-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> The combination of tremor and increased tone is considered to be at the origin of cogwheel rigidity.<sup id="cite_ref-Jankovic_book-Rigidity_13-0" class="reference"><a href="#cite_note-Jankovic_book-Rigidity-13"><span>[</span>13<span>]</span></a></sup> Rigidity may be associated with joint pain; such pain being a frequent initial manifestation of the disease.<sup id="cite_ref-Jankovic2008_1-16" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> In early stages of Parkinson's disease, rigidity is often asymmetrical and it tends to affect the neck and shoulder muscles prior to the muscles of the face and extremities.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> With the progression of the disease, rigidity typically affects the whole body and reduces the ability to move.</p>
<p><a href="/wiki/Postural_instability" title="Postural instability" class="mw-redirect">Postural instability</a> is typical in the late stages of the disease, leading to <a href="/wiki/Balance_disorder" title="Balance disorder">impaired balance</a> and frequent falls,<sup id="cite_ref-OFP_15-0" class="reference"><a href="#cite_note-OFP-15"><span>[</span>15<span>]</span></a></sup> and secondarily to bone fractures.<sup id="cite_ref-Jankovic2008_1-17" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Instability is often absent in the initial stages, especially in younger people.<sup id="cite_ref-pmid15172778_2-6" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> Up to 40% may experience falls and around 10% may have falls weekly, with number of falls being related to the severity of PD.<sup id="cite_ref-Jankovic2008_1-18" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Other recognized motor signs and symptoms include gait and posture disturbances such as <a href="/wiki/Parkinsonian_gait" title="Parkinsonian gait">festination</a> (rapid shuffling steps and a <a href="/wiki/Camptocormia" title="Camptocormia">forward-flexed posture</a> when walking),<sup id="cite_ref-Jankovic2008_1-19" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> speech and swallowing disturbances including <a href="/wiki/Dysphonia" title="Dysphonia">voice disorders</a>,<sup id="cite_ref-pmid20233583_16-0" class="reference"><a href="#cite_note-pmid20233583-16"><span>[</span>16<span>]</span></a></sup> <a href="/wiki/Hypomimia" title="Hypomimia">mask-like face expression</a> or <a href="/wiki/Micrographia_(handwriting)" title="Micrographia (handwriting)">small handwriting</a>, although the range of possible motor problems that can appear is large.<sup id="cite_ref-Jankovic2008_1-20" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Neuropsychiatric">Neuropsychiatric</span></h3>
<p>Parkinson's disease can cause <a href="/wiki/Neuropsychiatry" title="Neuropsychiatry">neuropsychiatric</a> disturbances which can range from mild to severe. This includes disorders of speech, cognition, mood, behaviour, and thought.<sup id="cite_ref-Jankovic2008_1-21" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Cognitive disturbances can occur in the initial stages of the disease and sometimes prior to diagnosis, and increase in prevalence with duration of the disease.<sup id="cite_ref-Jankovic2008_1-22" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid18175397_17-0" class="reference"><a href="#cite_note-pmid18175397-17"><span>[</span>17<span>]</span></a></sup> The most common cognitive deficit in affected individuals is <a href="/wiki/Executive_dysfunction" title="Executive dysfunction">executive dysfunction</a>, which can include problems with planning, cognitive flexibility, abstract thinking, rule acquisition, initiating appropriate actions and inhibiting inappropriate actions, and selecting relevant sensory information. Fluctuations in <a href="/wiki/Attention" title="Attention">attention</a> and <a href="/wiki/Bradyphrenia" title="Bradyphrenia">slowed cognitive speed</a> are among other cognitive difficulties. Memory is affected, specifically in <a href="/wiki/Recall_(memory)" title="Recall (memory)">recalling</a> learned information. Nevertheless, improvement appears when recall is aided by cues. Visuospatial difficulties are also part of the disease, seen for example when the individual is asked to perform tests of facial recognition and perception of the orientation of drawn lines.<sup id="cite_ref-pmid18175397_17-1" class="reference"><a href="#cite_note-pmid18175397-17"><span>[</span>17<span>]</span></a></sup></p>
<p>A person with PD has two to six times the risk of dementia compared to the general population.<sup id="cite_ref-Jankovic2008_1-23" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid18175397_17-2" class="reference"><a href="#cite_note-pmid18175397-17"><span>[</span>17<span>]</span></a></sup> The prevalence of dementia increases with duration of the disease.<sup id="cite_ref-pmid18175397_17-3" class="reference"><a href="#cite_note-pmid18175397-17"><span>[</span>17<span>]</span></a></sup> Dementia is associated with a reduced <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a> in people with PD and their <a href="/wiki/Caregiver" title="Caregiver">caregivers</a>, increased mortality, and a higher probability of needing nursing home care.<sup id="cite_ref-pmid18175397_17-4" class="reference"><a href="#cite_note-pmid18175397-17"><span>[</span>17<span>]</span></a></sup></p>
<p>Behavior and mood alterations are more common in PD without cognitive impairment than in the general population, and are usually present in PD with dementia. The most frequent mood difficulties are <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a>, <a href="/wiki/Apathy" title="Apathy">apathy</a> and <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>.<sup id="cite_ref-Jankovic2008_1-24" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Establishing the diagnosis of depression is complicated by symptoms that often occur in Parkinson's including dementia, decreased facial expression, <a href="/wiki/Bradykinesia" title="Bradykinesia" class="mw-redirect">decreased movement</a>, <a href="/wiki/Apathy" title="Apathy">a state of indifference</a>, and <a href="/wiki/Hypophonia" title="Hypophonia">quiet speech</a>.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> <a href="/wiki/Impulse_control_disorders" title="Impulse control disorders" class="mw-redirect">Impulse control</a> behaviors such as <a href="/wiki/Dopamine_dysregulation_syndrome" title="Dopamine dysregulation syndrome">medication overuse and craving</a>, <a href="/wiki/Binge_eating" title="Binge eating">binge eating</a>, <a href="/wiki/Hypersexuality" title="Hypersexuality">hypersexuality</a>, or <a href="/wiki/Pathological_gambling" title="Pathological gambling" class="mw-redirect">pathological gambling</a> can appear in PD and have been related to the medications used to manage the disease.<sup id="cite_ref-Jankovic2008_1-25" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid20123548_19-0" class="reference"><a href="#cite_note-pmid20123548-19"><span>[</span>19<span>]</span></a></sup> <a href="/wiki/Psychosis" title="Psychosis">Psychotic</a> symptoms—<a href="/wiki/Hallucination" title="Hallucination">hallucinations</a> or <a href="/wiki/Delusion" title="Delusion">delusions</a>—occur in 4% of people with PD, and it is assumed that the main precipitant of psychotic phenomena in Parkinson’s disease is dopaminergic excess secondary to treatment; it therefore becomes more common with increasing age and levodopa intake.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-pmid20538500_21-0" class="reference"><a href="#cite_note-pmid20538500-21"><span>[</span>21<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other">Other</span></h3>
<p>In addition to cognitive and motor symptoms, PD can impair other body functions. Sleep problems are a feature of the disease and can be worsened by medications.<sup id="cite_ref-Jankovic2008_1-26" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Symptoms can manifest as daytime <a href="/wiki/Somnolence" title="Somnolence">drowsiness</a>, disturbances in <a href="/wiki/Rapid_eye_movement_sleep" title="Rapid eye movement sleep">REM</a> sleep, or <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>.<sup id="cite_ref-Jankovic2008_1-27" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Alterations in the <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic nervous system</a> can lead to <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">orthostatic hypotension</a> (low blood pressure upon standing), oily skin and excessive sweating, <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary incontinence</a> and altered sexual function.<sup id="cite_ref-Jankovic2008_1-28" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> <a href="/wiki/Constipation" title="Constipation">Constipation</a> and <a href="/wiki/Gastrointestinal_dysmotility" title="Gastrointestinal dysmotility" class="mw-redirect">gastric dysmotility</a> can be severe enough to cause discomfort and even endanger health.<sup id="cite_ref-pmid19691125_22-0" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup> PD is related to several eye and vision abnormalities such as decreased <a href="/wiki/Blink" title="Blink">blink</a> rate, <a href="/wiki/Dry_eye" title="Dry eye" class="mw-redirect">dry eyes</a>, deficient <a href="/wiki/Smooth_pursuit" title="Smooth pursuit">ocular pursuit</a> (eye tracking) and <a href="/wiki/Saccade" title="Saccade">saccadic movements</a> (fast automatic movements of both eyes in the same direction), difficulties in directing gaze upward, and <a href="/wiki/Blurred_vision" title="Blurred vision">blurred</a> or <a href="/wiki/Double_vision" title="Double vision" class="mw-redirect">double vision</a>.<sup id="cite_ref-Jankovic2008_1-29" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid18271776_23-0" class="reference"><a href="#cite_note-pmid18271776-23"><span>[</span>23<span>]</span></a></sup> Changes in perception may include an impaired sense of <a href="/wiki/Olfaction" title="Olfaction">smell</a>, sensation of pain and <a href="/wiki/Paresthesia" title="Paresthesia">paresthesia</a> (skin tingling and numbness).<sup id="cite_ref-Jankovic2008_1-30" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> All of these symptoms can occur years before diagnosis of the disease.<sup id="cite_ref-Jankovic2008_1-31" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Causes">Causes</span></h2>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/Causes_of_Parkinson%27s_disease" title="Causes of Parkinson's disease">Causes of Parkinson's disease</a></div>
<p>Parkinson's disease in most people is <a href="/wiki/Idiopathic" title="Idiopathic">idiopathic</a> (having no specific known cause). However a small proportion of cases, can be attributed to known genetic factors. Other factors have been associated with the risk of developing PD, but no causal relationships have been proven.</p>
<h3><span class="mw-headline" id="Environmental_factors">Environmental factors</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg/220px-US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg" width="220" height="150" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg/330px-US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1f/US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg/440px-US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:US-Huey-helicopter-spraying-Agent-Orange-in-Vietnam.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
U.S. Army helicopter spraying <a href="/wiki/Agent_Orange" title="Agent Orange">Agent Orange</a> over Vietnamese agricultural land during the <a href="/wiki/Vietnam_war" title="Vietnam war" class="mw-redirect">Vietnam war</a>.</div>
</div>
</div>
<p>A number of environmental factors have been associated with an increased risk of Parkinson's including: pesticide exposure, head injuries, and living in the country or farming.<sup id="cite_ref-Noy2012_24-0" class="reference"><a href="#cite_note-Noy2012-24"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup> Rural environments and the drinking of well water may be risks as they are an indirect measures of exposure to pesticides.<sup id="cite_ref-pmid16713924_26-0" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-Veterans_27-0" class="reference"><a href="#cite_note-Veterans-27"><span>[</span>27<span>]</span></a></sup></p>
<p>Implicated agents include <a href="/wiki/Insecticides" title="Insecticides" class="mw-redirect">insecticides</a>, primarily <a href="/wiki/Chlorpyrifos" title="Chlorpyrifos">chlorpyrifos</a> and <a href="/wiki/Organochlorines" title="Organochlorines" class="mw-redirect">organochlorines</a><sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup> and <a href="/wiki/Pesticide" title="Pesticide">pesticides</a>, such as <a href="/wiki/Rotenone" title="Rotenone">rotenone</a> or <a href="/wiki/Paraquat" title="Paraquat">paraquat</a>, and <a href="/wiki/Herbicide" title="Herbicide">herbicides</a>, such as <a href="/wiki/Agent_Orange" title="Agent Orange">Agent Orange</a>.<sup id="cite_ref-pmid16713924_26-1" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-Veterans_27-1" class="reference"><a href="#cite_note-Veterans-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup> <a href="/wiki/Heavy_metal_(chemistry)" title="Heavy metal (chemistry)">Heavy metals</a> exposure has been proposed to be a risk factor, through possible accumulation in the substantia nigra; however, studies on the issue have been inconclusive.<sup id="cite_ref-pmid16713924_26-2" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Genetics">Genetics</span></h3>
<div class="thumb tleft">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Protein_PARK2_PDB_1iyf.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Protein_PARK2_PDB_1iyf.png/220px-Protein_PARK2_PDB_1iyf.png" width="220" height="136" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Protein_PARK2_PDB_1iyf.png/330px-Protein_PARK2_PDB_1iyf.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Protein_PARK2_PDB_1iyf.png/440px-Protein_PARK2_PDB_1iyf.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Protein_PARK2_PDB_1iyf.png" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB</a> rendering of <a href="/wiki/Parkin_(ligase)" title="Parkin (ligase)">Parkin (ligase)</a></div>
</div>
</div>
<p>PD traditionally has been considered a non-genetic disorder; however, around 15% of individuals with PD have a first-degree relative who has the disease.<sup id="cite_ref-pmid15172778_2-7" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> At least 5% of people are now known to have forms of the disease that occur because of a mutation of one of several specific genes.<sup id="cite_ref-lesage_30-0" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup></p>
<p>Mutations in specific genes have been conclusively shown to cause PD. These genes code for <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> (SNCA), <a href="/wiki/Parkin_(ligase)" title="Parkin (ligase)">parkin</a> (PRKN), leucine-rich repeat kinase 2 (<a href="/wiki/LRRK2" title="LRRK2">LRRK2</a> or dardarin), PTEN-induced putative kinase 1 (<a href="/wiki/PINK1" title="PINK1">PINK1</a>), <a href="/wiki/PARK7" title="PARK7">DJ-1</a> and <a href="/wiki/ATP13A2" title="ATP13A2">ATP13A2</a>.<sup id="cite_ref-pmid18398010_4-1" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-lesage_30-1" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup> In most cases, people with these mutations will develop PD. With the exception of LRRK2, however, they account for only a small minority of cases of PD.<sup id="cite_ref-pmid18398010_4-2" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup> The most extensively studied PD-related genes are SNCA and LRRK2. Mutations in genes including SNCA, LRRK2 and <a href="/wiki/Glucocerebrosidase" title="Glucocerebrosidase">glucocerebrosidase</a> (GBA) have been found to be risk factors for sporadic PD. Mutations in GBA are known to cause <a href="/wiki/Gaucher%27s_disease" title="Gaucher's disease">Gaucher's disease</a>.<sup id="cite_ref-lesage_30-2" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup> <a href="/wiki/Genome-wide_association_study" title="Genome-wide association study">Genome-wide association studies</a>, which search for mutated <a href="/wiki/Allele" title="Allele">alleles</a> with low penetrance in sporadic cases, have now yielded many positive results.<sup id="cite_ref-IPDGC_31-0" class="reference"><a href="#cite_note-IPDGC-31"><span>[</span>31<span>]</span></a></sup></p>
<p>The role of the SNCA gene is important in PD because the alpha-synuclein protein is the main component of <a href="/wiki/Lewy_body" title="Lewy body">Lewy bodies</a>.<sup id="cite_ref-lesage_30-3" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup> <a href="/wiki/Missense_mutation" title="Missense mutation">Missense mutations</a> of the gene (in which a single <a href="/wiki/Nucleotide" title="Nucleotide">nucleotide</a> is changed), and <a href="/wiki/Gene_duplication" title="Gene duplication">duplications</a> and triplications of the <a href="/wiki/Locus_(genetics)" title="Locus (genetics)">locus</a> containing it have been found in different groups with familial PD.<sup id="cite_ref-lesage_30-4" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup> Missense mutations are rare.<sup id="cite_ref-lesage_30-5" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup> On the other hand, multiplications of the SNCA locus account for around 2% of familial cases.<sup id="cite_ref-lesage_30-6" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup> Multiplications have been found in <a href="/wiki/Asymptomatic_carrier" title="Asymptomatic carrier">asymptomatic carriers</a>, which indicate that <a href="/wiki/Penetrance" title="Penetrance">penetrance</a> is incomplete or age-dependent.<sup id="cite_ref-lesage_30-7" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup></p>
<p>The LRRK2 gene (PARK8) encodes for a protein called <a href="/wiki/Dardarin" title="Dardarin" class="mw-redirect">dardarin</a>. The name dardarin was taken from a <a href="/wiki/Basque_language" title="Basque language">Basque</a> word for tremor, because this gene was first identified in families from England and the north of Spain.<sup id="cite_ref-pmid18398010_4-3" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup> Mutations in LRRK2 are the most common known cause of familial and sporadic PD, accounting for approximately 5% of individuals with a family history of the disease and 3% of sporadic cases.<sup id="cite_ref-pmid18398010_4-4" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-lesage_30-8" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup> There are many different mutations described in LRRK2, however unequivocal proof of causation only exists for a small number.<sup id="cite_ref-lesage_30-9" class="reference"><a href="#cite_note-lesage-30"><span>[</span>30<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathology">Pathology</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Lewy_Body_alphaSynuclein.jpg" class="image"><img alt="Several brain cells stained in blue. The largest one, a neurone, with an approximately circular form, has a brown circular body inside it. The brown body is about 40% the diameter of the cell in which it appears." src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Lewy_Body_alphaSynuclein.jpg/220px-Lewy_Body_alphaSynuclein.jpg" width="220" height="182" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Lewy_Body_alphaSynuclein.jpg/330px-Lewy_Body_alphaSynuclein.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Lewy_Body_alphaSynuclein.jpg/440px-Lewy_Body_alphaSynuclein.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Lewy_Body_alphaSynuclein.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A <a href="/wiki/Lewy_body" title="Lewy body">Lewy body</a> (stained brown) in a brain cell of the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> in Parkinson's disease. The brown colour is positive <a href="/wiki/Immunohistochemistry" title="Immunohistochemistry">immunohistochemistry</a> staining for <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a>.</div>
</div>
</div>
<h3><span class="mw-headline" id="Anatomical">Anatomical</span></h3>
<p>The <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, a group of "brain structures" <a href="//en.wiktionary.org/wiki/innervated" class="extiw" title="wikt:innervated">innervated</a> by the dopaminergic system, are the most seriously affected brain areas in PD.<sup id="cite_ref-pmid18781672_32-0" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup> The main <a href="/wiki/Pathology" title="Pathology">pathological</a> characteristic of PD is cell death in the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> and, more specifically, the ventral (front) part of the <a href="/wiki/Pars_compacta" title="Pars compacta" class="mw-redirect">pars compacta</a>, affecting up to 70% of the cells by the time death occurs.<sup id="cite_ref-pmid18398010_4-5" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup></p>
<p><a href="/wiki/Macroscopic" title="Macroscopic" class="mw-redirect">Macroscopic</a> alterations can be noticed on cut surfaces of the brainstem, where neuronal loss can be inferred from a reduction of <a href="/wiki/Melanin" title="Melanin">melanin</a> pigmentation in the substantia nigra and <a href="/wiki/Locus_coeruleus" title="Locus coeruleus">locus coeruleus</a>.<sup id="cite_ref-Jankovic_book-Neuropathology_33-0" class="reference"><a href="#cite_note-Jankovic_book-Neuropathology-33"><span>[</span>33<span>]</span></a></sup> The <a href="/wiki/Histopathology" title="Histopathology">histopathology</a> (microscopic anatomy) of the substantia nigra and several other brain regions shows <a href="/wiki/Neuron" title="Neuron">neuronal</a> loss and <a href="/wiki/Lewy_body" title="Lewy body">Lewy bodies</a> in many of the remaining nerve cells. Neuronal loss is accompanied by death of <a href="/wiki/Astrocytes" title="Astrocytes" class="mw-redirect">astrocytes</a> (star-shaped <a href="/wiki/Neuroglia" title="Neuroglia">glial</a> cells) and activation of the <a href="/wiki/Microglia" title="Microglia">microglia</a> (another type of glial cell). Lewy bodies are a key pathological feature of PD.<sup id="cite_ref-Jankovic_book-Neuropathology_33-1" class="reference"><a href="#cite_note-Jankovic_book-Neuropathology-33"><span>[</span>33<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Pathophysiology">Pathophysiology</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Journal.pone.0008247.g001.png" class="image"><img alt="Composite of three images, one in top row (referred to in caption as A), two in second row (referred to as B). Top shows a mid-line sagittal plane of the brainstem and cerebellum. There are three circles superimposed along the brainstem and an arrow linking them from bottom to top and continuing upward and forward towards the frontal lobes of the brain. A line of text accompanies each circle: lower is &quot;1. Dorsal Motor X Nucleus&quot;, middle is &quot;2. Gain Setting Nuclei&quot; and upper is &quot;3. Substantia Nigra/Amygdala&quot;. A fourth line of text above the others says &quot;4. ...&quot;. The two images at the bottom of the composite are magnetic resonance imaging (MRI) scans, one saggital and the other transverse, centred at the same brain coordinates (x=-1, y=-36, z=-49). A colored blob marking volume reduction covers most of the brainstem." src="//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Journal.pone.0008247.g001.png/220px-Journal.pone.0008247.g001.png" width="220" height="210" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Journal.pone.0008247.g001.png/330px-Journal.pone.0008247.g001.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Journal.pone.0008247.g001.png/440px-Journal.pone.0008247.g001.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Journal.pone.0008247.g001.png" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A. Schematic initial progression of Lewy body deposits in the first stages of Parkinson's disease, as proposed by Braak and colleagues<br />
B. Localization of the area of significant brain <a href="/wiki/Voxel-based_morphometry" title="Voxel-based morphometry">volume reduction</a> in initial PD compared with a group of participants without the disease in a neuroimaging study, which concluded that <a href="/wiki/Brain_stem" title="Brain stem" class="mw-redirect">brain stem</a> damage may be the first identifiable stage of PD <a href="/wiki/Neuropathology" title="Neuropathology">neuropathology</a><sup id="cite_ref-pmid20011063_34-0" class="reference"><a href="#cite_note-pmid20011063-34"><span>[</span>34<span>]</span></a></sup></div>
</div>
</div>
<p>The primary symptoms of Parkinson's disease result from greatly reduced activity of <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>-secreting cells caused by cell death in the <a href="/wiki/Pars_compacta" title="Pars compacta" class="mw-redirect">pars compacta</a> region of the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a>.<sup id="cite_ref-pmid18781672_32-1" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup></p>
<p>There are five major pathways in the brain connecting other brain areas with the basal ganglia. These are known as the motor, oculo-motor, associative, <a href="/wiki/Limbic_system" title="Limbic system">limbic</a> and <a href="/wiki/Orbitofrontal" title="Orbitofrontal" class="mw-redirect">orbitofrontal</a> circuits, with names indicating the main projection area of each circuit.<sup id="cite_ref-pmid18781672_32-2" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup> All of them are affected in PD, and their disruption explains many of the symptoms of the disease since these circuits are involved in a wide variety of functions including movement, attention and learning.<sup id="cite_ref-pmid18781672_32-3" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup> Scientifically, the motor circuit has been examined the most intensively.<sup id="cite_ref-pmid18781672_32-4" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup></p>
<p>A particular conceptual model of the motor circuit and its alteration with PD has been of great influence since 1980, although some limitations have been pointed out which have led to modifications.<sup id="cite_ref-pmid18781672_32-5" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup> In this model, the basal ganglia normally exert a constant inhibitory influence on a wide range of motor systems, preventing them from becoming active at inappropriate times. When a decision is made to perform a particular action, inhibition is reduced for the required motor system, thereby releasing it for activation. Dopamine acts to facilitate this release of inhibition, so high levels of dopamine function tend to promote motor activity, while low levels of dopamine function, such as occur in PD, demand greater exertions of effort for any given movement. Thus the net effect of dopamine depletion is to produce <a href="/wiki/Hypokinesia" title="Hypokinesia">hypokinesia</a>, an overall reduction in motor output.<sup id="cite_ref-pmid18781672_32-6" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup> Drugs that are used to treat PD, conversely, may produce excessive dopamine activity, allowing motor systems to be activated at inappropriate times and thereby producing <a href="/wiki/Dyskinesia" title="Dyskinesia">dyskinesias</a>.<sup id="cite_ref-pmid18781672_32-7" class="reference"><a href="#cite_note-pmid18781672-32"><span>[</span>32<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Brain_cell_death">Brain cell death</span></h3>
<p>There is speculation of several mechanisms by which the brain cells could be lost.<sup id="cite_ref-pmid20495568_35-0" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> One mechanism consists of an abnormal accumulation of the protein <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> bound to <a href="/wiki/Ubiquitin" title="Ubiquitin">ubiquitin</a> in the damaged cells. This insoluble <a href="/wiki/Protein" title="Protein">protein</a> accumulates inside neurones forming inclusions called <a href="/wiki/Lewy_bodies" title="Lewy bodies" class="mw-redirect">Lewy bodies</a>.<sup id="cite_ref-pmid18398010_4-6" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-pmid20563819_36-0" class="reference"><a href="#cite_note-pmid20563819-36"><span>[</span>36<span>]</span></a></sup> According to the <a href="/wiki/Braak_staging" title="Braak staging">Braak staging</a>, a classification of the disease based on pathological findings, Lewy bodies first appear in the <a href="/wiki/Olfactory_bulb" title="Olfactory bulb">olfactory bulb</a>, <a href="/wiki/Medulla_oblongata" title="Medulla oblongata">medulla oblongata</a> and <a href="/wiki/Pontine_tegmentum" title="Pontine tegmentum">pontine tegmentum</a>, with individuals at this stage being asymptomatic. As the disease progresses, Lewy bodies later develop in the substantia nigra, areas of the <a href="/wiki/Midbrain" title="Midbrain">midbrain</a> and basal <a href="/wiki/Forebrain" title="Forebrain" class="mw-redirect">forebrain</a>, and in a last step the <a href="/wiki/Neocortex" title="Neocortex">neocortex</a>.<sup id="cite_ref-pmid18398010_4-7" class="reference"><a href="#cite_note-pmid18398010-4"><span>[</span>4<span>]</span></a></sup> These brain sites are the main places of neuronal degeneration in PD; however, Lewy bodies may not cause cell death and they may be protective.<sup id="cite_ref-pmid20495568_35-1" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-pmid20563819_36-1" class="reference"><a href="#cite_note-pmid20563819-36"><span>[</span>36<span>]</span></a></sup> In people with dementia, a generalized presence of Lewy bodies is common in cortical areas. <a href="/wiki/Neurofibrillary_tangles" title="Neurofibrillary tangles" class="mw-redirect">Neurofibrillary tangles</a> and <a href="/wiki/Senile_plaque" title="Senile plaque" class="mw-redirect">senile plaques</a>, characteristic of <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a>, are not common unless the person is demented.<sup id="cite_ref-Jankovic_book-Neuropathology_33-2" class="reference"><a href="#cite_note-Jankovic_book-Neuropathology-33"><span>[</span>33<span>]</span></a></sup></p>
<p>Other cell-death mechanisms include <a href="/wiki/Proteosome" title="Proteosome" class="mw-redirect">proteosomal</a> and <a href="/wiki/Lysosome" title="Lysosome">lysosomal</a> system dysfunction and reduced <a href="/wiki/Mitochondria" title="Mitochondria" class="mw-redirect">mitochondrial</a> activity.<sup id="cite_ref-pmid20495568_35-2" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> Iron accumulation in the substantia nigra is typically observed in conjunction with the protein inclusions. It may be related to <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a>, <a href="/wiki/Protein_aggregation" title="Protein aggregation">protein aggregation</a> and neuronal death, but the mechanisms are not fully understood.<sup id="cite_ref-pmid20082992_37-0" class="reference"><a href="#cite_note-pmid20082992-37"><span>[</span>37<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:172px;"><a href="/wiki/File:PET-image.jpg" class="image"><img alt="Sagittal PET scan at the level of the striatum. Hottest areas are the cortical grey matter and the striatum." src="//upload.wikimedia.org/wikipedia/commons/thumb/c/c6/PET-image.jpg/170px-PET-image.jpg" width="170" height="192" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/c6/PET-image.jpg/255px-PET-image.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c6/PET-image.jpg/340px-PET-image.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:PET-image.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Fludeoxyglucose" title="Fludeoxyglucose" class="mw-redirect">Fludeoxyglucose</a> (<sup>18</sup>F) (FDG) <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">PET scan</a> of a healthy brain. Hotter areas reflect higher glucose uptake. A decreased activity in the <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a> can aid in diagnosing Parkinson's disease.</div>
</div>
</div>
<p>A physician will diagnose Parkinson's disease from the <a href="/wiki/Medical_history" title="Medical history">medical history</a> and a <a href="/wiki/Neurological_examination" title="Neurological examination">neurological examination</a>.<sup id="cite_ref-Jankovic2008_1-32" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> There is no lab test that will clearly identify the disease, but brain scans are sometimes used to rule out disorders that could give rise to similar symptoms. People may be given levodopa and resulting relief of motor impairment tends to confirm diagnosis. The finding of <a href="/wiki/Lewy_bodies" title="Lewy bodies" class="mw-redirect">Lewy bodies</a> in the midbrain on <a href="/wiki/Autopsy" title="Autopsy">autopsy</a> is usually considered proof that the person had Parkinson's disease. The progress of the illness over time may reveal it is not Parkinson's disease, and some authorities recommend that the diagnosis be periodically reviewed.<sup id="cite_ref-Jankovic2008_1-33" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Nice-Diagnosis_38-0" class="reference"><a href="#cite_note-Nice-Diagnosis-38"><span>[</span>38<span>]</span></a></sup></p>
<p>Other causes that can secondarily produce a parkinsonian syndrome are <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a>, multiple <a href="/wiki/Cerebral_infarction" title="Cerebral infarction">cerebral infarction</a> and drug-induced parkinsonism.<sup id="cite_ref-Nice-Diagnosis_38-1" class="reference"><a href="#cite_note-Nice-Diagnosis-38"><span>[</span>38<span>]</span></a></sup> <a href="/wiki/Parkinson_plus_syndrome" title="Parkinson plus syndrome">Parkinson plus syndromes</a> such as <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">progressive supranuclear palsy</a> and <a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">multiple system atrophy</a> must be ruled out.<sup id="cite_ref-Jankovic2008_1-34" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Anti-Parkinson's medications are typically less effective at controlling symptoms in Parkinson plus syndromes.<sup id="cite_ref-Jankovic2008_1-35" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Faster progression rates, early cognitive dysfunction or postural instability, minimal tremor or symmetry at onset may indicate a Parkinson plus disease rather than PD itself.<sup id="cite_ref-pmid12464118_39-0" class="reference"><a href="#cite_note-pmid12464118-39"><span>[</span>39<span>]</span></a></sup> Genetic forms are usually classified as PD, although the terms <i>familial Parkinson's disease</i> and <i>familial parkinsonism</i> are used for disease entities with an <a href="/wiki/Autosomal_dominant" title="Autosomal dominant" class="mw-redirect">autosomal dominant</a> or <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">recessive</a> pattern of inheritance.<sup id="cite_ref-pmid15172778_2-8" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Medical organizations have created <a href="/wiki/Diagnostic_criteria" title="Diagnostic criteria" class="mw-redirect">diagnostic criteria</a> to ease and standardize the diagnostic process, especially in the early stages of the disease. The most widely known criteria come from the UK <a href="/wiki/Parkinson%27s_UK" title="Parkinson's UK">Parkinson's Disease Society</a> Brain Bank and the U.S. <a href="/wiki/National_Institute_of_Neurological_Disorders_and_Stroke" title="National Institute of Neurological Disorders and Stroke">National Institute of Neurological Disorders and Stroke</a>.<sup id="cite_ref-Jankovic2008_1-36" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> The PD Society Brain Bank criteria require slowness of movement (bradykinesia) plus either rigidity, resting tremor, or postural instability. Other possible causes for these symptoms need to be ruled out. Finally, three or more of the following features are required during onset or evolution: unilateral onset, tremor at rest, progression in time, asymmetry of motor symptoms, response to levodopa for at least five years, clinical course of at least ten years and appearance of <a href="/wiki/Dyskinesia" title="Dyskinesia">dyskinesias</a> induced by the intake of excessive levodopa.<sup id="cite_ref-Jankovic2008_1-37" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup> Accuracy of diagnostic criteria evaluated at autopsy is 75–90%, with specialists such as neurologists having the highest rates.<sup id="cite_ref-Jankovic2008_1-38" class="reference"><a href="#cite_note-Jankovic2008-1"><span>[</span>1<span>]</span></a></sup></p>
<p><a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">Computed tomography</a> (CT) and <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> (MRI) brain scans of people with PD usually appear normal.<sup id="cite_ref-pmid20351351_40-0" class="reference"><a href="#cite_note-pmid20351351-40"><span>[</span>40<span>]</span></a></sup> These techniques are nevertheless useful to rule out other diseases that can be secondary causes of parkinsonism, such as basal ganglia <a href="/wiki/Tumor" title="Tumor" class="mw-redirect">tumors</a>, <a href="/wiki/Vascular" title="Vascular">vascular</a> pathology and <a href="/wiki/Hydrocephalus" title="Hydrocephalus">hydrocephalus</a>.<sup id="cite_ref-pmid20351351_40-1" class="reference"><a href="#cite_note-pmid20351351-40"><span>[</span>40<span>]</span></a></sup> A specific technique of MRI, <a href="/wiki/Diffusion_MRI" title="Diffusion MRI">diffusion MRI</a>, has been reported to be useful at discriminating between typical and atypical parkinsonism, although its exact diagnostic value is still under investigation.<sup id="cite_ref-pmid20351351_40-2" class="reference"><a href="#cite_note-pmid20351351-40"><span>[</span>40<span>]</span></a></sup> Dopaminergic function in the basal ganglia can be measured with different <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">PET</a> and <a href="/wiki/Single_photon_emission_computed_tomography" title="Single photon emission computed tomography" class="mw-redirect">SPECT</a> <a href="/wiki/Radiotracer" title="Radiotracer" class="mw-redirect">radiotracers</a>. Examples are <a href="/wiki/Ioflupane_(123I)" title="Ioflupane (123I)">ioflupane (<sup>123</sup>I)</a> (trade name <i>DaTSCAN</i>) and <a href="/wiki/RTI-55" title="RTI-55">iometopane</a> (<i>Dopascan</i>) for SPECT or <a href="/wiki/Fludeoxyglucose_(18F)" title="Fludeoxyglucose (18F)">fluorodeoxyglucose (<sup>18</sup>F)</a> for PET.<sup id="cite_ref-pmid20351351_40-3" class="reference"><a href="#cite_note-pmid20351351-40"><span>[</span>40<span>]</span></a></sup> A pattern of reduced dopaminergic activity in the basal ganglia can aid in diagnosing PD.<sup id="cite_ref-pmid20351351_40-4" class="reference"><a href="#cite_note-pmid20351351-40"><span>[</span>40<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prevention">Prevention</span></h2>
<p><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a> consumption appears protective against Parkinson's disease with a greater decrease in risk occurring with a larger intake of caffeinated beverages such as coffee.<sup id="cite_ref-pmid20182023_41-0" class="reference"><a href="#cite_note-pmid20182023-41"><span>[</span>41<span>]</span></a></sup> Although tobacco smoke decreases life expectancy and quality of life, it may reduce the risk of PD by a third when compared to non-smokers.<sup id="cite_ref-pmid16713924_26-3" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> The basis for this effect is not known, but possibilities include an effect of <a href="/wiki/Nicotine" title="Nicotine">nicotine</a> as a dopamine stimulant.<sup id="cite_ref-pmid16713924_26-4" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup> Tobacco smoke contains compounds that act as MAO inhibitors that also might contribute to this effect.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup></p>
<p><a href="/wiki/Antioxidant" title="Antioxidant">Antioxidants</a>, such as vitamins C and D, have been proposed to protect against the disease but results of studies have been contradictory and no positive effect has been proven.<sup id="cite_ref-pmid16713924_26-5" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> The results regarding fat and <a href="/wiki/Fatty_acid" title="Fatty acid">fatty acids</a> have been contradictory, with various studies reporting protective effects, risk-increasing effects or no effects.<sup id="cite_ref-pmid16713924_26-6" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> Finally there have been preliminary indications of a possible protective role of <a href="/wiki/Estrogen" title="Estrogen">estrogens</a> and <a href="/wiki/Non-steroidal_anti-inflammatory_drug" title="Non-steroidal anti-inflammatory drug">anti-inflammatory</a> drugs.<sup id="cite_ref-pmid16713924_26-7" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span></h2>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/Management_of_Parkinson%27s_disease" title="Management of Parkinson's disease">Management of Parkinson's disease</a></div>
<p>There is no cure for Parkinson's disease, but medications, surgery and multidisciplinary management can provide relief from the symptoms. The main families of drugs useful for treating motor symptoms are levodopa (usually combined with a <a href="/wiki/Dopa_decarboxylase_inhibitor" title="Dopa decarboxylase inhibitor" class="mw-redirect">dopa decarboxylase inhibitor</a> or <a href="/wiki/COMT_inhibitor" title="COMT inhibitor">COMT inhibitor</a>), <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonists</a> and <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAO-B inhibitors</a>.<sup id="cite_ref-Nice-pharma_44-0" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> The stage of the disease determines which group is most useful. Two stages are usually distinguished: an initial stage in which the individual with PD has already developed some disability for which he needs pharmacological treatment, then a second stage in which an individual develops motor complications related to levodopa usage.<sup id="cite_ref-Nice-pharma_44-1" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Treatment in the initial stage aims for an optimal tradeoff between good symptom control and side-effects resulting from improvement of dopaminergic function. The start of levodopa (or <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>) treatment may be delayed by using other medications such as MAO-B inhibitors and dopamine agonists, in the hope of delaying the onset of dyskinesias.<sup id="cite_ref-Nice-pharma_44-2" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> In the second stage the aim is to reduce symptoms while controlling fluctuations of the response to medication. Sudden withdrawals from medication or overuse have to be managed.<sup id="cite_ref-Nice-pharma_44-3" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> When medications are not enough to control symptoms, surgery and deep brain stimulation can be of use.<sup id="cite_ref-pmid20937936_45-0" class="reference"><a href="#cite_note-pmid20937936-45"><span>[</span>45<span>]</span></a></sup> In the final stages of the disease, <a href="/wiki/Palliative_care" title="Palliative care">palliative care</a> is provided to improve quality of life.<sup id="cite_ref-Nice-palliative_46-0" class="reference"><a href="#cite_note-Nice-palliative-46"><span>[</span>46<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Levodopa">Levodopa</span></h3>
<p>Levodopa has been the most widely used treatment for over 30 years.<sup id="cite_ref-Nice-pharma_44-4" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> L-DOPA is converted into dopamine in the dopaminergic neurons by <a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">dopa decarboxylase</a>.<sup id="cite_ref-Nice-pharma_44-5" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Since motor symptoms are produced by a lack of dopamine in the substantia nigra, the administration of L-DOPA temporarily diminishes the motor symptoms.<sup id="cite_ref-Nice-pharma_44-6" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup></p>
<p>Only 5–10% of L-DOPA crosses the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood–brain barrier</a>. The remainder is often metabolized to dopamine elsewhere, causing a variety of side effects including <a href="/wiki/Nausea" title="Nausea">nausea</a>, <a href="/wiki/Dyskinesia" title="Dyskinesia">dyskinesias</a> and joint stiffness.<sup id="cite_ref-Nice-pharma_44-7" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> <a href="/wiki/Carbidopa" title="Carbidopa">Carbidopa</a> and <a href="/wiki/Benserazide" title="Benserazide">benserazide</a> are peripheral <a href="/wiki/Dopa_decarboxylase_inhibitor" title="Dopa decarboxylase inhibitor" class="mw-redirect">dopa decarboxylase inhibitors</a>,<sup id="cite_ref-Nice-pharma_44-8" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> which help to prevent the metabolism of L-DOPA before it reaches the dopaminergic neurons, therefore reducing side effects and increasing <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a>. They are generally given as combination preparations with levodopa.<sup id="cite_ref-Nice-pharma_44-9" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Existing preparations are <a href="/wiki/Carbidopa/levodopa" title="Carbidopa/levodopa">carbidopa/levodopa</a> (co-careldopa) and <a href="/wiki/Benserazide" title="Benserazide">benserazide/levodopa</a> (co-beneldopa). Levodopa has been related to <a href="/wiki/Dopamine_dysregulation_syndrome" title="Dopamine dysregulation syndrome">dopamine dysregulation syndrome</a>, which is a compulsive overuse of the medication, and <a href="//en.wiktionary.org/wiki/punding" class="extiw" title="wikt:punding">punding</a>.<sup id="cite_ref-pmid20123548_19-1" class="reference"><a href="#cite_note-pmid20123548-19"><span>[</span>19<span>]</span></a></sup> There are controlled <a href="/wiki/Slow-release" title="Slow-release" class="mw-redirect">release</a> versions of levodopa in the form <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> and intestinal infusions that spread out the effect of the medication. These slow-release levodopa preparations have not shown an increased control of motor symptoms or motor complications when compared to immediate release preparations.<sup id="cite_ref-Nice-pharma_44-10" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-Jankovic_book-Pharma_47-0" class="reference"><a href="#cite_note-Jankovic_book-Pharma-47"><span>[</span>47<span>]</span></a></sup></p>
<p><a href="/wiki/Tolcapone" title="Tolcapone">Tolcapone</a> inhibits the <a href="/wiki/COMT" title="COMT" class="mw-redirect">COMT</a> enzyme, which degrades dopamine, thereby prolonging the effects of levodopa.<sup id="cite_ref-Nice-pharma_44-11" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> It has been used to complement levodopa; however, its usefulness is limited by possible side effects such as liver damage.<sup id="cite_ref-Nice-pharma_44-12" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> A similarly effective drug, <a href="/wiki/Entacapone" title="Entacapone">entacapone</a>, has not been shown to cause significant alterations of liver function.<sup id="cite_ref-Nice-pharma_44-13" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Licensed preparations of entacapone contain entacapone alone or in combination with carbidopa and levodopa.<sup id="cite_ref-Nice-pharma_44-14" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup></p>
<p>Levodopa preparations lead in the long term to the development of motor complications characterized by involuntary movements called <a href="/wiki/Dyskinesia" title="Dyskinesia">dyskinesias</a> and fluctuations in the response to medication.<sup id="cite_ref-Nice-pharma_44-15" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> When this occurs a person with PD can change from phases with good response to medication and few symptoms ("on" state), to phases with no response to medication and significant motor symptoms ("off" state).<sup id="cite_ref-Nice-pharma_44-16" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> For this reason, levodopa doses are kept as low as possible while maintaining functionality.<sup id="cite_ref-Nice-pharma_44-17" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Delaying the initiation of therapy with levodopa by using alternatives (dopamine agonists and MAO-B inhibitors) is common practice.<sup id="cite_ref-Nice-pharma_44-18" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> A former strategy to reduce motor complications was to withdraw L-DOPA medication for some time. This is discouraged now, since it can bring dangerous side effects such as <a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</a>.<sup id="cite_ref-Nice-pharma_44-19" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Most people with PD will eventually need levodopa and later develop motor side effects.<sup id="cite_ref-Nice-pharma_44-20" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Dopamine_agonists">Dopamine agonists</span></h3>
<p>Several <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonists</a> that bind to dopaminergic post-synaptic receptors in the brain have similar effects to levodopa.<sup id="cite_ref-Nice-pharma_44-21" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> These were initially used for individuals experiencing on-off fluctuations and dyskinesias as a complementary therapy to levodopa; they are now mainly used on their own as an initial therapy for motor symptoms with the aim of delaying motor complications.<sup id="cite_ref-Nice-pharma_44-22" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup> When used in late PD they are useful at reducing the off periods.<sup id="cite_ref-Nice-pharma_44-23" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Dopamine agonists include <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>, <a href="/wiki/Pramipexole" title="Pramipexole">pramipexole</a>, <a href="/wiki/Ropinirole" title="Ropinirole">ropinirole</a>, <a href="/wiki/Piribedil" title="Piribedil">piribedil</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Apomorphine" title="Apomorphine">apomorphine</a> and <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>.</p>
<p>Dopamine agonists produce significant, although usually mild, side effects including <a href="/wiki/Somnolence" title="Somnolence">drowsiness</a>, hallucinations, insomnia, nausea and constipation.<sup id="cite_ref-Nice-pharma_44-24" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Sometimes side effects appear even at a minimal clinically effective dose, leading the physician to search for a different drug.<sup id="cite_ref-Nice-pharma_44-25" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Compared with levodopa, dopamine agonists may delay motor complications of medication use but are less effective at controlling symptoms.<sup id="cite_ref-Nice-pharma_44-26" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Nevertheless, they are usually effective enough to manage symptoms in the initial years.<sup id="cite_ref-pmid15172778_2-9" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> They tend to be more expensive than levodopa.<sup id="cite_ref-pmid15172778_2-10" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> Dyskinesias due to dopamine agonists are rare in younger people who have PD, but along with other side effects, become more common with age at onset.<sup id="cite_ref-pmid15172778_2-11" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> Thus dopamine agonists are the preferred initial treatment for earlier onset, as opposed to levodopa in later onset.<sup id="cite_ref-pmid15172778_2-12" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> Agonists have been related to impulse control disorders (such as compulsive sexual activity and eating, and pathological gambling and shopping) even more strongly than levodopa.<sup id="cite_ref-pmid20123548_19-2" class="reference"><a href="#cite_note-pmid20123548-19"><span>[</span>19<span>]</span></a></sup></p>
<p><a href="/wiki/Apomorphine" title="Apomorphine">Apomorphine</a>, a non-orally administered dopamine agonist, may be used to reduce off periods and dyskinesia in late PD.<sup id="cite_ref-Nice-pharma_44-27" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> It is administered by intermittent injections or continuous <a href="/wiki/Subcutaneous_infusion" title="Subcutaneous infusion" class="mw-redirect">subcutaneous infusions</a>.<sup id="cite_ref-Nice-pharma_44-28" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Since secondary effects such as confusion and hallucinations are common, individuals receiving apomorphine treatment should be closely monitored.<sup id="cite_ref-Nice-pharma_44-29" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Two dopamine agonists that are administered through skin patches (<a href="/wiki/Lisuride" title="Lisuride">lisuride</a> and <a href="/wiki/Rotigotine" title="Rotigotine">rotigotine</a>) and are useful for people in the initial stages and possibly to control off states in those in the advanced state.<sup id="cite_ref-Jankovic_book-Pharma_47-1" class="reference"><a href="#cite_note-Jankovic_book-Pharma-47"><span>[</span>47<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="MAO-B_inhibitors">MAO-B inhibitors</span></h3>
<p><a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAO-B inhibitors</a> (<a href="/wiki/Selegiline" title="Selegiline">selegiline</a> and <a href="/wiki/Rasagiline" title="Rasagiline">rasagiline</a>) increase the level of dopamine in the basal ganglia by blocking its metabolism. They inhibit monoamine oxidase-B (MAO-B) which breaks down dopamine secreted by the dopaminergic neurons. The reduction in MAO-B activity results in increased L-DOPA in the <a href="/wiki/Striatum" title="Striatum">striatum</a>.<sup id="cite_ref-Nice-pharma_44-30" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> Like dopamine agonists, MAO-B inhibitors used as monotherapy improve motor symptoms and delay the need for levodopa in early disease, but produce more adverse effects and are less effective than levodopa. There are few studies of their effectiveness in the advanced stage, although results suggest that they are useful to reduce fluctuations between on and off periods.<sup id="cite_ref-Nice-pharma_44-31" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> An initial study indicated that selegiline in combination with levodopa increased the risk of death, but this was later disproven.<sup id="cite_ref-Nice-pharma_44-32" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other_drugs">Other drugs</span></h3>
<p>Other drugs such as <a href="/wiki/Amantadine" title="Amantadine">amantadine</a> and <a href="/wiki/Anticholinergic" title="Anticholinergic">anticholinergics</a> may be useful as treatment of motor symptoms. However, the evidence supporting them lacks quality, so they are not first choice treatments.<sup id="cite_ref-Nice-pharma_44-33" class="reference"><a href="#cite_note-Nice-pharma-44"><span>[</span>44<span>]</span></a></sup> In addition to motor symptoms, PD is accompanied by a diverse range of symptoms. A number of drugs have been used to treat some of these problems.<sup id="cite_ref-Nice-NonMotor_49-0" class="reference"><a href="#cite_note-Nice-NonMotor-49"><span>[</span>49<span>]</span></a></sup> Examples are the use of <a href="/wiki/Clozapine" title="Clozapine">clozapine</a> for psychosis, <a href="/wiki/Cholinesterase_inhibitors" title="Cholinesterase inhibitors" class="mw-redirect">cholinesterase inhibitors</a> for dementia, and <a href="/wiki/Modafinil" title="Modafinil">modafinil</a> for <a href="/wiki/Excessive_daytime_sleepiness" title="Excessive daytime sleepiness">daytime sleepiness</a>.<sup id="cite_ref-Nice-NonMotor_49-1" class="reference"><a href="#cite_note-Nice-NonMotor-49"><span>[</span>49<span>]</span></a></sup><sup id="cite_ref-pmid19559160_50-0" class="reference"><a href="#cite_note-pmid19559160-50"><span>[</span>50<span>]</span></a></sup> A 2010 <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> found that <a href="/wiki/Non-steroidal_anti-inflammatory_drug" title="Non-steroidal anti-inflammatory drug">non-steroidal anti-inflammatory drugs</a> (apart from <a href="/wiki/Acetaminophen" title="Acetaminophen" class="mw-redirect">acetaminophen</a> and <a href="/wiki/Aspirin" title="Aspirin">aspirin</a>), have been associated with at least a 15 percent (higher in long-term and regular users) reduction of incidence of the development of Parkinson's disease.<sup id="cite_ref-Gagne-2010_51-0" class="reference"><a href="#cite_note-Gagne-2010-51"><span>[</span>51<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Surgery">Surgery</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:172px;"><a href="/wiki/File:Parkinson_surgery.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Parkinson_surgery.jpg/170px-Parkinson_surgery.jpg" width="170" height="254" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Parkinson_surgery.jpg/255px-Parkinson_surgery.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/91/Parkinson_surgery.jpg/340px-Parkinson_surgery.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Parkinson_surgery.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Placement of an electrode into the brain. The head is stabilised in a frame for <a href="/wiki/Stereotactic_surgery" title="Stereotactic surgery">stereotactic surgery</a>.</div>
</div>
</div>
<p>Treating motor symptoms with surgery was once a common practice, but since the discovery of levodopa, the number of operations declined.<sup id="cite_ref-Nice-surgery_52-0" class="reference"><a href="#cite_note-Nice-surgery-52"><span>[</span>52<span>]</span></a></sup> Studies in the past few decades have led to great improvements in surgical techniques, so that surgery is again being used in people with advanced PD for whom drug therapy is no longer sufficient.<sup id="cite_ref-Nice-surgery_52-1" class="reference"><a href="#cite_note-Nice-surgery-52"><span>[</span>52<span>]</span></a></sup> Surgery for PD can be divided in two main groups: lesional and <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">deep brain stimulation</a> (DBS). Target areas for DBS or lesions include the <a href="/wiki/Thalamus" title="Thalamus">thalamus</a>, the <a href="/wiki/Globus_pallidus" title="Globus pallidus">globus pallidus</a> or the <a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">subthalamic nucleus</a>.<sup id="cite_ref-Nice-surgery_52-2" class="reference"><a href="#cite_note-Nice-surgery-52"><span>[</span>52<span>]</span></a></sup> <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">Deep brain stimulation</a> (DBS) is the most commonly used surgical treatment, developed in the 1980s by <a href="/wiki/Alim-Louis_Benabid" title="Alim-Louis Benabid">Alim-Louis Benabid</a> and others. It involves the implantation of a medical device called a <a href="/wiki/Brain_pacemaker" title="Brain pacemaker">brain pacemaker</a>, which sends electrical impulses to specific parts of the brain. DBS is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe <a href="//en.wiktionary.org/wiki/neuropsychiatric" class="extiw" title="wikt:neuropsychiatric">neuropsychiatric</a> problems.<sup id="cite_ref-pmid20937936_45-1" class="reference"><a href="#cite_note-pmid20937936-45"><span>[</span>45<span>]</span></a></sup> Other, less common, surgical therapies involve intentional formation of lesions to suppress overactivity of specific <a href="//en.wiktionary.org/wiki/subcortical" class="extiw" title="wikt:subcortical">subcortical</a> areas. For example, <a href="/wiki/Pallidotomy" title="Pallidotomy">pallidotomy</a> involves surgical destruction of the globus pallidus to control dyskinesia.<sup id="cite_ref-Nice-surgery_52-3" class="reference"><a href="#cite_note-Nice-surgery-52"><span>[</span>52<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Rehabilitation">Rehabilitation</span></h3>
<div class="rellink">Further information: <a href="/wiki/Rehabilitation_in_Parkinson%27s_disease" title="Rehabilitation in Parkinson's disease">Rehabilitation in Parkinson's disease</a></div>
<p>There is some evidence that speech or mobility problems can improve with rehabilitation, although studies are scarce and of low quality.<sup id="cite_ref-Nice-rehab_53-0" class="reference"><a href="#cite_note-Nice-rehab-53"><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid18181210_54-0" class="reference"><a href="#cite_note-pmid18181210-54"><span>[</span>54<span>]</span></a></sup> Regular <a href="/wiki/Physical_exercise" title="Physical exercise">physical exercise</a> with or without <a href="/wiki/Physiotherapy" title="Physiotherapy" class="mw-redirect">physiotherapy</a> can be beneficial to maintain and improve mobility, flexibility, strength, gait speed, and quality of life.<sup id="cite_ref-pmid18181210_54-1" class="reference"><a href="#cite_note-pmid18181210-54"><span>[</span>54<span>]</span></a></sup> However, when an exercise program is performed under the supervision of a physiotherapist, there are more improvements in motor symptoms, mental and emotional functions, daily living activities, and quality of life compared to a self-supervised exercise program at home.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup> In terms of improving flexibility and range of motion for people experiencing <a href="/wiki/Hypokinesia" title="Hypokinesia">rigidity</a>, generalized relaxation techniques such as gentle rocking have been found to decrease excessive muscle tension. Other effective techniques to promote relaxation include slow rotational movements of the extremities and trunk, rhythmic initiation, <a href="/wiki/Diaphragmatic_breathing" title="Diaphragmatic breathing">diaphragmatic breathing</a>, and <a href="/wiki/Meditation" title="Meditation">meditation</a> techniques.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup> As for gait and addressing the challenges associated with the disease such as <a href="/wiki/Hypokinesia" title="Hypokinesia">hypokinesia</a> (slowness of movement), shuffling and decreased arm swing; physiotherapists have a variety of strategies to improve functional mobility and safety. Areas of interest with respect to gait during rehabilitation programs focus on but are not limited to improving gait speed, base of support, stride length, trunk and arm swing movement. Strategies include utilizing assistive equipment (pole walking and treadmill walking), verbal cueing (manual, visual and auditory), exercises (marching and PNF patterns) and altering environments (surfaces, inputs, open vs. closed).<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup> Strengthening exercises have shown improvements in strength and motor function for people with primary muscular weakness and weakness related to inactivity with mild to moderate Parkinson’s disease. However, reports show a significant interaction between strength and the time the medications was taken. Therefore, it is recommended that people with PD should perform exercises 45 minutes to one hour after medications, when they are at their best.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span>[</span>58<span>]</span></a></sup> Also, due to the forward flexed posture, and respiratory dysfunctions in advanced Parkinson’s disease, deep diaphragmatic breathing exercises are beneficial in improving chest wall mobility and vital capacity.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup> Exercise may improve constipation.<sup id="cite_ref-pmid19691125_22-1" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup></p>
<p>One of the most widely practiced <a href="/wiki/Speech_therapy" title="Speech therapy" class="mw-redirect">treatments for speech</a> disorders associated with Parkinson's disease is the <a href="/wiki/Lee_Silverman_voice_treatment" title="Lee Silverman voice treatment">Lee Silverman voice treatment</a> (LSVT).<sup id="cite_ref-Nice-rehab_53-1" class="reference"><a href="#cite_note-Nice-rehab-53"><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid17117354_60-0" class="reference"><a href="#cite_note-pmid17117354-60"><span>[</span>60<span>]</span></a></sup> Speech therapy and specifically LSVT may improve speech.<sup id="cite_ref-Nice-rehab_53-2" class="reference"><a href="#cite_note-Nice-rehab-53"><span>[</span>53<span>]</span></a></sup> <a href="/wiki/Occupational_therapy" title="Occupational therapy">Occupational therapy</a> (OT) aims to promote health and quality of life by helping people with the disease to participate in as many of their <a href="/wiki/Daily_living_skills" title="Daily living skills" class="mw-redirect">daily living activities</a> as possible.<sup id="cite_ref-Nice-rehab_53-3" class="reference"><a href="#cite_note-Nice-rehab-53"><span>[</span>53<span>]</span></a></sup> There have been few studies on the effectiveness of OT and their quality is poor, although there is some indication that it may improve motor skills and quality of life for the duration of the therapy.<sup id="cite_ref-Nice-rehab_53-4" class="reference"><a href="#cite_note-Nice-rehab-53"><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid17636709_61-0" class="reference"><a href="#cite_note-pmid17636709-61"><span>[</span>61<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Palliative_care">Palliative care</span></h3>
<p><a href="/wiki/Palliative_care" title="Palliative care">Palliative care</a> is often required in the final stages of the disease when all other treatment strategies have become ineffective. The aim of palliative care is to maximize the <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a> for the person with the disease and those surrounding him or her. Some central issues of palliative care are: care in the community while adequate care can be given there, reducing or withdrawing drug intake to reduce drug side effects, preventing <a href="/wiki/Pressure_ulcer" title="Pressure ulcer">pressure ulcers</a> by management of pressure areas of inactive people, and facilitating <a href="/wiki/End-of-life_care" title="End-of-life care">end-of-life</a> decisions for the person as well as involved friends and relatives.<sup id="cite_ref-Nice-palliative_46-1" class="reference"><a href="#cite_note-Nice-palliative-46"><span>[</span>46<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other_treatments">Other treatments</span></h3>
<p>Muscles and nerves that control the digestive process may be affected by PD, resulting in <a href="/wiki/Constipation" title="Constipation">constipation</a> and <a href="/wiki/Gastroparesis" title="Gastroparesis">gastroparesis</a> (food remaining in the stomach for a longer period of time than normal).<sup id="cite_ref-pmid19691125_22-2" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup> A balanced diet, based on periodical nutritional assessments, is recommended and should be designed to avoid weight loss or gain and minimize consequences of gastrointestinal dysfunction.<sup id="cite_ref-pmid19691125_22-3" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup> As the disease advances, swallowing difficulties (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>) may appear. In such cases it may be helpful to use <a href="/wiki/Thickening_agent" title="Thickening agent">thickening agents</a> for liquid intake and an upright posture when eating, both measures reducing the risk of choking. <a href="/wiki/Gastrostomy" title="Gastrostomy">Gastrostomy</a> to deliver food directly into the stomach is possible in severe cases.<sup id="cite_ref-pmid19691125_22-4" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup></p>
<p>Levodopa and <a href="/wiki/Protein" title="Protein">proteins</a> use the same transportation system in the intestine and the blood–brain barrier, thereby competing for access.<sup id="cite_ref-pmid19691125_22-5" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup> When they are taken together, this results in a reduced effectiveness of the drug.<sup id="cite_ref-pmid19691125_22-6" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup> Therefore, when levodopa is introduced, excessive <a href="/wiki/Protein_(nutrient)" title="Protein (nutrient)">protein consumption</a> is discouraged and well balanced <a href="/wiki/Mediterranean_diet" title="Mediterranean diet">Mediterranean diet</a> is recommended. In advanced stages, additional intake of low-protein products such as bread or pasta is recommended for similar reasons.<sup id="cite_ref-pmid19691125_22-7" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup> To minimize interaction with proteins, levodopa should be taken 30 minutes before meals.<sup id="cite_ref-pmid19691125_22-8" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup> At the same time, regimens for PD restrict proteins during breakfast and lunch, allowing protein intake in the evening.<sup id="cite_ref-pmid19691125_22-9" class="reference"><a href="#cite_note-pmid19691125-22"><span>[</span>22<span>]</span></a></sup></p>
<p><a href="/wiki/Repetitive_transcranial_magnetic_stimulation" title="Repetitive transcranial magnetic stimulation" class="mw-redirect">Repetitive transcranial magnetic stimulation</a> temporarily improves levodopa-induced dyskinesias.<sup id="cite_ref-pmid20714078_62-0" class="reference"><a href="#cite_note-pmid20714078-62"><span>[</span>62<span>]</span></a></sup> Its usefulness in PD is an open research topic,<sup id="cite_ref-pmid20714064_63-0" class="reference"><a href="#cite_note-pmid20714064-63"><span>[</span>63<span>]</span></a></sup> although recent studies have shown no effect by rTMS.<sup id="cite_ref-pmid20669300_64-0" class="reference"><a href="#cite_note-pmid20669300-64"><span>[</span>64<span>]</span></a></sup> Several <a href="/wiki/Nutrient" title="Nutrient">nutrients</a> have been proposed as possible treatments; however there is no evidence that <a href="/wiki/Vitamin" title="Vitamin">vitamins</a> or <a href="/wiki/Food_additive" title="Food additive">food additives</a> improve symptoms.<sup id="cite_ref-pmid16606908_65-0" class="reference"><a href="#cite_note-pmid16606908-65"><span>[</span>65<span>]</span></a></sup> There is no evidence to substantiate that <a href="/wiki/Acupuncture" title="Acupuncture">acupuncture</a> and practice of <a href="/wiki/Qigong" title="Qigong">Qigong</a>, or <a href="/wiki/T%27ai_chi_ch%27uan" title="T'ai chi ch'uan">T'ai chi</a>, have any effect on the course of the disease or symptoms. Further research on the viability of Tai chi for balance or motor skills are necessary.<sup id="cite_ref-pmid18374620_66-0" class="reference"><a href="#cite_note-pmid18374620-66"><span>[</span>66<span>]</span></a></sup><sup id="cite_ref-pmid18973253_67-0" class="reference"><a href="#cite_note-pmid18973253-67"><span>[</span>67<span>]</span></a></sup><sup id="cite_ref-pmid18618661_68-0" class="reference"><a href="#cite_note-pmid18618661-68"><span>[</span>68<span>]</span></a></sup> <a href="/wiki/Fava_bean" title="Fava bean" class="mw-redirect">Fava beans</a> and <a href="/wiki/Velvet_bean" title="Velvet bean">velvet beans</a> are natural sources of levodopa and are eaten by many people with PD. While they have shown some effectiveness in clinical trials,<sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup> their intake is not free of risks. Life-threatening adverse reactions have been described, such as the <a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</a>.<sup id="cite_ref-pmid15719433_70-0" class="reference"><a href="#cite_note-pmid15719433-70"><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-pmid19678834_71-0" class="reference"><a href="#cite_note-pmid19678834-71"><span>[</span>71<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span></h2>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Unified_Parkinson%27s_Disease_Rating_Scale" title="Unified Parkinson's Disease Rating Scale">Unified Parkinson's Disease Rating Scale</a></div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Parkinson_disease_world_map_-_DALY_-_WHO2004.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Parkinson_disease_world_map_-_DALY_-_WHO2004.svg/220px-Parkinson_disease_world_map_-_DALY_-_WHO2004.svg.png" width="220" height="97" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Parkinson_disease_world_map_-_DALY_-_WHO2004.svg/330px-Parkinson_disease_world_map_-_DALY_-_WHO2004.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Parkinson_disease_world_map_-_DALY_-_WHO2004.svg/440px-Parkinson_disease_world_map_-_DALY_-_WHO2004.svg.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Parkinson_disease_world_map_-_DALY_-_WHO2004.svg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Global burden of Parkinson's disease, measured in <a href="/wiki/Disability-adjusted_life_year" title="Disability-adjusted life year">disability-adjusted life years</a> per 100,000&#160;inhabitants in 2004
<div>
<table style="width: 100%; background-color:transparent;table-layout:fixed; border:none; border-spacing:0;" role="presentation">
<tr style="vertical-align: top;">
<td>
<div style="margin-right:20px;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;no data</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;&lt;&#160;5</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;5–12.5</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;12.5–20</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;20–27.5</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;27.5–35</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;35–42.5</div>
</div>
</td>
<td>
<div style="margin-right: 20px;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;42.5–50</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;50–57.5</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;57.5–65</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;65–72.5</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;72.5–80</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;&gt;&#160;80</div>
</div>
</td>
</tr>
</table>
</div>
</div>
</div>
</div>
<p>PD invariably progresses with time. A severity rating method known as the <a href="/wiki/Unified_Parkinson%27s_Disease_Rating_Scale" title="Unified Parkinson's Disease Rating Scale">Unified Parkinson's Disease Rating Scale</a> (UPDRS) is the most commonly used metric for clinical study. A modified version known as the MDS-UPDRS is also sometimes used. An older scaling method known as the <a href="/wiki/Hoehn_and_Yahr_scale" title="Hoehn and Yahr scale">Hoehn and Yahr scale</a> (originally published in 1967), and a similar scale known as the Modified Hoehn and Yahr scale, have also been commonly used. The Hoehn and Yahr scale defines five basic stages of progression.</p>
<p>Motor symptoms, if not treated, advance aggressively in the early stages of the disease and more slowly later. Untreated, individuals are expected to lose independent <a href="/wiki/Ambulation" title="Ambulation" class="mw-redirect">ambulation</a> after an average of eight years and be bedridden after ten years.<sup id="cite_ref-pmid17131223_72-0" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> However, it is uncommon to find untreated people nowadays. Medication has improved the prognosis of motor symptoms, while at the same time it is a new source of disability because of the undesired effects of levodopa after years of use.<sup id="cite_ref-pmid17131223_72-1" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> In people taking levodopa, the progression time of symptoms to a stage of high dependency from caregivers may be over 15 years.<sup id="cite_ref-pmid17131223_72-2" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> However, it is hard to predict what course the disease will take for a given individual.<sup id="cite_ref-pmid17131223_72-3" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> Age is the best predictor of disease progression.<sup id="cite_ref-pmid20495568_35-3" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> The rate of motor decline is greater in those with less impairment at the time of diagnosis, while cognitive impairment is more frequent in those who are over 70 years of age at symptom onset.<sup id="cite_ref-pmid20495568_35-4" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup></p>
<p>Since current therapies improve motor symptoms, disability at present is mainly related to non-motor features of the disease.<sup id="cite_ref-pmid20495568_35-5" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> Nevertheless, the relationship between disease progression and disability is not linear. Disability is initially related to motor symptoms.<sup id="cite_ref-pmid17131223_72-4" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> As the disease advances, disability is more related to motor symptoms that do not respond adequately to medication, such as swallowing/speech difficulties, and gait/balance problems; and also to motor complications, which appear in up to 50% of individuals after 5 years of levodopa usage.<sup id="cite_ref-pmid17131223_72-5" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> Finally, after ten years most people with the disease have autonomic disturbances, sleep problems, mood alterations and cognitive decline.<sup id="cite_ref-pmid17131223_72-6" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> All of these symptoms, especially cognitive decline, greatly increase disability.<sup id="cite_ref-pmid20495568_35-6" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-pmid17131223_72-7" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup></p>
<p>The <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> of people with PD is reduced.<sup id="cite_ref-pmid17131223_72-8" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> <a href="/wiki/Standardized_mortality_ratio" title="Standardized mortality ratio">Mortality ratios</a> are around twice those of unaffected people.<sup id="cite_ref-pmid17131223_72-9" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> Cognitive decline and dementia, old age at onset, a more advanced disease state and presence of swallowing problems are all mortality <a href="/wiki/Risk_factor" title="Risk factor">risk factors</a>. On the other hand a disease pattern mainly characterized by tremor as opposed to rigidity predicts an improved survival.<sup id="cite_ref-pmid17131223_72-10" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup> Death from <a href="/wiki/Aspiration_pneumonia" title="Aspiration pneumonia">aspiration pneumonia</a> is twice as common in individuals with PD as in the healthy population.<sup id="cite_ref-pmid17131223_72-11" class="reference"><a href="#cite_note-pmid17131223-72"><span>[</span>72<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span></h2>
<p>PD is the second most common <a href="/wiki/Neurodegeneration" title="Neurodegeneration">neurodegenerative disorder</a> after <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a> and affects approximately seven million people globally and one million people in the United States.<sup id="cite_ref-OFP_15-1" class="reference"><a href="#cite_note-OFP-15"><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-pmid16713924_26-8" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> The <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> (proportion in a population at a given time) of PD is about 0.3% of the whole population in industrialized countries. PD is more common in the elderly and prevalence rises from 1% in those over 60 years of age to 4% of the population over 80.<sup id="cite_ref-pmid16713924_26-9" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> The mean age of onset is around 60 years, although 5–10% of cases, classified as young onset, begin between the ages of 20 and 50.<sup id="cite_ref-pmid15172778_2-13" class="reference"><a href="#cite_note-pmid15172778-2"><span>[</span>2<span>]</span></a></sup> PD may be less prevalent in those of African and Asian ancestry, although this finding is disputed.<sup id="cite_ref-pmid16713924_26-10" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> Some studies have proposed that it is more common in men than women, but others failed to detect any differences between the two sexes.<sup id="cite_ref-pmid16713924_26-11" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> The <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> of PD is between 8 and 18 per 100,000 person–years.<sup id="cite_ref-pmid16713924_26-12" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup></p>
<p>Many risk factors and protective factors have been proposed, sometimes in relation to theories concerning possible mechanisms of the disease, however none have been conclusively related to PD by empirical evidence. When epidemiological studies have been carried out in order to test the relationship between a given factor and PD, they have often been flawed and their results have in some cases been contradictory.<sup id="cite_ref-pmid16713924_26-13" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup> The most frequently replicated relationships are an increased risk of PD in those exposed to pesticides, and a reduced risk in smokers.<sup id="cite_ref-pmid16713924_26-14" class="reference"><a href="#cite_note-pmid16713924-26"><span>[</span>26<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span></h2>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/History_of_Parkinson%27s_disease" title="History of Parkinson's disease">History of Parkinson's disease</a></div>
<div class="thumb tleft">
<div class="thumbinner" style="width:172px;"><a href="/wiki/File:Charcot1893.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Charcot1893.jpg/170px-Charcot1893.jpg" width="170" height="269" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Charcot1893.jpg/255px-Charcot1893.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Charcot1893.jpg/340px-Charcot1893.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Charcot1893.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
An 1893 photograph of <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, who made important contributions to the understanding of the disease and proposed its current name honoring <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a></div>
</div>
</div>
<p>Several early sources, including an <a href="/wiki/Ancient_Egypt" title="Ancient Egypt">Egyptian</a> <a href="/wiki/Papyrus" title="Papyrus">papyrus</a>, an <a href="/wiki/Ayurveda" title="Ayurveda">Ayurvedic</a> medical treatise, the <a href="/wiki/Bible" title="Bible">Bible</a>, and <a href="/wiki/Galen" title="Galen">Galen</a>'s writings, describe symptoms resembling those of PD.<sup id="cite_ref-pmid15568171_73-0" class="reference"><a href="#cite_note-pmid15568171-73"><span>[</span>73<span>]</span></a></sup> After Galen there are no references unambiguously related to PD until the 17th century.<sup id="cite_ref-pmid15568171_73-1" class="reference"><a href="#cite_note-pmid15568171-73"><span>[</span>73<span>]</span></a></sup> In the 17th and 18th centuries, several authors wrote about elements of the disease, including <a href="/wiki/Franciscus_Sylvius" title="Franciscus Sylvius">Sylvius</a>, <a href="/wiki/Hieronymus_David_Gaubius" title="Hieronymus David Gaubius">Gaubius</a>, <a href="/wiki/John_Hunter_(surgeon)" title="John Hunter (surgeon)">Hunter</a> and <a href="/wiki/Auguste_Fran%C3%A7ois_Chomel" title="Auguste François Chomel">Chomel</a>.<sup id="cite_ref-pmid15568171_73-2" class="reference"><a href="#cite_note-pmid15568171-73"><span>[</span>73<span>]</span></a></sup><sup id="cite_ref-pmid19892136_74-0" class="reference"><a href="#cite_note-pmid19892136-74"><span>[</span>74<span>]</span></a></sup><sup id="cite_ref-pmid9380070_75-0" class="reference"><a href="#cite_note-pmid9380070-75"><span>[</span>75<span>]</span></a></sup></p>
<p>In 1817 an English doctor, <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a>, published his essay reporting six cases of paralysis agitans.<sup id="cite_ref-pmid18175393_76-0" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup> <i>An Essay on the Shaking Palsy</i> described the characteristic resting tremor, abnormal posture and gait, paralysis and diminished muscle strength, and the way that the disease progresses over time.<sup id="cite_ref-pmid18175393_76-1" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-pmid9399240_77-0" class="reference"><a href="#cite_note-pmid9399240-77"><span>[</span>77<span>]</span></a></sup> Early neurologists who made further additions to the knowledge of the disease include <a href="/wiki/Armand_Trousseau" title="Armand Trousseau">Trousseau</a>, <a href="/wiki/William_Richard_Gowers" title="William Richard Gowers" class="mw-redirect">Gowers</a>, <a href="/wiki/Samuel_Alexander_Kinnier_Wilson" title="Samuel Alexander Kinnier Wilson">Kinnier Wilson</a> and <a href="/wiki/Wilhelm_Heinrich_Erb" title="Wilhelm Heinrich Erb">Erb</a>, and most notably <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, whose studies between 1868 and 1881 were a landmark in the understanding of the disease.<sup id="cite_ref-pmid18175393_76-2" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup> Among other advances, he made the distinction between rigidity, weakness and bradykinesia.<sup id="cite_ref-pmid18175393_76-3" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup> He also championed the renaming of the disease in honor of James Parkinson.<sup id="cite_ref-pmid18175393_76-4" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup></p>
<p>In 1912 <a href="/wiki/Frederic_Lewy" title="Frederic Lewy">Frederic Lewy</a> described microscopic particles in affected brains, later named "<a href="/wiki/Lewy_body" title="Lewy body">Lewy bodies</a>".<sup id="cite_ref-pmid18175393_76-5" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup> In 1919 <a href="/wiki/Konstantin_Tretiakoff" title="Konstantin Tretiakoff">Konstantin Tretiakoff</a> reported that the substantia nigra was the main cerebral structure affected, but this finding was not widely accepted until it was confirmed by further studies published by <a href="/wiki/Rolf_Hassler" title="Rolf Hassler">Rolf Hassler</a> in 1938.<sup id="cite_ref-pmid18175393_76-6" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup> The underlying <a href="/wiki/Biochemical" title="Biochemical" class="mw-redirect">biochemical</a> changes in the <a href="/wiki/Brain" title="Brain">brain</a> were identified in the 1950s, due largely to the work of <a href="/wiki/Arvid_Carlsson" title="Arvid Carlsson">Arvid Carlsson</a> on the neurotransmitter dopamine and its role on PD.<sup id="cite_ref-pmid18781671_78-0" class="reference"><a href="#cite_note-pmid18781671-78"><span>[</span>78<span>]</span></a></sup> In 1997, alpha-synuclein was found to be the main component of Lewy bodies.<sup id="cite_ref-pmid20563819_36-2" class="reference"><a href="#cite_note-pmid20563819-36"><span>[</span>36<span>]</span></a></sup></p>
<p>Anticholinergics and surgery (lesioning of the <a href="/wiki/Corticospinal_pathway" title="Corticospinal pathway" class="mw-redirect">corticospinal pathway</a> or some of the basal ganglia structures) were the only treatments until the arrival of levodopa, which reduced their use dramatically.<sup id="cite_ref-pmid19892136_74-1" class="reference"><a href="#cite_note-pmid19892136-74"><span>[</span>74<span>]</span></a></sup><sup id="cite_ref-pmid9361073_79-0" class="reference"><a href="#cite_note-pmid9361073-79"><span>[</span>79<span>]</span></a></sup> <a href="/wiki/Levodopa" title="Levodopa" class="mw-redirect">Levodopa</a> was first synthesized in 1911 by <a href="/wiki/Casimir_Funk" title="Casimir Funk">Casimir Funk</a>, but it received little attention until the mid 20th century.<sup id="cite_ref-pmid18781671_78-1" class="reference"><a href="#cite_note-pmid18781671-78"><span>[</span>78<span>]</span></a></sup> It entered clinical practice in 1967 and brought about a revolution in the management of PD.<sup id="cite_ref-pmid18781671_78-2" class="reference"><a href="#cite_note-pmid18781671-78"><span>[</span>78<span>]</span></a></sup><sup id="cite_ref-80" class="reference"><a href="#cite_note-80"><span>[</span>80<span>]</span></a></sup> By the late 1980s <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">deep brain stimulation</a> emerged as a possible treatment.<sup id="cite_ref-pmid18684199_81-0" class="reference"><a href="#cite_note-pmid18684199-81"><span>[</span>81<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span></h2>
<h3><span class="mw-headline" id="Cost">Cost</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:172px;"><a href="/wiki/File:Muhammad_Ali,_Davos.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Muhammad_Ali%2C_Davos.jpg/170px-Muhammad_Ali%2C_Davos.jpg" width="170" height="347" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Muhammad_Ali%2C_Davos.jpg/255px-Muhammad_Ali%2C_Davos.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Muhammad_Ali%2C_Davos.jpg/340px-Muhammad_Ali%2C_Davos.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Muhammad_Ali,_Davos.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Muhammad_Ali" title="Muhammad Ali">Muhammad Ali</a> at the <a href="/wiki/World_Economic_Forum" title="World Economic Forum">World Economic Forum</a> in <a href="/wiki/Davos" title="Davos">Davos</a>, at the age of 64. He has shown signs of parkinsonism since the age of 38.</div>
</div>
</div>
<p>The costs of PD to society are high, but precise calculations are difficult due to methodological issues in research and differences between countries.<sup id="cite_ref-pmid17702630_82-0" class="reference"><a href="#cite_note-pmid17702630-82"><span>[</span>82<span>]</span></a></sup> The annual cost in the UK is estimated to be between 449 million and 3.3 billion pounds, while the cost per patient per year in the U.S. is probably around $10,000 and the total burden around 23 billion dollars.<sup id="cite_ref-pmid17702630_82-1" class="reference"><a href="#cite_note-pmid17702630-82"><span>[</span>82<span>]</span></a></sup> The largest share of direct cost comes from <a href="/wiki/Inpatient_care" title="Inpatient care">inpatient care</a> and nursing homes, while the share coming from medication is substantially lower.<sup id="cite_ref-pmid17702630_82-2" class="reference"><a href="#cite_note-pmid17702630-82"><span>[</span>82<span>]</span></a></sup> Indirect costs are high, due to reduced productivity and the burden on caregivers.<sup id="cite_ref-pmid17702630_82-3" class="reference"><a href="#cite_note-pmid17702630-82"><span>[</span>82<span>]</span></a></sup> In addition to economic costs, PD reduces <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a> of those with the disease and their caregivers.<sup id="cite_ref-pmid17702630_82-4" class="reference"><a href="#cite_note-pmid17702630-82"><span>[</span>82<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Advocacy">Advocacy</span></h3>
<p>11 April, the birthday of James Parkinson, has been designated as Parkinson's disease day.<sup id="cite_ref-pmid18175393_76-7" class="reference"><a href="#cite_note-pmid18175393-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-tulip_83-0" class="reference"><a href="#cite_note-tulip-83"><span>[</span>83<span>]</span></a></sup> A red tulip was chosen by international organizations as the symbol of the disease in 2005: it represents the James Parkinson Tulip <a href="/wiki/Cultivar" title="Cultivar">cultivar</a>, registered in 1981 by a Dutch horticulturalist.<sup id="cite_ref-tulip_83-1" class="reference"><a href="#cite_note-tulip-83"><span>[</span>83<span>]</span></a></sup> Advocacy organizations include the <a href="/wiki/National_Parkinson_Foundation" title="National Parkinson Foundation">National Parkinson Foundation</a>, which has provided more than $180 million in care, research and support services since 1982,<sup id="cite_ref-urlNational_Parkinson_Foundation_.E2.80.93_Mission_84-0" class="reference"><a href="#cite_note-urlNational_Parkinson_Foundation_.E2.80.93_Mission-84"><span>[</span>84<span>]</span></a></sup> <a href="/wiki/Parkinson%27s_Disease_Foundation" title="Parkinson's Disease Foundation">Parkinson's Disease Foundation</a>, which has distributed more than $100 million for research and $42 million for education and advocacy programs since its founding in 1957 by William Black;<sup id="cite_ref-85" class="reference"><a href="#cite_note-85"><span>[</span>85<span>]</span></a></sup><sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>86<span>]</span></a></sup> the <a href="/wiki/American_Parkinson_Disease_Association" title="American Parkinson Disease Association">American Parkinson Disease Association</a>, founded in 1961;<sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>87<span>]</span></a></sup> and the <a href="/wiki/European_Parkinson%27s_Disease_Association" title="European Parkinson's Disease Association">European Parkinson's Disease Association</a>, founded in 1992.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88"><span>[</span>88<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Notable_cases">Notable cases</span></h3>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/List_of_people_diagnosed_with_Parkinson%27s_disease" title="List of people diagnosed with Parkinson's disease">List of people diagnosed with Parkinson's disease</a></div>
<p>Actor <a href="/wiki/Michael_J._Fox" title="Michael J. Fox">Michael J. Fox</a> has PD and has greatly increased the public awareness of the disease. Fox was diagnosed in 1991 when he was 30, but kept his condition secret from the public for seven years.<sup id="cite_ref-MJF_TIME_89-0" class="reference"><a href="#cite_note-MJF_TIME-89"><span>[</span>89<span>]</span></a></sup> He has written two autobiographies in which his fight against the disease plays a major role,<sup id="cite_ref-MJF_guardian_90-0" class="reference"><a href="#cite_note-MJF_guardian-90"><span>[</span>90<span>]</span></a></sup> and appeared before the <a href="/wiki/United_States_Congress" title="United States Congress">United States Congress</a> without medication to illustrate the effects of the disease.<sup id="cite_ref-MJF_guardian_90-1" class="reference"><a href="#cite_note-MJF_guardian-90"><span>[</span>90<span>]</span></a></sup> <a href="/wiki/The_Michael_J._Fox_Foundation" title="The Michael J. Fox Foundation">The Michael J. Fox Foundation</a> aims to develop a cure for Parkinson's disease. In recent years it has been the major Parkinson's fundraiser in the U.S., providing $140 million in funding between 2001 and 2008.<sup id="cite_ref-MJF_guardian_90-2" class="reference"><a href="#cite_note-MJF_guardian-90"><span>[</span>90<span>]</span></a></sup> Fox was named one of the <a href="/wiki/Time_100" title="Time 100">100 people</a> "whose power, talent or moral example is transforming the world" in 2007 by <a href="/wiki/Time_(magazine)" title="Time (magazine)"><i>Time</i> magazine</a>,<sup id="cite_ref-MJF_TIME_89-1" class="reference"><a href="#cite_note-MJF_TIME-89"><span>[</span>89<span>]</span></a></sup> and he received an <a href="/wiki/Honorary_doctorate" title="Honorary doctorate" class="mw-redirect">honorary doctorate</a> in medicine from <a href="/wiki/Karolinska_Institutet" title="Karolinska Institutet">Karolinska Institutet</a> for his contributions to research in Parkinson's disease.<sup id="cite_ref-doctorate_Fox_91-0" class="reference"><a href="#cite_note-doctorate_Fox-91"><span>[</span>91<span>]</span></a></sup></p>
<p>Professional <a href="/wiki/Cyclist" title="Cyclist" class="mw-redirect">cyclist</a> and Olympic medalist <a href="/wiki/Davis_Phinney" title="Davis Phinney">Davis Phinney</a>, who was diagnosed with young onset Parkinson's at age 40, started a foundation in his name in 2004 to support Parkinson's research, focusing on quality of life for people with the disease.<sup id="cite_ref-Phinney_92-0" class="reference"><a href="#cite_note-Phinney-92"><span>[</span>92<span>]</span></a></sup><sup id="cite_ref-93" class="reference"><a href="#cite_note-93"><span>[</span>93<span>]</span></a></sup> The <a href="/wiki/Davis_Phinney_Foundation" title="Davis Phinney Foundation" class="mw-redirect">Davis Phinney Foundation</a>'s mission is to help people living with Parkinson's disease live well by providing them with information, inspiration and tools.<sup id="cite_ref-DPF_94-0" class="reference"><a href="#cite_note-DPF-94"><span>[</span>94<span>]</span></a></sup><sup id="cite_ref-Phinney2_95-0" class="reference"><a href="#cite_note-Phinney2-95"><span>[</span>95<span>]</span></a></sup> Phinney gives motivational speeches to people with Parkinson’s, pushing them to celebrate every victory, however small, like tying their shoes.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96"><span>[</span>96<span>]</span></a></sup></p>
<p><a href="/wiki/Muhammad_Ali" title="Muhammad Ali">Muhammad Ali</a> has been called the "world's most famous Parkinson's patient".<sup id="cite_ref-Ali_NN_comment_97-0" class="reference"><a href="#cite_note-Ali_NN_comment-97"><span>[</span>97<span>]</span></a></sup> He was 42 at diagnosis although he showed signs of Parkinson's when he was 38.<sup id="cite_ref-Ali_NN_98-0" class="reference"><a href="#cite_note-Ali_NN-98"><span>[</span>98<span>]</span></a></sup> Whether he has PD or a <a href="/wiki/Parkinsonism" title="Parkinsonism">parkinsonism</a> <a href="/wiki/Dementia_pugilistica" title="Dementia pugilistica">related to boxing</a> is unresolved.<sup id="cite_ref-Ali_NN_98-1" class="reference"><a href="#cite_note-Ali_NN-98"><span>[</span>98<span>]</span></a></sup><sup id="cite_ref-Ali_NYT_99-0" class="reference"><a href="#cite_note-Ali_NYT-99"><span>[</span>99<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Research">Research</span></h2>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Parkinson%27s_disease_clinical_research" title="Parkinson's disease clinical research">Parkinson's disease clinical research</a></div>
<p>There is little prospect of dramatic new PD treatments expected in a short time frame.<sup id="cite_ref-Dimond_100-0" class="reference"><a href="#cite_note-Dimond-100"><span>[</span>100<span>]</span></a></sup> Currently active research directions include the search for new <a href="/wiki/Animal_model" title="Animal model">animal models</a> of the disease and studies of the potential usefulness of <a href="/wiki/Gene_therapy" title="Gene therapy">gene therapy</a>, <a href="/wiki/Stem_cell" title="Stem cell">stem cell</a> transplants and <a href="/wiki/Neuroprotective" title="Neuroprotective" class="mw-redirect">neuroprotective</a> agents.<sup id="cite_ref-pmid20495568_35-7" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Animal_models">Animal models</span></h3>
<p>PD is not known to occur naturally in any species other than humans, although animal models which show some features of the disease are used in research. The appearance of parkinsonian symptoms in a group of drug addicts in the early 1980s who consumed a contaminated batch of the synthetic <a href="/wiki/Opiate" title="Opiate">opiate</a> <a href="/wiki/MPPP" title="MPPP" class="mw-redirect">MPPP</a> led to the discovery of the chemical <a href="/wiki/MPTP" title="MPTP">MPTP</a> as an agent that causes a parkinsonian syndrome in non-human primates as well as in humans.<sup id="cite_ref-pmid6823561_101-0" class="reference"><a href="#cite_note-pmid6823561-101"><span>[</span>101<span>]</span></a></sup> Other predominant toxin-based models employ the insecticide <a href="/wiki/Rotenone" title="Rotenone">rotenone</a>, the herbicide <a href="/wiki/Paraquat" title="Paraquat">paraquat</a> and the fungicide <a href="/wiki/Maneb" title="Maneb">maneb</a>.<sup id="cite_ref-pmid19729209_102-0" class="reference"><a href="#cite_note-pmid19729209-102"><span>[</span>102<span>]</span></a></sup> Models based on toxins are most commonly used in <a href="/wiki/Primate" title="Primate">primates</a>. <a href="/wiki/Transgenic" title="Transgenic" class="mw-redirect">Transgenic</a> rodent models that replicate various aspects of PD have been developed.<sup id="cite_ref-pmid18642640_103-0" class="reference"><a href="#cite_note-pmid18642640-103"><span>[</span>103<span>]</span></a></sup> Using the neurotoxin 6-hydroxydopamine, also known as 6-OHDA, it creates a model of Parkinson’s disease in rats by targeting and destroying dopaminergic neurons in the nigrostriatal pathway when injected into the substantia nigra <sup id="cite_ref-104" class="reference"><a href="#cite_note-104"><span>[</span>104<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Gene_therapy">Gene therapy</span></h3>
<p>Gene therapy involves the use of a non-infectious <a href="/wiki/Virus" title="Virus">virus</a> to shuttle a gene into a part of the brain. The gene used leads to the production of an <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> that helps to manage PD symptoms or protects the brain from further damage.<sup id="cite_ref-pmid20495568_35-8" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-pmid20155994_105-0" class="reference"><a href="#cite_note-pmid20155994-105"><span>[</span>105<span>]</span></a></sup> In 2010 there were four clinical trials using gene therapy in PD.<sup id="cite_ref-pmid20495568_35-9" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> There have not been important adverse effects in these trials although the clinical usefulness of gene therapy is still unknown.<sup id="cite_ref-pmid20495568_35-10" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> One of these reported positive results in 2011,<sup id="cite_ref-pmid21419704_106-0" class="reference"><a href="#cite_note-pmid21419704-106"><span>[</span>106<span>]</span></a></sup> but the company filed for bankruptcy in March 2012.<sup id="cite_ref-107" class="reference"><a href="#cite_note-107"><span>[</span>107<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Neuroprotective_treatments">Neuroprotective treatments</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:GDNF.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/GDNF.jpg/220px-GDNF.jpg" width="220" height="143" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/GDNF.jpg/330px-GDNF.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6a/GDNF.jpg/440px-GDNF.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:GDNF.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Several chemical compounds such as <a href="/wiki/GDNF" title="GDNF" class="mw-redirect">GDNF</a> (chemical structure pictured) have been proposed as neuroprotectors in PD, but their effectiveness has not been proven.</div>
</div>
</div>
<p>Investigations on <a href="/wiki/Neuroprotective" title="Neuroprotective" class="mw-redirect">neuroprotection</a> are at the forefront of PD research. Several molecules have been proposed as potential treatments.<sup id="cite_ref-pmid20495568_35-11" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> However, none of them have been conclusively demonstrated to reduce degeneration.<sup id="cite_ref-pmid20495568_35-12" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> Agents currently under investigation include <a href="/wiki/Apoptosis" title="Apoptosis">anti-apoptotics</a> (<a href="/wiki/Omigapil" title="Omigapil">omigapil</a>, <a href="/w/index.php?title=CEP-1347&amp;action=edit&amp;redlink=1" class="new" title="CEP-1347 (page does not exist)">CEP-1347</a>), <a href="/wiki/Glutamate" title="Glutamate" class="mw-redirect">antiglutamatergics</a>, <a href="/wiki/Monoamine_oxidase" title="Monoamine oxidase">monoamine oxidase</a> inhibitors (<a href="/wiki/Selegiline" title="Selegiline">selegiline</a>, <a href="/wiki/Rasagiline" title="Rasagiline">rasagiline</a>), <a href="/wiki/Mitochondrial" title="Mitochondrial" class="mw-redirect">promitochondrials</a> (<a href="/wiki/Coenzyme_Q10" title="Coenzyme Q10">coenzyme Q10</a>, <a href="/wiki/Creatine" title="Creatine">creatine</a>), <a href="/wiki/Calcium_channel_blocker" title="Calcium channel blocker">calcium channel blockers</a> (<a href="/wiki/Isradipine" title="Isradipine">isradipine</a>) and <a href="/wiki/Growth_factor" title="Growth factor">growth factors</a> (<a href="/wiki/GDNF" title="GDNF" class="mw-redirect">GDNF</a>).<sup id="cite_ref-pmid20495568_35-13" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> Preclinical research also targets <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a>.<sup id="cite_ref-Dimond_100-1" class="reference"><a href="#cite_note-Dimond-100"><span>[</span>100<span>]</span></a></sup> A <a href="/wiki/Vaccine" title="Vaccine">vaccine</a> that primes the human immune system to destroy <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a>, PD01A (developed by Austrian company, Affiris), has entered clinical trials in humans.<sup id="cite_ref-NS1_108-0" class="reference"><a href="#cite_note-NS1-108"><span>[</span>108<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Neural_transplantation">Neural transplantation</span></h3>
<p>Since early in the 1980s, <a href="/wiki/Fetus" title="Fetus">fetal</a>, <a href="/wiki/Pig" title="Pig">porcine</a>, <a href="/wiki/Common_carotid_artery" title="Common carotid artery">carotid</a> or <a href="/wiki/Retina" title="Retina">retinal</a> tissues have been used in cell transplants, in which dissociated cells are injected into the substantia nigra in the hope that they will incorporate themselves into the brain in a way that replaces the dopamine-producing cells that have been lost.<sup id="cite_ref-pmid20495568_35-14" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> Although there was initial evidence of <a href="/wiki/Mesencephalon" title="Mesencephalon" class="mw-redirect">mesencephalic</a> dopamine-producing cell transplants being beneficial, <a href="/wiki/Double-blind#Double-blind_trials" title="Double-blind" class="mw-redirect">double-blind trials</a> to date indicate that cell transplants produce no long-term benefit.<sup id="cite_ref-pmid20495568_35-15" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> An additional significant problem was the excess release of dopamine by the transplanted tissue, leading to <a href="/wiki/Dystonia" title="Dystonia">dystonias</a>.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109"><span>[</span>109<span>]</span></a></sup> <a href="/wiki/Stem_cell" title="Stem cell">Stem cell</a> transplants are a recent research target, because stem cells are easy to manipulate and stem cells transplanted into the brains of rodents and monkeys have been found to survive and reduce behavioral abnormalities.<sup id="cite_ref-pmid20495568_35-16" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-Science_Daily_110-0" class="reference"><a href="#cite_note-Science_Daily-110"><span>[</span>110<span>]</span></a></sup> Nevertheless, use of fetal stem cells is <a href="/wiki/Stem_cell_controversy" title="Stem cell controversy">controversial</a>.<sup id="cite_ref-pmid20495568_35-17" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup> It has been proposed that effective treatments may be developed in a less controversial way by use of <a href="/wiki/Induced_pluripotent_stem_cell" title="Induced pluripotent stem cell">induced pluripotent stem cells</a> taken from adults.<sup id="cite_ref-pmid20495568_35-18" class="reference"><a href="#cite_note-pmid20495568-35"><span>[</span>35<span>]</span></a></sup><br style="clear:both;" /></p>
<h2><span class="mw-headline" id="References">References</span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Jankovic2008-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jankovic2008_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-26"><sup><i><b>aa</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-27"><sup><i><b>ab</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-28"><sup><i><b>ac</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-29"><sup><i><b>ad</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-30"><sup><i><b>ae</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-31"><sup><i><b>af</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-32"><sup><i><b>ag</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-33"><sup><i><b>ah</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-34"><sup><i><b>ai</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-35"><sup><i><b>aj</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-36"><sup><i><b>ak</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-37"><sup><i><b>al</b></i></sup></a> <a href="#cite_ref-Jankovic2008_1-38"><sup><i><b>am</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Jankovic J (April 2008). <a rel="nofollow" class="external text" href="http://jnnp.bmj.com/content/79/4/368.full">"Parkinson's disease: clinical features and diagnosis"</a>. <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>79</b> (4): 368–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fjnnp.2007.131045">10.1136/jnnp.2007.131045</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18344392">18344392</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease%3A+clinical+features+and+diagnosis&amp;rft.au=Jankovic+J&amp;rft.aulast=Jankovic+J&amp;rft.date=April+2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjnnp.bmj.com%2Fcontent%2F79%2F4%2F368.full&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2007.131045&amp;rft_id=info%3Apmid%2F18344392&amp;rft.issue=4&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.pages=368%E2%80%9376&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=79" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15172778-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15172778_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid15172778_2-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Samii A, Nutt JG, Ransom BR (May 2004). "Parkinson's disease". <i>Lancet</i> <b>363</b> (9423): 1783–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2804%2916305-8">10.1016/S0140-6736(04)16305-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15172778">15172778</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease&amp;rft.aulast=Samii+A%2C+Nutt+JG%2C+Ransom+BR&amp;rft.au=Samii+A%2C+Nutt+JG%2C+Ransom+BR&amp;rft.date=May+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2804%2916305-8&amp;rft_id=info%3Apmid%2F15172778&amp;rft.issue=9423&amp;rft.jtitle=Lancet&amp;rft.pages=1783%E2%80%9393&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=363" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jankovic_book-Epidemiology-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jankovic_book-Epidemiology_3-0">^</a></b></span> <span class="reference-text"><span class="citation book">Schrag A (2007). "Epidemiology of movement disorders". In Tolosa E, Jankovic JJ. <i>Parkinson's disease and movement disorders</i>. Hagerstown, Maryland: Lippincott Williams &amp; Wilkins. pp.&#160;50–66. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-7881-6" title="Special:BookSources/0-7817-7881-6">0-7817-7881-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.aulast=Schrag+A&amp;rft.au=Schrag+A&amp;rft.btitle=Epidemiology+of+movement+disorders&amp;rft.date=2007&amp;rft.genre=bookitem&amp;rft.isbn=0-7817-7881-6&amp;rft.pages=50%E2%80%9366&amp;rft.place=Hagerstown%2C+Maryland&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18398010-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18398010_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18398010_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18398010_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18398010_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18398010_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18398010_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid18398010_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid18398010_4-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Davie CA (2008). "A review of Parkinson's disease". <i>Br. Med. Bull.</i> <b>86</b> (1): 109–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fbmb%2Fldn013">10.1093/bmb/ldn013</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18398010">18398010</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=A+review+of+Parkinson%27s+disease&amp;rft.au=Davie+CA&amp;rft.aulast=Davie+CA&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldn013&amp;rft_id=info%3Apmid%2F18398010&amp;rft.issue=1&amp;rft.jtitle=Br.+Med.+Bull.&amp;rft.pages=109%E2%80%9327&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20206672-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20206672_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Barnett-Cowan M, Dyde RT, Foxe SH, Moro E, Hutchison WD, Harris LR (June 2010). "Multisensory determinants of orientation perception in Parkinson's disease". <i>Neuroscience</i> <b>167</b> (4): 1138–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.neuroscience.2010.02.065">10.1016/j.neuroscience.2010.02.065</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20206672">20206672</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Multisensory+determinants+of+orientation+perception+in+Parkinson%27s+disease&amp;rft.au=Barnett-Cowan+M%2C+Dyde+RT%2C+Foxe+SH%2C+Moro+E%2C+Hutchison+WD%2C+Harris+LR&amp;rft.aulast=Barnett-Cowan+M%2C+Dyde+RT%2C+Foxe+SH%2C+Moro+E%2C+Hutchison+WD%2C+Harris+LR&amp;rft.date=June+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuroscience.2010.02.065&amp;rft_id=info%3Apmid%2F20206672&amp;rft.issue=4&amp;rft.jtitle=Neuroscience&amp;rft.pages=1138%E2%80%9350&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=167" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20506312-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20506312_6-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (July 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3056147">"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update"</a>. <i>Human Mutatation</i> <b>31</b> (7): 763–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fhumu.21277">10.1002/humu.21277</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3056147">3056147</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20506312">20506312</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Genetic+etiology+of+Parkinson+disease+associated+with+mutations+in+the+SNCA%2C+PARK2%2C+PINK1%2C+PARK7%2C+and+LRRK2+genes%3A+a+mutation+update&amp;rft.aulast=Nuytemans+K%2C+Theuns+J%2C+Cruts+M%2C+Van+Broeckhoven+C&amp;rft.au=Nuytemans+K%2C+Theuns+J%2C+Cruts+M%2C+Van+Broeckhoven+C&amp;rft.date=July+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056147&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.21277&amp;rft_id=info%3Apmc%2F3056147&amp;rft_id=info%3Apmid%2F20506312&amp;rft.issue=7&amp;rft.jtitle=Human+Mutatation&amp;rft.pages=763%E2%80%9380&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16489609-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16489609_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16489609_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Galpern WR, Lang AE (March 2006). "Interface between tauopathies and synucleinopathies: a tale of two proteins". <i>Annals of Neurology</i> <b>59</b> (3): 449–58. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fana.20819">10.1002/ana.20819</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16489609">16489609</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Interface+between+tauopathies+and+synucleinopathies%3A+a+tale+of+two+proteins&amp;rft.au=Galpern+WR%2C+Lang+AE&amp;rft.aulast=Galpern+WR%2C+Lang+AE&amp;rft.date=March+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fana.20819&amp;rft_id=info%3Apmid%2F16489609&amp;rft.issue=3&amp;rft.jtitle=Annals+of+Neurology&amp;rft.pages=449%E2%80%9358&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=59" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19173762-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19173762_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19173762_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Aarsland D, Londos E, Ballard C (April 2009). "Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity". <i>Int. Psychogeriatr.</i> <b>21</b> (2): 216–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1017%2FS1041610208008612">10.1017/S1041610208008612</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19173762">19173762</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease+dementia+and+dementia+with+Lewy+bodies%3A+different+aspects+of+one+entity&amp;rft.au=Aarsland+D%2C+Londos+E%2C+Ballard+C&amp;rft.aulast=Aarsland+D%2C+Londos+E%2C+Ballard+C&amp;rft.date=April+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS1041610208008612&amp;rft_id=info%3Apmid%2F19173762&amp;rft.issue=2&amp;rft.jtitle=Int.+Psychogeriatr.&amp;rft.pages=216%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Cooper-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cooper_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cooper_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Cooper G, Eichhorn G, Rodnitzky RL (2008). "Parkinson's disease". In Conn PM. <i>Neuroscience in medicine</i>. Totowa, NJ: Humana Press. pp.&#160;508–12. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-60327-454-8" title="Special:BookSources/978-1-60327-454-8">978-1-60327-454-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Neuroscience+in+medicine&amp;rft.au=Cooper+G%2C+Eichhorn+G%2C+Rodnitzky+RL&amp;rft.aulast=Cooper+G%2C+Eichhorn+G%2C+Rodnitzky+RL&amp;rft.btitle=Parkinson%27s+disease&amp;rft.date=2008&amp;rft.genre=bookitem&amp;rft.isbn=978-1-60327-454-8&amp;rft.pages=508%E2%80%9312&amp;rft.place=Totowa%2C+NJ&amp;rft.pub=Humana+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19909911-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19909911_10-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rodriguez-Oroz MC, Jahanshahi M, Krack P, <i>et al.</i> (December 2009). "Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms". <i>Lancet Neurol.</i> <b>8</b> (12): 1128–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS1474-4422%2809%2970293-5">10.1016/S1474-4422(09)70293-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19909911">19909911</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Initial+clinical+manifestations+of+Parkinson%27s+disease%3A+features+and+pathophysiological+mechanisms&amp;rft.aulast=Rodriguez-Oroz+MC%2C+Jahanshahi+M%2C+Krack+P%2C+%27%27et+al.%27%27&amp;rft.au=Rodriguez-Oroz+MC%2C+Jahanshahi+M%2C+Krack+P%2C+%27%27et+al.%27%27&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2809%2970293-5&amp;rft_id=info%3Apmid%2F19909911&amp;rft.issue=12&amp;rft.jtitle=Lancet+Neurol.&amp;rft.pages=1128%E2%80%9339&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Banich-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Banich_11-0">^</a></b></span> <span class="reference-text"><span class="citation book">Banich MT, Compton RJ (2011). "Motor control". <i>Cognitive neuroscience</i>. Belmont, CA: Wadsworth, Cengage learning. pp.&#160;108–44. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-8400-3298-6" title="Special:BookSources/0-8400-3298-6">0-8400-3298-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Cognitive+neuroscience&amp;rft.au=Banich+MT%2C+Compton+RJ&amp;rft.aulast=Banich+MT%2C+Compton+RJ&amp;rft.btitle=Motor+control&amp;rft.date=2011&amp;rft.genre=bookitem&amp;rft.isbn=0-8400-3298-6&amp;rft.pages=108%E2%80%9344&amp;rft.place=Belmont%2C+CA&amp;rft.pub=Wadsworth%2C+Cengage+learning&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation book">Longmore, Murray; Wilkinson, Ian B.; Turmezei, Tom; Cheung, Chee Kay (4 January 2007). <i>Oxford Handbook of Clinical Medicine</i>. <a href="/wiki/Oxford_University_Press" title="Oxford University Press">Oxford University Press</a>. p.&#160;486. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-19-856837-7" title="Special:BookSources/978-0-19-856837-7">978-0-19-856837-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.au=Cheung%2C+Chee+Kay&amp;rft.aufirst=Murray&amp;rft.aulast=Longmore&amp;rft.au=Longmore%2C+Murray&amp;rft.au=Turmezei%2C+Tom&amp;rft.au=Wilkinson%2C+Ian+B.&amp;rft.btitle=Oxford+Handbook+of+Clinical+Medicine&amp;rft.date=4+January+2007&amp;rft.genre=book&amp;rft.isbn=978-0-19-856837-7&amp;rft.pages=486&amp;rft.pub=Oxford+University+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jankovic_book-Rigidity-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jankovic_book-Rigidity_13-0">^</a></b></span> <span class="reference-text"><span class="citation book">Fung VSC, Thompson PD (2007). "Rigidity and spasticity". In Tolosa E, Jankovic JJ. <i>Parkinson's disease and movement disorders</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. pp.&#160;504–13. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-7881-6" title="Special:BookSources/0-7817-7881-6">0-7817-7881-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.au=Fung+VSC%2C+Thompson+PD&amp;rft.aulast=Fung+VSC%2C+Thompson+PD&amp;rft.btitle=Rigidity+and+spasticity&amp;rft.date=2007&amp;rft.genre=bookitem&amp;rft.isbn=0-7817-7881-6&amp;rft.pages=504%E2%80%9313&amp;rft.place=Hagerstown%2C+MD&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span id="CITEREFO.27SullivanSchmitz2007" class="citation book">O'Sullivan, Susan B; Schmitz, Thomas J (2007). "Parkinson's Disease". <i>Physical Rehabilitation</i> (5th ed.). Philadelphia: F.A. Davis. pp.&#160;856–7.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Physical+Rehabilitation&amp;rft.aufirst=Susan+B&amp;rft.aulast=O%27Sullivan&amp;rft.au=O%27Sullivan%2C+Susan+B&amp;rft.au=Schmitz%2C+Thomas+J&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.date=2007&amp;rft.edition=5th&amp;rft.genre=bookitem&amp;rft.pages=856%E2%80%937&amp;rft.place=Philadelphia&amp;rft.pub=F.A.+Davis&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-OFP-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-OFP_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OFP_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Yao, S.C.; Hart, A.D.; Terzella, M.J. (May 2013). "An evidence-based osteopathic approach to Parkinson disease". <i>Osteopathic Family Physician</i> <b>5</b> (3): 96–101. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.osfp.2013.01.003">10.1016/j.osfp.2013.01.003</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=An+evidence-based+osteopathic+approach+to+Parkinson+disease&amp;rft.aufirst=S.C.&amp;rft.au=Hart%2C+A.D.&amp;rft.aulast=Yao&amp;rft.au=Terzella%2C+M.J.&amp;rft.au=Yao%2C+S.C.&amp;rft.date=May+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.osfp.2013.01.003&amp;rft.issue=3&amp;rft.jtitle=Osteopathic+Family+Physician&amp;rft.pages=96%E2%80%93101&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20233583-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20233583_16-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Russell JA, Ciucci MR, Connor NP, Schallert T. (23 June 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2908992">"Targeted exercise therapy for voice and swallow in persons with Parkinson's disease"</a>. <i>Brain Res.</i> <b>1341</b>: 3–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.brainres.2010.03.029">10.1016/j.brainres.2010.03.029</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2908992">2908992</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20233583">20233583</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Targeted+exercise+therapy+for+voice+and+swallow+in+persons+with+Parkinson%27s+disease&amp;rft.aulast=Russell+JA%2C+Ciucci+MR%2C+Connor+NP%2C+Schallert+T.&amp;rft.au=Russell+JA%2C+Ciucci+MR%2C+Connor+NP%2C+Schallert+T.&amp;rft.date=23+June+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2908992&amp;rft_id=info%3Adoi%2F10.1016%2Fj.brainres.2010.03.029&amp;rft_id=info%3Apmc%2F2908992&amp;rft_id=info%3Apmid%2F20233583&amp;rft.jtitle=Brain+Res.&amp;rft.pages=3%E2%80%9311&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1341" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18175397-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18175397_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18175397_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18175397_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18175397_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18175397_17-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Caballol N, Martí MJ, Tolosa E (September 2007). "Cognitive dysfunction and dementia in Parkinson disease". <i>Mov. Disord.</i> <b>22</b> (Suppl 17): S358–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.21677">10.1002/mds.21677</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18175397">18175397</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Cognitive+dysfunction+and+dementia+in+Parkinson+disease&amp;rft.au=Caballol+N%2C+Mart%C3%AD+MJ%2C+Tolosa+E&amp;rft.aulast=Caballol+N%2C+Mart%C3%AD+MJ%2C+Tolosa+E&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21677&amp;rft_id=info%3Apmid%2F18175397&amp;rft.issue=Suppl+17&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=S358%E2%80%9366&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation book">Murray ED, Buttner N, Price BH (2012). "Depression and Psychosis in Neurological Practice". In Bradley WG, Daroff RB, Fenichel GM, Jankovic J. <i>Bradley's Neurology in Clinical Practice: Expert Consult – Online and Print, 6e (Bradley, Neurology in Clinical Practice e-dition 2v Set)</i> <b>1</b> (6th ed.). Philadelphia, PA: Elsevier/Saunders. pp.&#160;102–103. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-4377-0434-4" title="Special:BookSources/1-4377-0434-4">1-4377-0434-4</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Bradley%27s+Neurology+in+Clinical+Practice%3A+Expert+Consult+%E2%80%93+Online+and+Print%2C+6e+%28Bradley%2C+Neurology+in+Clinical+Practice+e-dition+2v+Set%29&amp;rft.aulast=Murray+ED%2C+Buttner+N%2C+Price+BH&amp;rft.au=Murray+ED%2C+Buttner+N%2C+Price+BH&amp;rft.btitle=Depression+and+Psychosis+in+Neurological+Practice&amp;rft.date=2012&amp;rft.edition=6th&amp;rft.genre=bookitem&amp;rft.isbn=1-4377-0434-4&amp;rft.pages=102%E2%80%93103&amp;rft.place=Philadelphia%2C+PA&amp;rft.pub=Elsevier%2FSaunders&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20123548-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20123548_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20123548_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20123548_19-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ceravolo R, Frosini D, Rossi C, Bonuccelli U (December 2009). "Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management". <i>Parkinsonism Relat. Disord.</i> <b>15</b> (Suppl 4): S111–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS1353-8020%2809%2970847-8">10.1016/S1353-8020(09)70847-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20123548">20123548</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Impulse+control+disorders+in+Parkinson%27s+disease%3A+definition%2C+epidemiology%2C+risk+factors%2C+neurobiology+and+management&amp;rft.au=Ceravolo+R%2C+Frosini+D%2C+Rossi+C%2C+Bonuccelli+U&amp;rft.aulast=Ceravolo+R%2C+Frosini+D%2C+Rossi+C%2C+Bonuccelli+U&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1353-8020%2809%2970847-8&amp;rft_id=info%3Apmid%2F20123548&amp;rft.issue=Suppl+4&amp;rft.jtitle=Parkinsonism+Relat.+Disord.&amp;rft.pages=S111%E2%80%935&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Shergill SS, Walker Z, Le Katona C (October 1998). <a rel="nofollow" class="external text" href="http://jnnp.bmj.com/cgi/pmidlookup?view=long&amp;pmid=9771806">"A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis"</a>. <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>65</b> (4): 610–1. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fjnnp.65.4.610">10.1136/jnnp.65.4.610</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2170290">2170290</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9771806">9771806</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=A+preliminary+investigation+of+laterality+in+Parkinson%27s+disease+and+susceptibility+to+psychosis&amp;rft.aulast=Shergill+SS%2C+Walker+Z%2C+Le+Katona+C&amp;rft.au=Shergill+SS%2C+Walker+Z%2C+Le+Katona+C&amp;rft.date=October+1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjnnp.bmj.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D9771806&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.65.4.610&amp;rft_id=info%3Apmc%2F2170290&amp;rft_id=info%3Apmid%2F9771806&amp;rft.issue=4&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.pages=610%E2%80%931&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20538500-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20538500_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Friedman JH (June 2010). "Parkinson's disease psychosis 2010: A review article". <i>Parkinsonism Relat. Disord.</i> <b>16</b> (9): 553–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.parkreldis.2010.05.004">10.1016/j.parkreldis.2010.05.004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20538500">20538500</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease+psychosis+2010%3A+A+review+article&amp;rft.au=Friedman+JH&amp;rft.aulast=Friedman+JH&amp;rft.date=June+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2010.05.004&amp;rft_id=info%3Apmid%2F20538500&amp;rft.issue=9&amp;rft.jtitle=Parkinsonism+Relat.+Disord.&amp;rft.pages=553%E2%80%9360&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19691125-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19691125_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid19691125_22-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Barichella M, Cereda E, Pezzoli G (October 2009). "Major nutritional issues in the management of Parkinson's disease". <i>Mov. Disord.</i> <b>24</b> (13): 1881–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.22705">10.1002/mds.22705</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19691125">19691125</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Major+nutritional+issues+in+the+management+of+Parkinson%27s+disease&amp;rft.au=Barichella+M%2C+Cereda+E%2C+Pezzoli+G&amp;rft.aulast=Barichella+M%2C+Cereda+E%2C+Pezzoli+G&amp;rft.date=October+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22705&amp;rft_id=info%3Apmid%2F19691125&amp;rft.issue=13&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=1881%E2%80%9392&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18271776-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18271776_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Armstrong RA (March 2008). "Visual signs and symptoms of Parkinson's disease". <i>Clin. Exp. Optom.</i> <b>91</b> (2): 129–38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1444-0938.2007.00211.x">10.1111/j.1444-0938.2007.00211.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18271776">18271776</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Visual+signs+and+symptoms+of+Parkinson%27s+disease&amp;rft.au=Armstrong+RA&amp;rft.aulast=Armstrong+RA&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1444-0938.2007.00211.x&amp;rft_id=info%3Apmid%2F18271776&amp;rft.issue=2&amp;rft.jtitle=Clin.+Exp.+Optom.&amp;rft.pages=129%E2%80%9338&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Noy2012-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Noy2012_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Noyce AJ, Bestwick JP, Silveira-Moriyama L, <i>et al.</i> (December 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3556649">"Meta-analysis of early nonmotor features and risk factors for Parkinson disease"</a>. <i>Annals of Neurology</i> <b>72</b> (6): 893–901. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fana.23687">10.1002/ana.23687</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3556649">3556649</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23071076">23071076</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Meta-analysis+of+early+nonmotor+features+and+risk+factors+for+Parkinson+disease&amp;rft.aulast=Noyce+AJ%2C+Bestwick+JP%2C+Silveira-Moriyama+L%2C+%27%27et+al.%27%27&amp;rft.au=Noyce+AJ%2C+Bestwick+JP%2C+Silveira-Moriyama+L%2C+%27%27et+al.%27%27&amp;rft.date=December+2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556649&amp;rft_id=info%3Adoi%2F10.1002%2Fana.23687&amp;rft_id=info%3Apmc%2F3556649&amp;rft_id=info%3Apmid%2F23071076&amp;rft.issue=6&amp;rft.jtitle=Annals+of+Neurology&amp;rft.pages=893%E2%80%93901&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=72" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Van Maele-Fabry G, Hoet P, Vilain F, Lison D (October 2012). "Occupational exposure to pesticides and Parkinson's disease: a systematic review and meta-analysis of cohort studies". <i>Environ Int</i> <b>46</b>: 30–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.envint.2012.05.004">10.1016/j.envint.2012.05.004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22698719">22698719</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Occupational+exposure+to+pesticides+and+Parkinson%27s+disease%3A+a+systematic+review+and+meta-analysis+of+cohort+studies&amp;rft.aulast=Van+Maele-Fabry+G%2C+Hoet+P%2C+Vilain+F%2C+Lison+D&amp;rft.au=Van+Maele-Fabry+G%2C+Hoet+P%2C+Vilain+F%2C+Lison+D&amp;rft.date=October+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.envint.2012.05.004&amp;rft_id=info%3Apmid%2F22698719&amp;rft.jtitle=Environ+Int&amp;rft.pages=30%E2%80%9343&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16713924-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16713924_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid16713924_26-14"><sup><i><b>o</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">de Lau LM, Breteler MM (June 2006). "Epidemiology of Parkinson's disease". <i>Lancet Neurol.</i> <b>5</b> (6): 525–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS1474-4422%2806%2970471-9">10.1016/S1474-4422(06)70471-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16713924">16713924</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Epidemiology+of+Parkinson%27s+disease&amp;rft.au=de+Lau+LM%2C+Breteler+MM&amp;rft.aulast=de+Lau+LM%2C+Breteler+MM&amp;rft.date=June+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2806%2970471-9&amp;rft_id=info%3Apmid%2F16713924&amp;rft.issue=6&amp;rft.jtitle=Lancet+Neurol.&amp;rft.pages=525%E2%80%9335&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Veterans-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-Veterans_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Veterans_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">IOM (Institute of Medicine), ed. (2009). <a rel="nofollow" class="external text" href="http://www.nap.edu/catalog.php?record_id=12662">"Neurologic disorders"</a>. <i>Veterans and Agent Orange: Update 2008</i>. Washington D.C.: The National Academies press. pp.&#160;510–45. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-309-13884-1" title="Special:BookSources/0-309-13884-1">0-309-13884-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Veterans+and+Agent+Orange%3A+Update+2008&amp;rft.btitle=Neurologic+disorders&amp;rft.date=2009&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fwww.nap.edu%2Fcatalog.php%3Frecord_id%3D12662&amp;rft.isbn=0-309-13884-1&amp;rft.pages=510%E2%80%9345&amp;rft.place=Washington+D.C.&amp;rft.pub=The+National+Academies+press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Freire C, Koifman S (October 2012). "Pesticide exposure and Parkinson's disease: epidemiological evidence of association". <i>Neurotoxicology</i> <b>33</b> (5): 947–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.neuro.2012.05.011">10.1016/j.neuro.2012.05.011</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22627180">22627180</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Pesticide+exposure+and+Parkinson%27s+disease%3A+epidemiological+evidence+of+association&amp;rft.au=Freire+C%2C+Koifman+S&amp;rft.aulast=Freire+C%2C+Koifman+S&amp;rft.date=October+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuro.2012.05.011&amp;rft_id=info%3Apmid%2F22627180&amp;rft.issue=5&amp;rft.jtitle=Neurotoxicology&amp;rft.pages=947%E2%80%9371&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Tanner CM, Kamel F, Ross GW, <i>et al.</i> (January 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3114824">"Rotenone, Paraquat and Parkinson's Disease"</a>. <i><a href="/wiki/Environ_Health_Perspect" title="Environ Health Perspect" class="mw-redirect">Environ Health Perspect</a></i> <b>119</b> (6): 866–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1289%2Fehp.1002839">10.1289/ehp.1002839</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3114824">3114824</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21269927">21269927</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Rotenone%2C+Paraquat+and+Parkinson%27s+Disease&amp;rft.aulast=Tanner+CM%2C+Kamel+F%2C+Ross+GW%2C+%27%27et+al.%27%27&amp;rft.au=Tanner+CM%2C+Kamel+F%2C+Ross+GW%2C+%27%27et+al.%27%27&amp;rft.date=January+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3114824&amp;rft_id=info%3Adoi%2F10.1289%2Fehp.1002839&amp;rft_id=info%3Apmc%2F3114824&amp;rft_id=info%3Apmid%2F21269927&amp;rft.issue=6&amp;rft.jtitle=Environ+Health+Perspect&amp;rft.pages=866%E2%80%9372&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=119" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-lesage-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-lesage_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-lesage_30-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-lesage_30-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-lesage_30-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-lesage_30-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-lesage_30-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-lesage_30-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-lesage_30-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-lesage_30-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-lesage_30-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lesage S, Brice A (April 2009). "Parkinson's disease: from monogenic forms to genetic susceptibility factors". <i>Hum. Mol. Genet.</i> <b>18</b> (R1): R48–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fhmg%2Fddp012">10.1093/hmg/ddp012</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19297401">19297401</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease%3A+from+monogenic+forms+to+genetic+susceptibility+factors&amp;rft.aulast=Lesage+S%2C+Brice+A&amp;rft.au=Lesage+S%2C+Brice+A&amp;rft.date=April+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2Fddp012&amp;rft_id=info%3Apmid%2F19297401&amp;rft.issue=R1&amp;rft.jtitle=Hum.+Mol.+Genet.&amp;rft.pages=R48%E2%80%9359&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-IPDGC-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-IPDGC_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">IPDGC; Nalls, MA; Plagnol, V; Hernandez, DG; Sharma, M; Sheerin, UM; Saad, M; Simón-Sánchez, J; Schulte, C (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3696507">"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies"</a>. <i>Lancet</i> <b>377</b> (9766): 641–49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2810%2962345-8">10.1016/S0140-6736(10)62345-8</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3696507">3696507</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21292315">21292315</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Imputation+of+sequence+variants+for+identification+of+genetic+risks+for+Parkinson%27s+disease%3A+a+meta-analysis+of+genome-wide+association+studies&amp;rft.au=Hernandez%2C+DG&amp;rft.au=IPDGC&amp;rft.aulast=IPDGC&amp;rft.au=Nalls%2C+MA&amp;rft.au=Plagnol%2C+V&amp;rft.au=Saad%2C+M&amp;rft.au=Schulte%2C+C&amp;rft.au=Sharma%2C+M&amp;rft.au=Sheerin%2C+UM&amp;rft.au=Sim%C3%B3n-S%C3%A1nchez%2C+J&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3696507&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2810%2962345-8&amp;rft_id=info%3Apmc%2F3696507&amp;rft_id=info%3Apmid%2F21292315&amp;rft.issue=9766&amp;rft.jtitle=Lancet&amp;rft.pages=641%E2%80%9349&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=377" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18781672-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18781672_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18781672_32-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18781672_32-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18781672_32-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18781672_32-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18781672_32-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid18781672_32-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid18781672_32-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, <i>et al.</i> (2008). "Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease". <i>Mov. Disord.</i> <b>23</b> (Suppl 3): S548–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.22062">10.1002/mds.22062</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18781672">18781672</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Functional+organization+of+the+basal+ganglia%3A+therapeutic+implications+for+Parkinson%27s+disease&amp;rft.aulast=Obeso+JA%2C+Rodr%C3%ADguez-Oroz+MC%2C+Benitez-Temino+B%2C+%27%27et+al.%27%27&amp;rft.au=Obeso+JA%2C+Rodr%C3%ADguez-Oroz+MC%2C+Benitez-Temino+B%2C+%27%27et+al.%27%27&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22062&amp;rft_id=info%3Apmid%2F18781672&amp;rft.issue=Suppl+3&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=S548%E2%80%9359&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jankovic_book-Neuropathology-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jankovic_book-Neuropathology_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jankovic_book-Neuropathology_33-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jankovic_book-Neuropathology_33-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Dickson DV (2007). "Neuropathology of movement disorders". In Tolosa E, Jankovic JJ. <i>Parkinson's disease and movement disorders</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. pp.&#160;271–83. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-7881-6" title="Special:BookSources/0-7817-7881-6">0-7817-7881-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.au=Dickson+DV&amp;rft.aulast=Dickson+DV&amp;rft.btitle=Neuropathology+of+movement+disorders&amp;rft.date=2007&amp;rft.genre=bookitem&amp;rft.isbn=0-7817-7881-6&amp;rft.pages=271%E2%80%9383&amp;rft.place=Hagerstown%2C+MD&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20011063-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20011063_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jubault T, Brambati SM, Degroot C, <i>et al.</i> (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2784293">"Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI"</a>. In Gendelman, Howard E. <i>PLoS ONE</i> <b>4</b> (12): e8247. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1371%2Fjournal.pone.0008247">10.1371/journal.pone.0008247</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2784293">2784293</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20011063">20011063</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Regional+brain+stem+atrophy+in+idiopathic+Parkinson%27s+disease+detected+by+anatomical+MRI&amp;rft.au=Jubault+T%2C+Brambati+SM%2C+Degroot+C%2C+%27%27et+al.%27%27&amp;rft.aulast=Jubault+T%2C+Brambati+SM%2C+Degroot+C%2C+%27%27et+al.%27%27&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2784293&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0008247&amp;rft_id=info%3Apmc%2F2784293&amp;rft_id=info%3Apmid%2F20011063&amp;rft.issue=12&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e8247&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20495568-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20495568_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-pmid20495568_35-18"><sup><i><b>s</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Obeso JA, Rodriguez-Oroz MC, Goetz CG, <i>et al.</i> (May 2010). "Missing pieces in the Parkinson's disease puzzle". <i>Nat. Med.</i> <b>16</b> (6): 653–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fnm.2165">10.1038/nm.2165</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20495568">20495568</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Missing+pieces+in+the+Parkinson%27s+disease+puzzle&amp;rft.aulast=Obeso+JA%2C+Rodriguez-Oroz+MC%2C+Goetz+CG%2C+%27%27et+al.%27%27&amp;rft.au=Obeso+JA%2C+Rodriguez-Oroz+MC%2C+Goetz+CG%2C+%27%27et+al.%27%27&amp;rft.date=May+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.2165&amp;rft_id=info%3Apmid%2F20495568&amp;rft.issue=6&amp;rft.jtitle=Nat.+Med.&amp;rft.pages=653%E2%80%9361&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20563819-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20563819_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20563819_36-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20563819_36-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Schulz-Schaeffer WJ (August 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2892607">"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia"</a>. <i>Acta Neuropathol.</i> <b>120</b> (2): 131–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00401-010-0711-0">10.1007/s00401-010-0711-0</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2892607">2892607</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20563819">20563819</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+synaptic+pathology+of+alpha-synuclein+aggregation+in+dementia+with+Lewy+bodies%2C+Parkinson%27s+disease+and+Parkinson%27s+disease+dementia&amp;rft.aulast=Schulz-Schaeffer+WJ&amp;rft.au=Schulz-Schaeffer+WJ&amp;rft.date=August+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2892607&amp;rft_id=info%3Adoi%2F10.1007%2Fs00401-010-0711-0&amp;rft_id=info%3Apmc%2F2892607&amp;rft_id=info%3Apmid%2F20563819&amp;rft.issue=2&amp;rft.jtitle=Acta+Neuropathol.&amp;rft.pages=131%E2%80%9343&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20082992-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20082992_37-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hirsch EC (December 2009). "Iron transport in Parkinson's disease". <i>Parkinsonism Relat. Disord.</i> <b>15</b> (Suppl 3): S209–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS1353-8020%2809%2970816-8">10.1016/S1353-8020(09)70816-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20082992">20082992</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Iron+transport+in+Parkinson%27s+disease&amp;rft.au=Hirsch+EC&amp;rft.aulast=Hirsch+EC&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1353-8020%2809%2970816-8&amp;rft_id=info%3Apmid%2F20082992&amp;rft.issue=Suppl+3&amp;rft.jtitle=Parkinsonism+Relat.+Disord.&amp;rft.pages=S209%E2%80%9311&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nice-Diagnosis-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-Diagnosis_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-Diagnosis_38-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Diagnosing Parkinson's Disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;29–47. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-86016-283-5" title="Special:BookSources/1-86016-283-5">1-86016-283-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+Disease&amp;rft.btitle=Diagnosing+Parkinson%27s+Disease&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rft.isbn=1-86016-283-5&amp;rft.pages=29%E2%80%9347&amp;rft.place=London&amp;rft.pub=Royal+College+of+Physicians&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12464118-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12464118_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Poewe W, Wenning G (November 2002). "The differential diagnosis of Parkinson's disease". <i>Eur. J. Neurol.</i> <b>9</b> (Suppl 3): 23–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1046%2Fj.1468-1331.9.s3.3.x">10.1046/j.1468-1331.9.s3.3.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12464118">12464118</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+differential+diagnosis+of+Parkinson%27s+disease&amp;rft.aulast=Poewe+W%2C+Wenning+G&amp;rft.au=Poewe+W%2C+Wenning+G&amp;rft.date=November+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1468-1331.9.s3.3.x&amp;rft_id=info%3Apmid%2F12464118&amp;rft.issue=Suppl+3&amp;rft.jtitle=Eur.+J.+Neurol.&amp;rft.pages=23%E2%80%9330&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20351351-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20351351_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20351351_40-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20351351_40-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid20351351_40-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid20351351_40-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Brooks DJ (April 2010). "Imaging approaches to Parkinson disease". <i>J. Nucl. Med.</i> <b>51</b> (4): 596–609. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2967%2Fjnumed.108.059998">10.2967/jnumed.108.059998</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20351351">20351351</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Imaging+approaches+to+Parkinson+disease&amp;rft.au=Brooks+DJ&amp;rft.aulast=Brooks+DJ&amp;rft.date=April+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2967%2Fjnumed.108.059998&amp;rft_id=info%3Apmid%2F20351351&amp;rft.issue=4&amp;rft.jtitle=J.+Nucl.+Med.&amp;rft.pages=596%E2%80%93609&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20182023-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20182023_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A (2010). "Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies". <i>J. Alzheimers Dis.</i> <b>20</b> (Suppl 1): S221–38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3233%2FJAD-2010-091525">10.3233/JAD-2010-091525</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20182023">20182023</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Caffeine+exposure+and+the+risk+of+Parkinson%27s+disease%3A+a+systematic+review+and+meta-analysis+of+observational+studies&amp;rft.au=Costa+J%2C+Lunet+N%2C+Santos+C%2C+Santos+J%2C+Vaz-Carneiro+A&amp;rft.aulast=Costa+J%2C+Lunet+N%2C+Santos+C%2C+Santos+J%2C+Vaz-Carneiro+A&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3233%2FJAD-2010-091525&amp;rft_id=info%3Apmid%2F20182023&amp;rft.issue=Suppl+1&amp;rft.jtitle=J.+Alzheimers+Dis.&amp;rft.pages=S221%E2%80%9338&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation journal">Quik M, Huang LZ, Parameswaran N, Bordia T, Campos C, Perez XA (1 October 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2815339">"Multiple roles for nicotine in Parkinson's disease"</a>. <i>Biochem Pharmacol</i> <b>78</b> (7): 677–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.bcp.2009.05.003">10.1016/j.bcp.2009.05.003</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2815339">2815339</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19433069">19433069</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Multiple+roles+for+nicotine+in+Parkinson%27s+disease&amp;rft.aulast=Quik+M%2C+Huang+LZ%2C+Parameswaran+N%2C+Bordia+T%2C+Campos+C%2C+Perez+XA&amp;rft.au=Quik+M%2C+Huang+LZ%2C+Parameswaran+N%2C+Bordia+T%2C+Campos+C%2C+Perez+XA&amp;rft.date=1+October+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2815339&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bcp.2009.05.003&amp;rft_id=info%3Apmc%2F2815339&amp;rft_id=info%3Apmid%2F19433069&amp;rft.issue=7&amp;rft.jtitle=Biochem+Pharmacol&amp;rft.pages=677%E2%80%9385&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=78" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><span class="citation journal">Castagnoli K, Murugesan T (January 2004). "Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?". <i>Neurotoxicology</i> <b>25</b> (1–2): 279–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0161-813X%2803%2900107-4">10.1016/S0161-813X(03)00107-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14697903">14697903</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Tobacco+leaf%2C+smoke+and+smoking%2C+MAO+inhibitors%2C+Parkinson%27s+disease+and+neuroprotection%3B+are+there+links%3F&amp;rft.au=Castagnoli+K%2C+Murugesan+T&amp;rft.aulast=Castagnoli+K%2C+Murugesan+T&amp;rft.date=January+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0161-813X%2803%2900107-4&amp;rft_id=info%3Apmid%2F14697903&amp;rft.issue=1%E2%80%932&amp;rft.jtitle=Neurotoxicology&amp;rft.pages=279%E2%80%9391&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nice-pharma-44"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-pharma_44-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-26"><sup><i><b>aa</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-27"><sup><i><b>ab</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-28"><sup><i><b>ac</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-29"><sup><i><b>ad</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-30"><sup><i><b>ae</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-31"><sup><i><b>af</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-32"><sup><i><b>ag</b></i></sup></a> <a href="#cite_ref-Nice-pharma_44-33"><sup><i><b>ah</b></i></sup></a></span> <span class="reference-text"><span class="citation book">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Symptomatic pharmacological therapy in Parkinson’s disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;59–100. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-86016-283-5" title="Special:BookSources/1-86016-283-5">1-86016-283-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+Disease&amp;rft.btitle=Symptomatic+pharmacological+therapy+in+Parkinson%E2%80%99s+disease&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rft.isbn=1-86016-283-5&amp;rft.pages=59%E2%80%93100&amp;rft.place=London&amp;rft.pub=Royal+College+of+Physicians&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20937936-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20937936_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20937936_45-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bronstein JM, Tagliati M, Alterman RL, <i>et al.</i> (February 2011). "Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues". <i>Arch. Neurol.</i> <b>68</b> (2): 165. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchneurol.2010.260">10.1001/archneurol.2010.260</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20937936">20937936</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Deep+brain+stimulation+for+Parkinson+disease%3A+an+expert+consensus+and+review+of+key+issues&amp;rft.au=Bronstein+JM%2C+Tagliati+M%2C+Alterman+RL%2C+%27%27et+al.%27%27&amp;rft.aulast=Bronstein+JM%2C+Tagliati+M%2C+Alterman+RL%2C+%27%27et+al.%27%27&amp;rft.date=February+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchneurol.2010.260&amp;rft_id=info%3Apmid%2F20937936&amp;rft.issue=2&amp;rft.jtitle=Arch.+Neurol.&amp;rft.pages=165&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nice-palliative-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-palliative_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-palliative_46-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Palliative care in Parkinson’s disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;147–51. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-86016-283-5" title="Special:BookSources/1-86016-283-5">1-86016-283-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+Disease&amp;rft.btitle=Palliative+care+in+Parkinson%E2%80%99s+disease&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rft.isbn=1-86016-283-5&amp;rft.pages=147%E2%80%9351&amp;rft.place=London&amp;rft.pub=Royal+College+of+Physicians&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jankovic_book-Pharma-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jankovic_book-Pharma_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jankovic_book-Pharma_47-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Tolosa E, Katzenschlager R (2007). "Pharmacological management of Parkinson's disease". In Tolosa E, Jankovic JJ. <i>Parkinson's disease and movement disorders</i>. Hagerstwon, MD: Lippincott Williams &amp; Wilkins. pp.&#160;110–45. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-7881-6" title="Special:BookSources/0-7817-7881-6">0-7817-7881-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.aulast=Tolosa+E%2C+Katzenschlager+R&amp;rft.au=Tolosa+E%2C+Katzenschlager+R&amp;rft.btitle=Pharmacological+management+of+Parkinson%27s+disease&amp;rft.date=2007&amp;rft.genre=bookitem&amp;rft.isbn=0-7817-7881-6&amp;rft.pages=110%E2%80%9345&amp;rft.place=Hagerstwon%2C+MD&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">Goldenberg MM (October 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2730785">"Medical management of Parkinson's disease"</a>. <i>P &amp; T</i> <b>33</b> (10): 590–606. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2730785">2730785</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19750042">19750042</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Medical+management+of+Parkinson%27s+disease&amp;rft.au=Goldenberg+MM&amp;rft.aulast=Goldenberg+MM&amp;rft.date=October+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2730785&amp;rft_id=info%3Apmc%2F2730785&amp;rft_id=info%3Apmid%2F19750042&amp;rft.issue=10&amp;rft.jtitle=P+%26+T&amp;rft.pages=590%E2%80%93606&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nice-NonMotor-49"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-NonMotor_49-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-NonMotor_49-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Non-motor features of Parkinson's disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;113–33. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-86016-283-5" title="Special:BookSources/1-86016-283-5">1-86016-283-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+Disease&amp;rft.btitle=Non-motor+features+of+Parkinson%27s+disease&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rft.isbn=1-86016-283-5&amp;rft.pages=113%E2%80%9333&amp;rft.place=London&amp;rft.pub=Royal+College+of+Physicians&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19559160-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19559160_50-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hasnain M, Vieweg WV, Baron MS, Beatty-Brooks M, Fernandez A, Pandurangi AK (July 2009). "Pharmacological management of psychosis in elderly patients with parkinsonism". <i>Am. J. Med.</i> <b>122</b> (7): 614–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.amjmed.2009.01.025">10.1016/j.amjmed.2009.01.025</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19559160">19559160</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Pharmacological+management+of+psychosis+in+elderly+patients+with+parkinsonism&amp;rft.au=Hasnain+M%2C+Vieweg+WV%2C+Baron+MS%2C+Beatty-Brooks+M%2C+Fernandez+A%2C+Pandurangi+AK&amp;rft.aulast=Hasnain+M%2C+Vieweg+WV%2C+Baron+MS%2C+Beatty-Brooks+M%2C+Fernandez+A%2C+Pandurangi+AK&amp;rft.date=July+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2009.01.025&amp;rft_id=info%3Apmid%2F19559160&amp;rft.issue=7&amp;rft.jtitle=Am.+J.+Med.&amp;rft.pages=614%E2%80%9322&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=122" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gagne-2010-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gagne-2010_51-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gagne JJ, Power MC (Mar 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2848103">"Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis"</a>. <i>Neurology</i> <b>74</b> (12): 995–1002. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1212%2FWNL.0b013e3181d5a4a3">10.1212/WNL.0b013e3181d5a4a3</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2848103">2848103</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20308684">20308684</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Anti-inflammatory+drugs+and+risk+of+Parkinson+disease%3A+a+meta-analysis&amp;rft.au=Gagne+JJ%2C+Power+MC&amp;rft.aulast=Gagne+JJ%2C+Power+MC&amp;rft.date=Mar+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2848103&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0b013e3181d5a4a3&amp;rft_id=info%3Apmc%2F2848103&amp;rft_id=info%3Apmid%2F20308684&amp;rft.issue=12&amp;rft.jtitle=Neurology&amp;rft.pages=995%E2%80%931002&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=74" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nice-surgery-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-surgery_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-surgery_52-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nice-surgery_52-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nice-surgery_52-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Surgery for Parkinson’s disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;101–11. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-86016-283-5" title="Special:BookSources/1-86016-283-5">1-86016-283-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+Disease&amp;rft.btitle=Surgery+for+Parkinson%E2%80%99s+disease&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rft.isbn=1-86016-283-5&amp;rft.pages=101%E2%80%9311&amp;rft.place=London&amp;rft.pub=Royal+College+of+Physicians&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nice-rehab-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-rehab_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-rehab_53-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nice-rehab_53-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nice-rehab_53-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nice-rehab_53-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation book">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Other key interventions"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;135–46. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-86016-283-5" title="Special:BookSources/1-86016-283-5">1-86016-283-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Parkinson%27s+Disease&amp;rft.btitle=Other+key+interventions&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rft.isbn=1-86016-283-5&amp;rft.pages=135%E2%80%9346&amp;rft.place=London&amp;rft.pub=Royal+College+of+Physicians&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18181210-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18181210_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18181210_54-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (April 2008). "The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis". <i>Mov. Disord.</i> <b>23</b> (5): 631–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.21922">10.1002/mds.21922</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18181210">18181210</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+effectiveness+of+exercise+interventions+for+people+with+Parkinson%27s+disease%3A+a+systematic+review+and+meta-analysis&amp;rft.au=Goodwin+VA%2C+Richards+SH%2C+Taylor+RS%2C+Taylor+AH%2C+Campbell+JL&amp;rft.aulast=Goodwin+VA%2C+Richards+SH%2C+Taylor+RS%2C+Taylor+AH%2C+Campbell+JL&amp;rft.date=April+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21922&amp;rft_id=info%3Apmid%2F18181210&amp;rft.issue=5&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=631%E2%80%9340&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><span class="citation journal">Dereli EE, Yaliman A (April 2010). <a rel="nofollow" class="external text" href="http://cre.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=20360152">"Comparison of the effects of a physiotherapist-supervised exercise programme and a self-supervised exercise programme on quality of life in patients with Parkinson's disease"</a>. <i>Clin Rehabil</i> <b>24</b> (4): 352–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1177%2F0269215509358933">10.1177/0269215509358933</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20360152">20360152</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Comparison+of+the+effects+of+a+physiotherapist-supervised+exercise+programme+and+a+self-supervised+exercise+programme+on+quality+of+life+in+patients+with+Parkinson%27s+disease&amp;rft.au=Dereli+EE%2C+Yaliman+A&amp;rft.aulast=Dereli+EE%2C+Yaliman+A&amp;rft.date=April+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcre.sagepub.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D20360152&amp;rft_id=info%3Adoi%2F10.1177%2F0269215509358933&amp;rft_id=info%3Apmid%2F20360152&amp;rft.issue=4&amp;rft.jtitle=Clin+Rehabil&amp;rft.pages=352%E2%80%9362&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><a href="#CITEREFO.27SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, pp.&#160;873, 876</span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><a href="#CITEREFO.27SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, p.&#160;879</span></li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><a href="#CITEREFO.27SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, p.&#160;877</span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><a href="#CITEREFO.27SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, p.&#160;880</span></li>
<li id="cite_note-pmid17117354-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17117354_60-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (November 2006). "The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders". <i>Semin. Speech. Lang.</i> <b>27</b> (4): 283–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1055%2Fs-2006-955118">10.1055/s-2006-955118</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17117354">17117354</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+science+and+practice+of+LSVT%2FLOUD%3A+neural+plasticity-principled+approach+to+treating+individuals+with+Parkinson+disease+and+other+neurological+disorders&amp;rft.au=Fox+CM%2C+Ramig+LO%2C+Ciucci+MR%2C+Sapir+S%2C+McFarland+DH%2C+Farley+BG&amp;rft.aulast=Fox+CM%2C+Ramig+LO%2C+Ciucci+MR%2C+Sapir+S%2C+McFarland+DH%2C+Farley+BG&amp;rft.date=November+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2006-955118&amp;rft_id=info%3Apmid%2F17117354&amp;rft.issue=4&amp;rft.jtitle=Semin.+Speech.+Lang.&amp;rft.pages=283%E2%80%9399&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17636709-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17636709_61-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dixon L, Duncan D, Johnson P, <i>et al.</i> (2007). "Occupational therapy for patients with Parkinson's disease". In Deane, Katherine. <i>Cochrane Database of Systematic Reviews</i> (3): CD002813. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD002813.pub2">10.1002/14651858.CD002813.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17636709">17636709</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Occupational+therapy+for+patients+with+Parkinson%27s+disease&amp;rft.au=Dixon+L%2C+Duncan+D%2C+Johnson+P%2C+%27%27et+al.%27%27&amp;rft.aulast=Dixon+L%2C+Duncan+D%2C+Johnson+P%2C+%27%27et+al.%27%27&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002813.pub2&amp;rft_id=info%3Apmid%2F17636709&amp;rft.issue=3&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.pages=CD002813&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20714078-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20714078_62-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Koch G (2010). "rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets". <i>Restor. Neurol. Neurosci.</i> <b>28</b> (4): 561–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3233%2FRNN-2010-0556">10.3233/RNN-2010-0556</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20714078">20714078</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=rTMS+effects+on+levodopa+induced+dyskinesias+in+Parkinson%27s+disease+patients%3A+searching+for+effective+cortical+targets&amp;rft.au=Koch+G&amp;rft.aulast=Koch+G&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3233%2FRNN-2010-0556&amp;rft_id=info%3Apmid%2F20714078&amp;rft.issue=4&amp;rft.jtitle=Restor.+Neurol.+Neurosci.&amp;rft.pages=561%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20714064-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20714064_63-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Platz T, Rothwell JC (2010). "Brain stimulation and brain repair—rTMS: from animal experiment to clinical trials—what do we know?". <i>Restor. Neurol. Neurosci.</i> <b>28</b> (4): 387–98. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3233%2FRNN-2010-0570">10.3233/RNN-2010-0570</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20714064">20714064</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Brain+stimulation+and+brain+repair%E2%80%94rTMS%3A+from+animal+experiment+to+clinical+trials%E2%80%94what+do+we+know%3F&amp;rft.aulast=Platz+T%2C+Rothwell+JC&amp;rft.au=Platz+T%2C+Rothwell+JC&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3233%2FRNN-2010-0570&amp;rft_id=info%3Apmid%2F20714064&amp;rft.issue=4&amp;rft.jtitle=Restor.+Neurol.+Neurosci.&amp;rft.pages=387%E2%80%9398&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20669300-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20669300_64-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Arias P, Vivas J, Grieve KL, Cudeiro J (September 2010). "Controlled trial on the effect of 10 days low-frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's disease". <i>Mov. Disord.</i> <b>25</b> (12): 1830–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.23055">10.1002/mds.23055</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20669300">20669300</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Controlled+trial+on+the+effect+of+10+days+low-frequency+repetitive+transcranial+magnetic+stimulation+%28rTMS%29+on+motor+signs+in+Parkinson%27s+disease&amp;rft.au=Arias+P%2C+Vivas+J%2C+Grieve+KL%2C+Cudeiro+J&amp;rft.aulast=Arias+P%2C+Vivas+J%2C+Grieve+KL%2C+Cudeiro+J&amp;rft.date=September+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.23055&amp;rft_id=info%3Apmid%2F20669300&amp;rft.issue=12&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=1830%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16606908-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16606908_65-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ (April 2006). "Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". <i>Neurology</i> <b>66</b> (7): 976–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1212%2F01.wnl.0000206363.57955.1b">10.1212/01.wnl.0000206363.57955.1b</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16606908">16606908</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Practice+Parameter%3A+neuroprotective+strategies+and+alternative+therapies+for+Parkinson+disease+%28an+evidence-based+review%29%3A+report+of+the+Quality+Standards+Subcommittee+of+the+American+Academy+of+Neurology&amp;rft.aulast=Suchowersky+O%2C+Gronseth+G%2C+Perlmutter+J%2C+Reich+S%2C+Zesiewicz+T%2C+Weiner+WJ&amp;rft.au=Suchowersky+O%2C+Gronseth+G%2C+Perlmutter+J%2C+Reich+S%2C+Zesiewicz+T%2C+Weiner+WJ&amp;rft.date=April+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000206363.57955.1b&amp;rft_id=info%3Apmid%2F16606908&amp;rft.issue=7&amp;rft.jtitle=Neurology&amp;rft.pages=976%E2%80%9382&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18374620-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18374620_66-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee MS, Lam P, Ernst E (December 2008). "Effectiveness of tai chi for Parkinson's disease: a critical review". <i>Parkinsonism Relat. Disord.</i> <b>14</b> (8): 589–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.parkreldis.2008.02.003">10.1016/j.parkreldis.2008.02.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18374620">18374620</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Effectiveness+of+tai+chi+for+Parkinson%27s+disease%3A+a+critical+review&amp;rft.aulast=Lee+MS%2C+Lam+P%2C+Ernst+E&amp;rft.au=Lee+MS%2C+Lam+P%2C+Ernst+E&amp;rft.date=December+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2008.02.003&amp;rft_id=info%3Apmid%2F18374620&amp;rft.issue=8&amp;rft.jtitle=Parkinsonism+Relat.+Disord.&amp;rft.pages=589%E2%80%9394&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18973253-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18973253_67-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee MS, Ernst E (January 2009). "Qigong for movement disorders: A systematic review". <i>Mov. Disord.</i> <b>24</b> (2): 301–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.22275">10.1002/mds.22275</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18973253">18973253</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Qigong+for+movement+disorders%3A+A+systematic+review&amp;rft.aulast=Lee+MS%2C+Ernst+E&amp;rft.au=Lee+MS%2C+Ernst+E&amp;rft.date=January+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22275&amp;rft_id=info%3Apmid%2F18973253&amp;rft.issue=2&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=301%E2%80%933&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18618661-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18618661_68-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee MS, Shin BC, Kong JC, Ernst E (August 2008). "Effectiveness of acupuncture for Parkinson's disease: a systematic review". <i>Mov. Disord.</i> <b>23</b> (11): 1505–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.21993">10.1002/mds.21993</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18618661">18618661</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Effectiveness+of+acupuncture+for+Parkinson%27s+disease%3A+a+systematic+review&amp;rft.aulast=Lee+MS%2C+Shin+BC%2C+Kong+JC%2C+Ernst+E&amp;rft.au=Lee+MS%2C+Shin+BC%2C+Kong+JC%2C+Ernst+E&amp;rft.date=August+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21993&amp;rft_id=info%3Apmid%2F18618661&amp;rft.issue=11&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=1505%E2%80%9315&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation journal">Katzenschlager R, Evans A, Manson A, <i>et al</i> (2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1738871">"Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study"</a>. <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>75</b> (12): 1672–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fjnnp.2003.028761">10.1136/jnnp.2003.028761</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1738871">1738871</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15548480">15548480</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Mucuna+pruriens+in+Parkinson%27s+disease%3A+a+double+blind+clinical+and+pharmacological+study&amp;rft.au=Katzenschlager+R%2C+Evans+A%2C+Manson+A%2C+%27%27et+al%27%27&amp;rft.aulast=Katzenschlager+R%2C+Evans+A%2C+Manson+A%2C+%27%27et+al%27%27&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1738871&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2003.028761&amp;rft_id=info%3Apmc%2F1738871&amp;rft_id=info%3Apmid%2F15548480&amp;rft.issue=12&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.pages=1672%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=75" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15719433-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15719433_70-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ladha SS, Walker R, Shill HA (May 2005). "Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance". <i>Mov. Disord.</i> <b>20</b> (5): 630–1. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.20380">10.1002/mds.20380</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15719433">15719433</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Case+of+neuroleptic+malignant-like+syndrome+precipitated+by+abrupt+fava+bean+discontinuance&amp;rft.au=Ladha+SS%2C+Walker+R%2C+Shill+HA&amp;rft.aulast=Ladha+SS%2C+Walker+R%2C+Shill+HA&amp;rft.date=May+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.20380&amp;rft_id=info%3Apmid%2F15719433&amp;rft.issue=5&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=630%E2%80%931&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19678834-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19678834_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Raguthu L, Varanese S, Flancbaum L, Tayler E, Di Rocco A (October 2009). "Fava beans and Parkinson's disease: useful 'natural supplement' or useless risk?". <i>Eur. J. Neurol.</i> <b>16</b> (10): e171. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1468-1331.2009.02766.x">10.1111/j.1468-1331.2009.02766.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19678834">19678834</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Fava+beans+and+Parkinson%27s+disease%3A+useful+%27natural+supplement%27+or+useless+risk%3F&amp;rft.aulast=Raguthu+L%2C+Varanese+S%2C+Flancbaum+L%2C+Tayler+E%2C+Di+Rocco+A&amp;rft.au=Raguthu+L%2C+Varanese+S%2C+Flancbaum+L%2C+Tayler+E%2C+Di+Rocco+A&amp;rft.date=October+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1468-1331.2009.02766.x&amp;rft_id=info%3Apmid%2F19678834&amp;rft.issue=10&amp;rft.jtitle=Eur.+J.+Neurol.&amp;rft.pages=e171&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17131223-72"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17131223_72-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid17131223_72-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Poewe W (December 2006). "The natural history of Parkinson's disease". <i>J. Neurol.</i> <b>253</b> (Suppl 7): VII2–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00415-006-7002-7">10.1007/s00415-006-7002-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17131223">17131223</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+natural+history+of+Parkinson%27s+disease&amp;rft.aulast=Poewe+W&amp;rft.au=Poewe+W&amp;rft.date=December+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00415-006-7002-7&amp;rft_id=info%3Apmid%2F17131223&amp;rft.issue=Suppl+7&amp;rft.jtitle=J.+Neurol.&amp;rft.pages=VII2%E2%80%936&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=253" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15568171-73"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15568171_73-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15568171_73-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15568171_73-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">García Ruiz PJ (December 2004). "Prehistoria de la enfermedad de Parkinson" [[Prehistory of Parkinson's disease]]. <i>Neurologia</i> (in Spanish; Castilian) <b>19</b> (10): 735–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15568171">15568171</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Prehistoria+de+la+enfermedad+de+Parkinson&amp;rft.au=Garc%C3%ADa+Ruiz+PJ&amp;rft.aulast=Garc%C3%ADa+Ruiz+PJ&amp;rft.date=December+2004&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15568171&amp;rft.issue=10&amp;rft.jtitle=Neurologia&amp;rft.pages=735%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19892136-74"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19892136_74-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19892136_74-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lanska DJ (2010). "Chapter 33: the history of movement disorders". <i>Handb. Clin. Neurol</i>. Handbook of Clinical Neurology <b>95</b>: 501–46. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0072-9752%2808%2902133-7">10.1016/S0072-9752(08)02133-7</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780444520098" title="Special:BookSources/9780444520098">9780444520098</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19892136">19892136</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Chapter+33%3A+the+history+of+movement+disorders&amp;rft.au=Lanska+DJ&amp;rft.aulast=Lanska+DJ&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0072-9752%2808%2902133-7&amp;rft_id=info%3Apmid%2F19892136&amp;rft.isbn=9780444520098&amp;rft.jtitle=Handb.+Clin.+Neurol.&amp;rft.pages=501%E2%80%9346&amp;rft.series=Handbook+of+Clinical+Neurology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=95" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9380070-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9380070_75-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Koehler PJ, Keyser A (September 1997). "Tremor in Latin texts of Dutch physicians: 16th–18th centuries". <i>Mov. Disord.</i> <b>12</b> (5): 798–806. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.870120531">10.1002/mds.870120531</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9380070">9380070</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Tremor+in+Latin+texts+of+Dutch+physicians%3A+16th%E2%80%9318th+centuries&amp;rft.au=Koehler+PJ%2C+Keyser+A&amp;rft.aulast=Koehler+PJ%2C+Keyser+A&amp;rft.date=September+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.870120531&amp;rft_id=info%3Apmid%2F9380070&amp;rft.issue=5&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=798%E2%80%93806&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18175393-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18175393_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18175393_76-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18175393_76-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18175393_76-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18175393_76-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18175393_76-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid18175393_76-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid18175393_76-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lees AJ (September 2007). "Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday". <i>Mov. Disord.</i> <b>22</b> (Suppl 17): S327–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.21684">10.1002/mds.21684</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18175393">18175393</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Unresolved+issues+relating+to+the+shaking+palsy+on+the+celebration+of+James+Parkinson%27s+250th+birthday&amp;rft.aulast=Lees+AJ&amp;rft.au=Lees+AJ&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21684&amp;rft_id=info%3Apmid%2F18175393&amp;rft.issue=Suppl+17&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=S327%E2%80%9334&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9399240-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9399240_77-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Louis ED (November 1997). "The shaking palsy, the first forty-five years: a journey through the British literature". <i>Mov. Disord.</i> <b>12</b> (6): 1068–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.870120638">10.1002/mds.870120638</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9399240">9399240</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+shaking+palsy%2C+the+first+forty-five+years%3A+a+journey+through+the+British+literature&amp;rft.aulast=Louis+ED&amp;rft.au=Louis+ED&amp;rft.date=November+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.870120638&amp;rft_id=info%3Apmid%2F9399240&amp;rft.issue=6&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=1068%E2%80%9372&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18781671-78"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18781671_78-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18781671_78-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18781671_78-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Fahn S (2008). "The history of dopamine and levodopa in the treatment of Parkinson's disease". <i>Mov. Disord.</i> <b>23</b> (Suppl 3): S497–508. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fmds.22028">10.1002/mds.22028</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18781671">18781671</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+history+of+dopamine+and+levodopa+in+the+treatment+of+Parkinson%27s+disease&amp;rft.au=Fahn+S&amp;rft.aulast=Fahn+S&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22028&amp;rft_id=info%3Apmid%2F18781671&amp;rft.issue=Suppl+3&amp;rft.jtitle=Mov.+Disord.&amp;rft.pages=S497%E2%80%93508&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9361073-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9361073_79-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Guridi J, Lozano AM (November 1997). "A brief history of pallidotomy". <i>Neurosurgery</i> <b>41</b> (5): 1169–80; discussion 1180–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2F00006123-199711000-00029">10.1097/00006123-199711000-00029</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9361073">9361073</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=A+brief+history+of+pallidotomy&amp;rft.au=Guridi+J%2C+Lozano+AM&amp;rft.aulast=Guridi+J%2C+Lozano+AM&amp;rft.date=November+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00006123-199711000-00029&amp;rft_id=info%3Apmid%2F9361073&amp;rft.issue=5&amp;rft.jtitle=Neurosurgery&amp;rft.pages=1169%E2%80%9380%3B+discussion+1180%E2%80%933&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><span class="citation journal">Hornykiewicz O (2002). "L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent". <i>Amino Acids</i> <b>23</b> (1–3): 65–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00726-001-0111-9">10.1007/s00726-001-0111-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12373520">12373520</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=L-DOPA%3A+from+a+biologically+inactive+amino+acid+to+a+successful+therapeutic+agent&amp;rft.au=Hornykiewicz+O&amp;rft.aulast=Hornykiewicz+O&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00726-001-0111-9&amp;rft_id=info%3Apmid%2F12373520&amp;rft.issue=1%E2%80%933&amp;rft.jtitle=Amino+Acids&amp;rft.pages=65%E2%80%9370&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18684199-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18684199_81-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Coffey RJ (March 2009). "Deep brain stimulation devices: a brief technical history and review". <i>Artif. Organs</i> <b>33</b> (3): 208–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1525-1594.2008.00620.x">10.1111/j.1525-1594.2008.00620.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18684199">18684199</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Deep+brain+stimulation+devices%3A+a+brief+technical+history+and+review&amp;rft.au=Coffey+RJ&amp;rft.aulast=Coffey+RJ&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1525-1594.2008.00620.x&amp;rft_id=info%3Apmid%2F18684199&amp;rft.issue=3&amp;rft.jtitle=Artif.+Organs&amp;rft.pages=208%E2%80%9320&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17702630-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17702630_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17702630_82-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17702630_82-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17702630_82-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17702630_82-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Findley LJ (September 2007). "The economic impact of Parkinson's disease". <i>Parkinsonism Relat. Disord.</i> <b>13</b> (Suppl): S8–S12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.parkreldis.2007.06.003">10.1016/j.parkreldis.2007.06.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17702630">17702630</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=The+economic+impact+of+Parkinson%27s+disease&amp;rft.au=Findley+LJ&amp;rft.aulast=Findley+LJ&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2007.06.003&amp;rft_id=info%3Apmid%2F17702630&amp;rft.issue=Suppl&amp;rft.jtitle=Parkinsonism+Relat.+Disord.&amp;rft.pages=S8%E2%80%93S12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-tulip-83"><span class="mw-cite-backlink">^ <a href="#cite_ref-tulip_83-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-tulip_83-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.gsk.com/infocus/parkinsons.htm">"Parkinson's – 'the shaking palsy<span style="padding-right:0.2em;">'</span>"</a>. GlaxoSmithKline. 1 April 2009.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=Parkinson%27s+%E2%80%93+%27the+shaking+palsy%27&amp;rft.date=1+April+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2Finfocus%2Fparkinsons.htm&amp;rft.pub=GlaxoSmithKline&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlNational_Parkinson_Foundation_.E2.80.93_Mission-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlNational_Parkinson_Foundation_.E2.80.93_Mission_84-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.parkinson.org/About-Us/Mission">"National Parkinson Foundation – Mission"</a><span class="reference-accessdate">. Retrieved 28 March 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=National+Parkinson+Foundation+%E2%80%93+Mission&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.parkinson.org%2FAbout-Us%2FMission&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><span class="citation journal"><a rel="nofollow" class="external text" href="http://www.time.com/time/magazine/article/0,9171,828597,00.html">"Education: Joy in Giving"</a>. <i>Time</i>. 18 January 1960<span class="reference-accessdate">. Retrieved 2 April 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Education%3A+Joy+in+Giving&amp;rft.date=18+January+1960&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fmagazine%2Farticle%2F0%2C9171%2C828597%2C00.html&amp;rft.jtitle=Time&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.pdf.org/en/about_pdf">"About PDF"</a>. Parkinson's Disease Foundation<span class="reference-accessdate">. Retrieved 25 July 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=About+PDF&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.pdf.org%2Fen%2Fabout_pdf&amp;rft.pub=Parkinson%27s+Disease+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.apdaparkinson.org/userND/index.asp">"American Parkinson Disease Association: Home"</a>. American Parkinson Disease Association<span class="reference-accessdate">. Retrieved 9 August 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=American+Parkinson+Disease+Association%3A+Home&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.apdaparkinson.org%2FuserND%2Findex.asp&amp;rft.pub=American+Parkinson+Disease+Association&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.epda.eu.com/about-us/">"About EPDA"</a>. European Parkinson's Disease Association. 2010<span class="reference-accessdate">. Retrieved 9 August 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=About+EPDA&amp;rft.date=2010&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.epda.eu.com%2Fabout-us%2F&amp;rft.pub=European+Parkinson%27s+Disease+Association&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MJF_TIME-89"><span class="mw-cite-backlink">^ <a href="#cite_ref-MJF_TIME_89-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MJF_TIME_89-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation news">Davis P (3 May 2007). <a rel="nofollow" class="external text" href="http://www.time.com/time/specials/2007/time100/article/0,28804,1595326_1615754_1615882,00.html">"Michael J. Fox"</a>. <i>The TIME 100</i> (<a href="/wiki/Time_(magazine)" title="Time (magazine)">Time</a>)<span class="reference-accessdate">. Retrieved 2 April 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Michael+J.+Fox&amp;rft.au=Davis+P&amp;rft.aulast=Davis+P&amp;rft.date=3+May+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fspecials%2F2007%2Ftime100%2Farticle%2F0%2C28804%2C1595326_1615754_1615882%2C00.html&amp;rft.jtitle=The+TIME+100&amp;rft.pub=Time&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MJF_guardian-90"><span class="mw-cite-backlink">^ <a href="#cite_ref-MJF_guardian_90-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MJF_guardian_90-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MJF_guardian_90-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation news">Brockes E (11 April 2009). <a rel="nofollow" class="external text" href="http://www.guardian.co.uk/lifeandstyle/2009/apr/11/michael-j-fox-parkinsons">"<span style="padding-left:0.2em;">'</span>It's the gift that keeps on taking<span style="padding-right:0.2em;">'</span>"</a>. <i>The Guardian</i><span class="reference-accessdate">. Retrieved 25 October 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=%27It%27s+the+gift+that+keeps+on+taking%27&amp;rft.au=Brockes+E&amp;rft.aulast=Brockes+E&amp;rft.date=11+April+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.guardian.co.uk%2Flifeandstyle%2F2009%2Fapr%2F11%2Fmichael-j-fox-parkinsons&amp;rft.jtitle=The+Guardian&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-doctorate_Fox-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-doctorate_Fox_91-0">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://ki.se/ki/jsp/polopoly.jsp?d=25844&amp;a=96573&amp;l=en&amp;newsdep=25844">"Michael J. Fox to be made honorary doctor at Karolinska Institutet"</a>. Karolinska Institutet. 5 March 2010<span class="reference-accessdate">. Retrieved 2 April 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=Michael+J.+Fox+to+be+made+honorary+doctor+at+Karolinska+Institutet&amp;rft.date=5+March+2010&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fki.se%2Fki%2Fjsp%2Fpolopoly.jsp%3Fd%3D25844%26a%3D96573%26l%3Den%26newsdep%3D25844&amp;rft.pub=Karolinska+Institutet&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Phinney-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-Phinney_92-0">^</a></b></span> <span class="reference-text"><span class="citation news">Roelofs T (10 May 2010). <a rel="nofollow" class="external text" href="http://www.mlive.com/news/grand-rapids/index.ssf/2010/05/tour_de_france_bicyclist_davis.html">"Tour de France bicyclist Davis Phinney talks about life with Parkinson's Disease"</a>. The Grand Rapids Press<span class="reference-accessdate">. Retrieved 25 October 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.aulast=Roelofs+T&amp;rft.au=Roelofs+T&amp;rft.btitle=Tour+de+France+bicyclist+Davis+Phinney+talks+about+life+with+Parkinson%27s+Disease&amp;rft.date=10+May+2010&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.mlive.com%2Fnews%2Fgrand-rapids%2Findex.ssf%2F2010%2F05%2Ftour_de_france_bicyclist_davis.html&amp;rft.pub=The+Grand+Rapids+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><span class="citation web">Macur, Juliet (26 March 2008). <a rel="nofollow" class="external text" href="http://www.nytimes.com/2008/03/26/sports/othersports/26cycling.html?pagewanted=all&amp;_r=0">"For the Phinney Family, a Dream and a Challenge"</a>. The New York Times<span class="reference-accessdate">. Retrieved 25 May 2013</span>. "About 1.5 million Americans have received a diagnosis of Parkinson’s disease, but only 5 to 10 percent learn of it before age 40, according to the National Parkinson Foundation. Davis Phinney was among the few."</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.aufirst=Juliet&amp;rft.aulast=Macur&amp;rft.au=Macur%2C+Juliet&amp;rft.btitle=For+the+Phinney+Family%2C+a+Dream+and+a+Challenge&amp;rft.date=26+March+2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2008%2F03%2F26%2Fsports%2Fothersports%2F26cycling.html%3Fpagewanted%3Dall%26_r%3D0&amp;rft.pub=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DPF-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-DPF_94-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://davisphinneyfoundation.org/dpf/who-we-are/">"Who We Are"</a>. Davis Phinney Foundation<span class="reference-accessdate">. Retrieved 18 January 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=Who+We+Are&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fdavisphinneyfoundation.org%2Fdpf%2Fwho-we-are%2F&amp;rft.pub=Davis+Phinney+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Phinney2-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-Phinney2_95-0">^</a></b></span> <span class="reference-text"><span class="citation pressrelease">Emanuel, W (19 October 2010). <a rel="nofollow" class="external text" href="http://www.davisphinneyfoundation.org/atf/cf/%7B79AE86BA-CFD7-437E-A98E-2A5F5429BA65%7D/Exercise%20Video%20Release%20FNL.pdf">"Davis Phinney foundation launches exercise-focused tools to help people live well with Parkinson's"</a> (Press release). Davis Phinney foundation<span class="reference-accessdate">. Retrieved 2 April 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.au=Emanuel%2C+W&amp;rft.aulast=Emanuel%2C+W&amp;rft.btitle=Davis+Phinney+foundation+launches+exercise-focused+tools+to+help+people+live+well+with+Parkinson%27s&amp;rft.date=19+October+2010&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.davisphinneyfoundation.org%2Fatf%2Fcf%2F%257B79AE86BA-CFD7-437E-A98E-2A5F5429BA65%257D%2FExercise%2520Video%2520Release%2520FNL.pdf&amp;rft.pub=Davis+Phinney+foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><span class="citation web">Macur, Juliet (26 March 2008). <a rel="nofollow" class="external text" href="http://www.nytimes.com/2008/03/26/sports/othersports/26cycling.html?pagewanted=all&amp;_r=0">"For the Phinney Family, a Dream and a Challenge"</a>. The New York Times<span class="reference-accessdate">. Retrieved 25 May 2013</span>. "...[Davis Phinney] started an organization in his name, the Davis Phinney Foundation, and gives motivational speeches to Parkinson’s patients, pushing them to celebrate every victory, however small, like tying their shoes. The high doses of medication he needs to get through those talks cause side effects, like the involuntary swaying of his head. But he endures."</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.aufirst=Juliet&amp;rft.aulast=Macur&amp;rft.au=Macur%2C+Juliet&amp;rft.btitle=For+the+Phinney+Family%2C+a+Dream+and+a+Challenge&amp;rft.date=26+March+2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2008%2F03%2F26%2Fsports%2Fothersports%2F26cycling.html%3Fpagewanted%3Dall%26_r%3D0&amp;rft.pub=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ali_NN_comment-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ali_NN_comment_97-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Brey RL (April 2006). <a rel="nofollow" class="external text" href="http://www.aan.com/elibrary/neurologynow/?event=home.showArticle&amp;id=ovid.com:/bib/ovftdb/01222928-200602020-00003">"Muhammad Ali's Message: Keep Moving Forward"</a>. <i>Neurology Now</i> (American Academy of Neurology) <b>2</b> (2): 8<span class="reference-accessdate">. Retrieved 2 April 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Muhammad+Ali%27s+Message%3A+Keep+Moving+Forward&amp;rft.au=Brey+RL&amp;rft.aulast=Brey+RL&amp;rft.date=April+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.aan.com%2Felibrary%2Fneurologynow%2F%3Fevent%3Dhome.showArticle%26id%3Dovid.com%3A%2Fbib%2Fovftdb%2F01222928-200602020-00003&amp;rft.issue=2&amp;rft.jtitle=Neurology+Now&amp;rft.pages=8&amp;rft.pub=American+Academy+of+Neurology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ali_NN-98"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ali_NN_98-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ali_NN_98-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Matthews W (April 2006). <a rel="nofollow" class="external text" href="http://journals.lww.com/neurologynow/Fulltext/2006/02020/Ali_s_Fighting_Spirit.4.aspx">"Ali's Fighting Spirit"</a>. <i>Neurology Now</i> (American Academy of Neurology) <b>2</b> (2): 10–23<span class="reference-accessdate">. Retrieved 2 April 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Ali%27s+Fighting+Spirit&amp;rft.aulast=Matthews+W&amp;rft.au=Matthews+W&amp;rft.date=April+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjournals.lww.com%2Fneurologynow%2FFulltext%2F2006%2F02020%2FAli_s_Fighting_Spirit.4.aspx&amp;rft.issue=2&amp;rft.jtitle=Neurology+Now&amp;rft.pages=10%E2%80%9323&amp;rft.pub=American+Academy+of+Neurology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ali_NYT-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ali_NYT_99-0">^</a></b></span> <span class="reference-text"><span class="citation news">Tauber P (17 July 1988). <a rel="nofollow" class="external text" href="http://www.nytimes.com/1988/07/17/magazine/ali-still-magic.html">"Ali: Still Magic"</a>. <i>New York Times</i><span class="reference-accessdate">. Retrieved 2 April 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Ali%3A+Still+Magic&amp;rft.aulast=Tauber+P&amp;rft.au=Tauber+P&amp;rft.date=17+July+1988&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F1988%2F07%2F17%2Fmagazine%2Fali-still-magic.html&amp;rft.jtitle=New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dimond-100"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dimond_100-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dimond_100-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Dimond PF (16 August 2010). <a rel="nofollow" class="external text" href="http://www.genengnews.com/analysis-and-insight/no-new-parkinson-disease-drug-expected-anytime-soon/77899336/">"No New Parkinson Disease Drug Expected Anytime Soon"</a>. <i>GEN news highlights</i>. GEN-Genetic Engineering &amp; Biotechnology News.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=No+New+Parkinson+Disease+Drug+Expected+Anytime+Soon&amp;rft.au=Dimond+PF&amp;rft.aulast=Dimond+PF&amp;rft.date=16+August+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fanalysis-and-insight%2Fno-new-parkinson-disease-drug-expected-anytime-soon%2F77899336%2F&amp;rft.jtitle=GEN+news+highlights&amp;rft.pub=GEN-Genetic+Engineering+%26+Biotechnology+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid6823561-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid6823561_101-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Langston JW, Ballard P, Tetrud JW, Irwin I (February 1983). "Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis". <i>Science</i> <b>219</b> (4587): 979–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1126%2Fscience.6823561">10.1126/science.6823561</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6823561">6823561</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Chronic+Parkinsonism+in+humans+due+to+a+product+of+meperidine-analog+synthesis&amp;rft.au=Langston+JW%2C+Ballard+P%2C+Tetrud+JW%2C+Irwin+I&amp;rft.aulast=Langston+JW%2C+Ballard+P%2C+Tetrud+JW%2C+Irwin+I&amp;rft.date=February+1983&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.6823561&amp;rft_id=info%3Apmid%2F6823561&amp;rft.issue=4587&amp;rft.jtitle=Science&amp;rft.pages=979%E2%80%9380&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=219" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19729209-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19729209_102-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Cicchetti F, Drouin-Ouellet J, Gross RE (September 2009). "Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?". <i>Trends Pharmacol. Sci.</i> <b>30</b> (9): 475–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.tips.2009.06.005">10.1016/j.tips.2009.06.005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19729209">19729209</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Environmental+toxins+and+Parkinson%27s+disease%3A+what+have+we+learned+from+pesticide-induced+animal+models%3F&amp;rft.au=Cicchetti+F%2C+Drouin-Ouellet+J%2C+Gross+RE&amp;rft.aulast=Cicchetti+F%2C+Drouin-Ouellet+J%2C+Gross+RE&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tips.2009.06.005&amp;rft_id=info%3Apmid%2F19729209&amp;rft.issue=9&amp;rft.jtitle=Trends+Pharmacol.+Sci.&amp;rft.pages=475%E2%80%9383&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18642640-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18642640_103-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Harvey BK, Wang Y, Hoffer BJ (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2613245">"Transgenic rodent models of Parkinson's disease"</a>. <i>Acta Neurochir. Suppl</i>. Acta Neurochirurgica Supplementum <b>101</b>: 89–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2F978-3-211-78205-7_15">10.1007/978-3-211-78205-7_15</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-211-78204-0" title="Special:BookSources/978-3-211-78204-0">978-3-211-78204-0</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2613245">2613245</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18642640">18642640</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Transgenic+rodent+models+of+Parkinson%27s+disease&amp;rft.au=Harvey+BK%2C+Wang+Y%2C+Hoffer+BJ&amp;rft.aulast=Harvey+BK%2C+Wang+Y%2C+Hoffer+BJ&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2613245&amp;rft_id=info%3Adoi%2F10.1007%2F978-3-211-78205-7_15&amp;rft_id=info%3Apmc%2F2613245&amp;rft_id=info%3Apmid%2F18642640&amp;rft.isbn=978-3-211-78204-0&amp;rft.jtitle=Acta+Neurochir.+Suppl.&amp;rft.pages=89%E2%80%9392&amp;rft.series=Acta+Neurochirurgica+Supplementum&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><span class="citation journal">Blum, et al., (October 2001). "Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease". <i>Progress in Neurobiology</i> <b>65</b> (2): 135–172. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0301-0082%2801%2900003-X">10.1016/S0301-0082(01)00003-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11403877">11403877</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Molecular+pathways+involved+in+the+neurotoxicity+of+6-OHDA%2C+dopamine+++++and+MPTP%3A+contribution+to+the+apoptotic+theory+in+Parkinson%27s+disease&amp;rft.au=Blum%2C+et+al.%2C&amp;rft.aufirst=et+al.%2C&amp;rft.aulast=Blum&amp;rft.date=October+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0301-0082%2801%2900003-X&amp;rft_id=info%3Apmid%2F11403877&amp;rft.issue=2&amp;rft.jtitle=Progress+in+Neurobiology&amp;rft.pages=135%E2%80%93172&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20155994-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20155994_105-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Feng, LR, Maguire-Zeiss KA (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2886503">"Gene Therapy in Parkinson's Disease: Rationale and Current Status"</a>. <i>CNS Drugs</i> <b>24</b> (3): 177–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F11533740-000000000-00000">10.2165/11533740-000000000-00000</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2886503">2886503</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20155994">20155994</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Gene+Therapy+in+Parkinson%27s+Disease%3A+Rationale+and+Current+Status&amp;rft.au=Feng%2C+LR%2C+Maguire-Zeiss+KA&amp;rft.aulast=Feng%2C+LR%2C+Maguire-Zeiss+KA&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2886503&amp;rft_id=info%3Adoi%2F10.2165%2F11533740-000000000-00000&amp;rft_id=info%3Apmc%2F2886503&amp;rft_id=info%3Apmid%2F20155994&amp;rft.issue=3&amp;rft.jtitle=CNS+Drugs&amp;rft.pages=177%E2%80%9392&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21419704-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21419704_106-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lewitt PA, Rezai AR, Leehey MA, <i>et al.</i> (April 2011). "AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial". <i>Lancet Neurol</i> <b>10</b> (4): 309–19. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS1474-4422%2811%2970039-4">10.1016/S1474-4422(11)70039-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21419704">21419704</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=AAV2-GAD+gene+therapy+for+advanced+Parkinson%27s+disease%3A+a+double-blind%2C+sham-surgery+controlled%2C+randomised+trial&amp;rft.aulast=Lewitt+PA%2C+Rezai+AR%2C+Leehey+MA%2C+%27%27et+al.%27%27&amp;rft.au=Lewitt+PA%2C+Rezai+AR%2C+Leehey+MA%2C+%27%27et+al.%27%27&amp;rft.date=April+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2811%2970039-4&amp;rft_id=info%3Apmid%2F21419704&amp;rft.issue=4&amp;rft.jtitle=Lancet+Neurol&amp;rft.pages=309%E2%80%9319&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2012-03-16/neurologix-files-to-liquidate-under-chapter-7-bankruptcy-1-.html">"Neurologix Files to Liquidate Under Chapter 7 Bankruptcy"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=Neurologix+Files+to+Liquidate+Under+Chapter+7+Bankruptcy&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2012-03-16%2Fneurologix-files-to-liquidate-under-chapter-7-bankruptcy-1-.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NS1-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-NS1_108-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.newscientist.com/article/mg21428682.000-worlds-first-parkinsons-vaccine-is-trialled.html">"World's first Parkinson's vaccine is trialled"</a>. New Scientist. 7 June 2012.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=World%27s+first+Parkinson%27s+vaccine+is+trialled&amp;rft.date=7+June+2012&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.newscientist.com%2Farticle%2Fmg21428682.000-worlds-first-parkinsons-vaccine-is-trialled.html&amp;rft.pub=New+Scientist&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><span class="citation journal">Redmond DE (October 2002). "Cellular replacement therapy for Parkinson's disease—where we are today?". <i>The Neuroscientist</i> <b>8</b> (5): 457–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1177%2F107385802237703">10.1177/107385802237703</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12374430">12374430</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.atitle=Cellular+replacement+therapy+for+Parkinson%27s+disease%E2%80%94where+we+are+today%3F&amp;rft.aulast=Redmond+DE&amp;rft.au=Redmond+DE&amp;rft.date=October+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1177%2F107385802237703&amp;rft_id=info%3Apmid%2F12374430&amp;rft.issue=5&amp;rft.jtitle=The+Neuroscientist&amp;rft.pages=457%E2%80%9388&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Science_Daily-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-Science_Daily_110-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.sciencedaily.com/releases/2006/12/061204123212.htm">"Stem Cell Research Aims to Tackle Parkinson's Disease"</a><span class="reference-accessdate">. Retrieved 16 April 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease&amp;rft.btitle=Stem+Cell+Research+Aims+to+Tackle+Parkinson%27s+Disease&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.sciencedaily.com%2Freleases%2F2006%2F12%2F061204123212.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span></h2>
<table class="metadata plainlinks mbox-small" style="padding:0.25em 0.5em 0.5em 0.75em;border:1px solid #aaa;background:#f9f9f9;">
<tr style="height:25px;">
<td colspan="2" style="padding-bottom:0.5em;border-bottom:1px solid #aaa;margin:auto;text-align:center;">Find more about <b>Parkinson's disease</b> at Wikipedia's <a href="/wiki/Wikipedia:Wikimedia_sister_projects" title="Wikipedia:Wikimedia sister projects">sister projects</a></td>
</tr>
<tr style="height:25px;">
<td style="padding-top:0.75em;"><a href="//en.wiktionary.org/wiki/Special:Search/Parkinson%27s_disease" title="Search Wiktionary"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/23px-Wiktionary-logo-en.svg.png" width="23" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/35px-Wiktionary-logo-en.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/46px-Wiktionary-logo-en.svg.png 2x" /></a></td>
<td style="padding-top:0.75em;"><a href="//en.wiktionary.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="wikt:Special:Search/Parkinson's disease">Definitions and translations</a> from Wiktionary</td>
</tr>
<tr style="height:25px;">
<td><a href="//commons.wikimedia.org/wiki/Special:Search/Parkinson%27s_disease" title="Search Commons"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/18px-Commons-logo.svg.png" width="18" height="25" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/28px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/37px-Commons-logo.svg.png 2x" /></a></td>
<td><a href="//commons.wikimedia.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="commons:Special:Search/Parkinson's disease">Media</a> from Commons</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikiquote.org/wiki/Special:Search/Parkinson%27s_disease" title="Search Wikiquote"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/21px-Wikiquote-logo.svg.png" width="21" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/32px-Wikiquote-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/42px-Wikiquote-logo.svg.png 2x" /></a></td>
<td><a href="//en.wikiquote.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="q:Special:Search/Parkinson's disease">Quotations</a> from Wikiquote</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikisource.org/wiki/Special:Search/Parkinson%27s_disease" title="Search Wikisource"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/24px-Wikisource-logo.svg.png" width="24" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/36px-Wikisource-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/48px-Wikisource-logo.svg.png 2x" /></a></td>
<td><a href="//en.wikisource.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="s:Special:Search/Parkinson's disease">Source texts</a> from Wikisource</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikibooks.org/wiki/Special:Search/Parkinson%27s_disease" title="Search Wikibooks"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/25px-Wikibooks-logo.svg.png" width="25" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/38px-Wikibooks-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/50px-Wikibooks-logo.svg.png 2x" /></a></td>
<td><a href="//en.wikibooks.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="b:Special:Search/Parkinson's disease">Textbooks</a> from Wikibooks</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikiversity.org/wiki/Special:Search/Parkinson%27s_disease" title="Search Wikiversity"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Wikiversity-logo-en.svg/25px-Wikiversity-logo-en.svg.png" width="25" height="23" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Wikiversity-logo-en.svg/38px-Wikiversity-logo-en.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Wikiversity-logo-en.svg/50px-Wikiversity-logo-en.svg.png 2x" /></a></td>
<td><a href="//en.wikiversity.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="v:Special:Search/Parkinson's disease">Learning resources</a> from Wikiversity</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.dmoz.org/Health/Conditions_and_Diseases/Neurological_Disorders/Parkinson's_Disease/">Parkinson's Disease</a> on the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a rel="nofollow" class="external text" href="http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm">Parkinson's Disease: Hope Through Research (National Institute of Neurological Disorders and Stroke)</a></li>
<li><a rel="nofollow" class="external text" href="http://www.wpda.org/">World Parkinson Disease Association</a></li>
<li><a rel="nofollow" class="external text" href="http://www.pdgene.org/">PDGENE – Database for Parkinson's Disease genetic association studies</a></li>
</ul>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks hlist collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Mental_and_behavioral_disorders" title="Template:Mental and behavioral disorders"><span title="View this template" style=";;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Mental_and_behavioral_disorders" title="Template talk:Mental and behavioral disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Mental_and_behavioral_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Mental_disorder" title="Mental disorder">Mental</a> and <a href="/wiki/Emotional_and_behavioral_disorders" title="Emotional and behavioral disorders">behavioral disorders</a> (<a href="/wiki/ICD-10_Chapter_V:_Mental_and_behavioural_disorders" title="ICD-10 Chapter V: Mental and behavioural disorders">F</a> <a href="/wiki/List_of_ICD-9_codes_290%E2%80%93319:_mental_disorders" title="List of ICD-9 codes 290–319: mental disorders">290–319</a>)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible uncollapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;">Neurological/symptomatic</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dementia" title="Dementia">Dementia</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Mild_cognitive_impairment" title="Mild cognitive impairment">Mild cognitive impairment</a></li>
<li><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a></li>
<li><a href="/wiki/Vascular_dementia" title="Vascular dementia">Vascular dementia</a></li>
<li><a href="/wiki/Pick%27s_disease" title="Pick's disease">Pick's disease</a></li>
<li><a href="/wiki/Creutzfeldt%E2%80%93Jakob_disease" title="Creutzfeldt–Jakob disease">Creutzfeldt–Jakob disease</a></li>
<li><a href="/wiki/Huntington%27s_disease" title="Huntington's disease">Huntington's disease</a></li>
<li><strong class="selflink">Parkinson's disease</strong></li>
<li><a href="/wiki/AIDS_dementia_complex" title="AIDS dementia complex" class="mw-redirect">AIDS dementia complex</a></li>
<li><a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a></li>
<li><a href="/wiki/Sundowning_(dementia)" title="Sundowning (dementia)" class="mw-redirect">Sundowning</a></li>
<li><a href="/wiki/Wandering_(dementia)" title="Wandering (dementia)">Wandering</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Autism_spectrum" title="Autism spectrum">Autism spectrum</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Autism" title="Autism">Autism</a></li>
<li><a href="/wiki/Asperger_syndrome" title="Asperger syndrome">Asperger syndrome</a></li>
<li><a href="/wiki/Savant_syndrome" title="Savant syndrome">Savant syndrome</a></li>
<li><a href="/wiki/PDD-NOS" title="PDD-NOS">PDD-NOS</a></li>
<li><a href="/wiki/High-functioning_autism" title="High-functioning autism">High-functioning autism</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Delirium" title="Delirium">Delirium</a></li>
<li><a href="/wiki/Post-concussion_syndrome" title="Post-concussion syndrome">Post-concussion syndrome</a></li>
<li><a href="/wiki/Organic_brain_syndrome" title="Organic brain syndrome">Organic brain syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Psychoactive" title="Psychoactive" class="mw-redirect">Psychoactive</a> substances, <a href="/wiki/Substance_abuse" title="Substance abuse">substance abuse</a>, <a href="/wiki/Drug_abuse" title="Drug abuse" class="mw-redirect">drug abuse</a> and substance-related disorders</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Substance_intoxication" title="Substance intoxication">Intoxication</a>/<a href="/wiki/Drug_overdose" title="Drug overdose">Drug overdose</a></li>
<li><a href="/wiki/Physical_dependence" title="Physical dependence">Physical dependence</a></li>
<li><a href="/wiki/Substance_dependence" title="Substance dependence">Substance dependence</a></li>
<li><a href="/wiki/Rebound_effect" title="Rebound effect">Rebound effect</a></li>
<li><a href="/wiki/Double_rebound" title="Double rebound" class="mw-redirect">Double rebound</a></li>
<li><a href="/wiki/Drug_withdrawal" title="Drug withdrawal">Withdrawal</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Schizophrenia" title="Schizophrenia">Schizophrenia</a>, <a href="/wiki/Schizotypal_personality_disorder" title="Schizotypal personality disorder">schizotypal</a> and <a href="/wiki/Delusional_disorder" title="Delusional disorder">delusional</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Psychosis" title="Psychosis">Psychosis</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Schizoaffective_disorder" title="Schizoaffective disorder">Schizoaffective disorder</a></li>
<li><a href="/wiki/Schizophreniform_disorder" title="Schizophreniform disorder">Schizophreniform disorder</a></li>
<li><a href="/wiki/Brief_reactive_psychosis" title="Brief reactive psychosis">Brief reactive psychosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Schizophrenia" title="Schizophrenia">Schizophrenia</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Disorganized_schizophrenia" title="Disorganized schizophrenia">Disorganized schizophrenia</a></li>
<li><a href="/wiki/Delusional_disorder" title="Delusional disorder">Delusional disorder</a></li>
<li><a href="/wiki/Folie_%C3%A0_deux" title="Folie à deux">Folie à deux</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Mood_disorder" title="Mood disorder">Mood</a> (affective)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Mania" title="Mania">Mania</a></li>
<li><a href="/wiki/Bipolar_disorder" title="Bipolar disorder">Bipolar disorder</a></li>
<li>(<a href="/wiki/Bipolar_I_disorder" title="Bipolar I disorder">Bipolar I</a></li>
<li><a href="/wiki/Bipolar_II_disorder" title="Bipolar II disorder">Bipolar II</a></li>
<li><a href="/wiki/Cyclothymia" title="Cyclothymia">Cyclothymia</a></li>
<li><a href="/wiki/Bipolar_disorder_NOS" title="Bipolar disorder NOS" class="mw-redirect">Bipolar NOS</a>)</li>
<li><a href="/wiki/Depression_(mood)" title="Depression (mood)">Depression</a></li>
<li>(<a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">Major depressive disorder</a></li>
<li><a href="/wiki/Dysthymia" title="Dysthymia">Dysthymia</a></li>
<li><a href="/wiki/Seasonal_affective_disorder" title="Seasonal affective disorder">Seasonal affective disorder</a></li>
<li><a href="/wiki/Atypical_depression" title="Atypical depression">Atypical depression</a></li>
<li><a href="/wiki/Melancholic_depression" title="Melancholic depression">Melancholic depression</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Neurosis" title="Neurosis">Neurotic</a>, <a href="/wiki/Stress_(biology)" title="Stress (biology)">stress</a>-related and <a href="/wiki/Somatoform_disorder" title="Somatoform disorder">somatoform</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Anxiety_disorder" title="Anxiety disorder">Anxiety disorder</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Phobia" title="Phobia">Phobia</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Agoraphobia" title="Agoraphobia">Agoraphobia</a></li>
<li><a href="/wiki/Social_anxiety" title="Social anxiety">Social anxiety</a></li>
<li><a href="/wiki/Social_anxiety_disorder" title="Social anxiety disorder">Social phobia</a></li>
<li>(<a href="/wiki/Anthropophobia" title="Anthropophobia">Anthropophobia</a>)</li>
<li><a href="/wiki/Specific_phobia" title="Specific phobia">Specific phobia</a></li>
<li>(<a href="/wiki/Claustrophobia" title="Claustrophobia">Claustrophobia</a>)</li>
<li><a href="/wiki/Specific_social_phobia" title="Specific social phobia">Specific social phobia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Panic_disorder" title="Panic disorder">Panic disorder</a></li>
<li><a href="/wiki/Panic_attack" title="Panic attack">Panic attack</a></li>
<li><a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">Generalized anxiety disorder</a></li>
<li><a href="/wiki/Obsessive%E2%80%93compulsive_disorder" title="Obsessive–compulsive disorder">OCD</a></li>
<li><i>stress</i></li>
<li>(<a href="/wiki/Acute_stress_reaction" title="Acute stress reaction">Acute stress reaction</a></li>
<li><a href="/wiki/Posttraumatic_stress_disorder" title="Posttraumatic stress disorder">PTSD</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Adjustment_disorder" title="Adjustment disorder">Adjustment disorder</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Adjustment_disorder" title="Adjustment disorder">Adjustment disorder with depressed mood</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Somatoform_disorder" title="Somatoform disorder">Somatoform disorder</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Somatization_disorder" title="Somatization disorder">Somatization disorder</a></li>
<li><a href="/wiki/Body_dysmorphic_disorder" title="Body dysmorphic disorder">Body dysmorphic disorder</a></li>
<li><a href="/wiki/Hypochondriasis" title="Hypochondriasis">Hypochondriasis</a></li>
<li><a href="/wiki/Nosophobia" title="Nosophobia">Nosophobia</a></li>
<li><a href="/wiki/Da_Costa%27s_syndrome" title="Da Costa's syndrome">Da Costa's syndrome</a></li>
<li><a href="/wiki/Psychogenic_pain" title="Psychogenic pain">Psychalgia</a></li>
<li><a href="/wiki/Conversion_disorder" title="Conversion disorder">Conversion disorder</a></li>
<li>(<a href="/wiki/Ganser_syndrome" title="Ganser syndrome">Ganser syndrome</a></li>
<li><a href="/wiki/Globus_pharyngis" title="Globus pharyngis">Globus pharyngis</a>)</li>
<li><a href="/wiki/Neurasthenia" title="Neurasthenia">Neurasthenia</a></li>
<li><a href="/wiki/Mass_Psychogenic_Illness" title="Mass Psychogenic Illness" class="mw-redirect">Mass Psychogenic Illness</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dissociative_disorder" title="Dissociative disorder">Dissociative disorder</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Dissociative_identity_disorder" title="Dissociative identity disorder">Dissociative identity disorder</a></li>
<li><a href="/wiki/Psychogenic_amnesia" title="Psychogenic amnesia">Psychogenic amnesia</a></li>
<li><a href="/wiki/Fugue_state" title="Fugue state">Fugue state</a></li>
<li><a href="/wiki/Depersonalization_disorder" title="Depersonalization disorder">Depersonalization disorder</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;">Physiological/physical behavioral</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Eating_disorder" title="Eating disorder">Eating disorder</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Anorexia_nervosa" title="Anorexia nervosa">Anorexia nervosa</a></li>
<li><a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">Bulimia nervosa</a></li>
<li><a href="/wiki/Rumination_syndrome" title="Rumination syndrome">Rumination syndrome</a></li>
<li><a href="/wiki/Eating_disorder_not_otherwise_specified" title="Eating disorder not otherwise specified">NOS</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;">Nonorganic<br />
<a href="/wiki/Sleep_disorder" title="Sleep disorder">sleep disorders</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li>(<a href="/wiki/Hypersomnia" title="Hypersomnia">Nonorganic hypersomnia</a></li>
<li><a href="/wiki/Insomnia" title="Insomnia">Nonorganic insomnia</a>)</li>
<li><a href="/wiki/Parasomnia" title="Parasomnia">Parasomnia</a></li>
<li>(<a href="/wiki/Rapid_eye_movement_behavior_disorder" title="Rapid eye movement behavior disorder">REM behavior disorder</a></li>
<li><a href="/wiki/Night_terror" title="Night terror">Night terror</a></li>
<li><a href="/wiki/Nightmare" title="Nightmare">Nightmare</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">Sexual<br />
dysfunction</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i><a href="/wiki/Sexual_dysfunction#Sexual_desire_disorders" title="Sexual dysfunction">sexual desire</a></i></li>
<li>(<a href="/wiki/Hypoactive_sexual_desire_disorder" title="Hypoactive sexual desire disorder">Hypoactive sexual desire disorder</a></li>
<li><a href="/wiki/Hypersexuality" title="Hypersexuality">Hypersexuality</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Sexual_dysfunction#Sexual_arousal_disorders" title="Sexual dysfunction">sexual arousal</a></i></li>
<li>(<a href="/wiki/Female_sexual_arousal_disorder" title="Female sexual arousal disorder">Female sexual arousal disorder</a>)</li>
<li><a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">Erectile dysfunction</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Sexual_dysfunction#Orgasm_disorders" title="Sexual dysfunction">orgasm</a></i></li>
<li>(<a href="/wiki/Anorgasmia" title="Anorgasmia">Anorgasmia</a></li>
<li><a href="/wiki/Delayed_ejaculation" title="Delayed ejaculation">Delayed ejaculation</a></li>
<li><a href="/wiki/Premature_ejaculation" title="Premature ejaculation">Premature ejaculation</a></li>
<li><a href="/wiki/Sexual_anhedonia" title="Sexual anhedonia">Sexual anhedonia</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Sexual_dysfunction#Sexual_pain_disorders" title="Sexual dysfunction">pain</a></i></li>
<li>(<a href="/wiki/Vaginismus" title="Vaginismus">Vaginismus</a></li>
<li><a href="/wiki/Dyspareunia" title="Dyspareunia">Dyspareunia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Psychiatric_disorders_of_childbirth" title="Psychiatric disorders of childbirth">Postnatal</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Postpartum_depression" title="Postpartum depression">Postpartum depression</a></li>
<li><a href="/wiki/Postnatal_psychosis" title="Postnatal psychosis" class="mw-redirect">Postnatal psychosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;">Adult personality and behavior</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><i><a href="/wiki/Sexual_identity" title="Sexual identity">Sexual</a> and<br />
<a href="/wiki/Gender_identity_disorder" title="Gender identity disorder">gender identity</a></i></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Sexual_maturation_disorder" title="Sexual maturation disorder">Sexual maturation disorder</a></li>
<li><a href="/wiki/Ego-dystonic_sexual_orientation" title="Ego-dystonic sexual orientation">Ego-dystonic sexual orientation</a></li>
<li><a href="/wiki/Sexual_relationship_disorder" title="Sexual relationship disorder">Sexual relationship disorder</a></li>
<li><a href="/wiki/Paraphilia" title="Paraphilia">Paraphilia</a></li>
<li>(<a href="/wiki/Voyeurism" title="Voyeurism">Voyeurism</a></li>
<li><a href="/wiki/Sexual_Fetishism" title="Sexual Fetishism" class="mw-redirect">Fetishism</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Personality_disorder" title="Personality disorder">Personality disorder</a></li>
<li><a href="/wiki/Impulse_control_disorder" title="Impulse control disorder">Impulse control disorder</a></li>
<li>(<a href="/wiki/Kleptomania" title="Kleptomania">Kleptomania</a></li>
<li><a href="/wiki/Trichotillomania" title="Trichotillomania">Trichotillomania</a></li>
<li><a href="/wiki/Pyromania" title="Pyromania">Pyromania</a></li>
<li><a href="/wiki/Dermatillomania" title="Dermatillomania">Dermatillomania</a>)</li>
<li><a href="/wiki/Body-focused_repetitive_behavior" title="Body-focused repetitive behavior">Body-focused repetitive behavior</a></li>
<li><a href="/wiki/Factitious_disorder" title="Factitious disorder">Factitious disorder</a></li>
<li>(<a href="/wiki/M%C3%BCnchausen_syndrome" title="Münchausen syndrome">Münchausen syndrome</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Mental_disorders_diagnosed_in_childhood" title="Mental disorders diagnosed in childhood">Mental disorders diagnosed in childhood</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Intellectual_disability" title="Intellectual disability">Intellectual disability</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/X-Linked_mental_retardation" title="X-Linked mental retardation" class="mw-redirect">X-Linked mental retardation</a></li>
<li>(<a href="/wiki/Lujan-Fryns_syndrome" title="Lujan-Fryns syndrome" class="mw-redirect">Lujan-Fryns syndrome</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;">Psychological development<br />
(<a href="/wiki/Developmental_disorder" title="Developmental disorder">developmental disorder</a>)</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Specific_developmental_disorder" title="Specific developmental disorder">Specific</a></li>
<li><a href="/wiki/Pervasive_developmental_disorder" title="Pervasive developmental disorder">Pervasive</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Emotional_and_behavioral_disorders" title="Emotional and behavioral disorders">Emotional and behavioral</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Attention-deficit_hyperactivity_disorder" title="Attention-deficit hyperactivity disorder" class="mw-redirect">ADHD</a></li>
<li><a href="/wiki/Conduct_disorder" title="Conduct disorder">Conduct disorder</a></li>
<li>(<a href="/wiki/Oppositional_defiant_disorder" title="Oppositional defiant disorder">ODD</a>)</li>
<li><i>emotional disorder</i></li>
<li>(<a href="/wiki/Separation_anxiety_disorder" title="Separation anxiety disorder">Separation anxiety disorder</a>)</li>
<li><i>social functioning</i></li>
<li>(<a href="/wiki/Selective_mutism" title="Selective mutism">Selective mutism</a></li>
<li><a href="/wiki/Reactive_attachment_disorder" title="Reactive attachment disorder">RAD</a></li>
<li><a href="/wiki/Disinhibited_attachment_disorder" title="Disinhibited attachment disorder">DAD</a>)</li>
<li><a href="/wiki/Tic_disorder" title="Tic disorder">Tic disorder</a></li>
<li>(<a href="/wiki/Tourette_syndrome" title="Tourette syndrome">Tourette syndrome</a>)</li>
<li><i><a href="/wiki/Speech_disorder" title="Speech disorder">Speech</a></i></li>
<li>(<a href="/wiki/Stuttering" title="Stuttering">Stuttering</a></li>
<li><a href="/wiki/Cluttering" title="Cluttering">Cluttering</a>)</li>
<li><a href="/wiki/Movement_disorder" title="Movement disorder">Movement disorder</a></li>
<li>(<a href="/wiki/Stereotypic_movement_disorder" title="Stereotypic movement disorder">Stereotypic</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;">Symptoms and uncategorized</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Catatonia" title="Catatonia">Catatonia</a></li>
<li><a href="/wiki/False_pregnancy" title="False pregnancy">False pregnancy</a></li>
<li><a href="/wiki/Intermittent_explosive_disorder" title="Intermittent explosive disorder">Intermittent explosive disorder</a></li>
<li><a href="/wiki/Psychomotor_agitation" title="Psychomotor agitation">Psychomotor agitation</a></li>
<li><a href="/wiki/Sexual_addiction" title="Sexual addiction">Sexual addiction</a></li>
<li><a href="/wiki/Stereotypy" title="Stereotypy">Stereotypy</a></li>
<li><a href="/wiki/Psychogenic_non-epileptic_seizures" title="Psychogenic non-epileptic seizures">Psychogenic non-epileptic seizures</a></li>
<li><a href="/wiki/Kl%C3%BCver-Bucy_syndrome" title="Klüver-Bucy syndrome" class="mw-redirect">Klüver-Bucy syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:LemonChiffon; width: 25%;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Psychology" title="Psychology">PSO</a>/<a href="/wiki/Psychiatry" title="Psychiatry">PSI</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white; width: 25%;;width:10em;">
<div>
<p><a href="/wiki/Template:Mental_processes" title="Template:Mental processes">mepr</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver; width: 25%;;width:10em;">
<div>
<p><a href="/wiki/Template:Mental_and_behavioral_disorders" title="Template:Mental and behavioral disorders">dsrd</a> (<a href="/wiki/Template:Obsessive%E2%80%93compulsive_disorder" title="Template:Obsessive–compulsive disorder">o</a>, <a href="/wiki/Template:Pervasive_developmental_disorders" title="Template:Pervasive developmental disorders">p</a>, <a href="/wiki/Template:Mood_disorders" title="Template:Mood disorders">m</a>, <a href="/wiki/Template:Psychoactive_substance_use" title="Template:Psychoactive substance use">p</a>, <a href="/wiki/Template:Attention-deficit_hyperactivity_disorder" title="Template:Attention-deficit hyperactivity disorder">a</a>, <a href="/wiki/Template:Dyslexia_and_specific_developmental_disorders" title="Template:Dyslexia and specific developmental disorders">d</a>, <a href="/wiki/Template:Sleep" title="Template:Sleep">s</a>), <a href="/wiki/Template:Cognition,_perception,_emotional_state_and_behaviour_symptoms_and_signs" title="Template:Cognition, perception, emotional state and behaviour symptoms and signs">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_nervous_system" title="Template:Eponymous medical signs for nervous system">epon</a>, <a href="/wiki/Template:Symptoms_involving_head_and_neck" title="Template:Symptoms involving head and neck">spvo</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf; width: 25%;;width:10em;">
<div>
<p>proc (<a href="/wiki/Template:Psychologic_and_psychiatric_evaluation_and_testing" title="Template:Psychologic and psychiatric evaluation and testing" class="mw-redirect">eval</a>/<a href="/wiki/Template:Psychotherapy" title="Template:Psychotherapy">thrp</a>), drug (<a href="/wiki/Template:Antipsychotics" title="Template:Antipsychotics">N5A</a>/<a href="/wiki/Template:Anxiolytics" title="Template:Anxiolytics">5B</a>/<a href="/wiki/Template:Hypnotics_and_sedatives" title="Template:Hypnotics and sedatives">5C</a>/<a href="/wiki/Template:Antidepressants" title="Template:Antidepressants">6A</a>/<a href="/wiki/Template:Psychostimulants,_agents_used_for_ADHD_and_nootropics" title="Template:Psychostimulants, agents used for ADHD and nootropics">6B</a>/<a href="/wiki/Template:Anti-dementia_drugs" title="Template:Anti-dementia drugs">6D</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background: Silver;;">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:CNS_diseases_of_the_nervous_system" title="Template:CNS diseases of the nervous system"><span title="View this template" style=";background: Silver;;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:CNS_diseases_of_the_nervous_system" title="Template talk:CNS diseases of the nervous system"><span title="Discuss this template" style=";background: Silver;;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:CNS_diseases_of_the_nervous_system&amp;action=edit"><span title="Edit this template" style=";background: Silver;;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Pathology" title="Pathology">Pathology</a> of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, primarily <a href="/wiki/Central_nervous_system_disease" title="Central nervous system disease">CNS</a> (<a href="/wiki/ICD-10_Chapter_VI:_Diseases_of_the_nervous_system" title="ICD-10 Chapter VI: Diseases of the nervous system">G04–G47</a>, <a href="/wiki/List_of_ICD-9_codes_320%E2%80%93359:_diseases_of_the_nervous_system" title="List of ICD-9 codes 320–359: diseases of the nervous system">323–349</a>)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: LemonChiffon;"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Human_brain" title="Human brain">Brain</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Encephalitis" title="Encephalitis">Encephalitis</a>
<ul>
<li><a href="/wiki/Viral_encephalitis" title="Viral encephalitis">Viral encephalitis</a></li>
<li><a href="/wiki/Herpesviral_encephalitis" title="Herpesviral encephalitis">Herpesviral encephalitis</a></li>
<li><a href="/wiki/Limbic_encephalitis" title="Limbic encephalitis">Limbic encephalitis</a></li>
<li><a href="/wiki/Encephalitis_lethargica" title="Encephalitis lethargica">Encephalitis lethargica</a></li>
</ul>
</li>
<li><a href="/wiki/Cavernous_sinus_thrombosis" title="Cavernous sinus thrombosis">Cavernous sinus thrombosis</a></li>
<li><a href="/wiki/Brain_abscess" title="Brain abscess">Brain abscess</a>
<ul>
<li><a href="/wiki/Amoebic_brain_abscess" title="Amoebic brain abscess">Amoebic</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Spinal_cord" title="Spinal cord">Spinal cord</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Myelitis" title="Myelitis">Myelitis</a>: <a href="/wiki/Poliomyelitis" title="Poliomyelitis">Poliomyelitis</a></li>
<li><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating disease</a>
<ul>
<li><a href="/wiki/Transverse_myelitis" title="Transverse myelitis">Transverse myelitis</a></li>
</ul>
</li>
<li><a href="/wiki/Tropical_spastic_paraparesis" title="Tropical spastic paraparesis">Tropical spastic paraparesis</a></li>
<li><a href="/wiki/Epidural_abscess" title="Epidural abscess" class="mw-redirect">Epidural abscess</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;">Both/either</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a>
<ul>
<li><a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated</a></li>
</ul>
</li>
<li><a href="/wiki/Meningoencephalitis" title="Meningoencephalitis">Meningoencephalitis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: LemonChiffon;"><a href="/wiki/Human_brain" title="Human brain">Brain</a>/<br />
<a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease" class="mw-redirect">Degenerative</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Extrapyramidal_system" title="Extrapyramidal system">Extrapyramidal</a> and<br />
<a href="/wiki/Movement_disorder" title="Movement disorder">movement disorders</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Basal_ganglia_disease" title="Basal ganglia disease">Basal ganglia disease</a>
<ul>
<li><a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a>
<ul>
<li><strong class="selflink">PD</strong></li>
<li><a href="/wiki/Postencephalitic_parkinsonism" title="Postencephalitic parkinsonism">Postencephalitic</a></li>
<li><a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">NMS</a></li>
</ul>
</li>
<li><a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">PKAN</a></li>
<li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul>
<li><a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">PSP</a></li>
</ul>
</li>
<li><a href="/wiki/Striatonigral_degeneration" title="Striatonigral degeneration" class="mw-redirect">Striatonigral degeneration</a></li>
<li><a href="/wiki/Hemiballismus" title="Hemiballismus">Hemiballismus</a></li>
<li><a href="/wiki/Huntington%27s_disease" title="Huntington's disease">HD</a></li>
<li><a href="/wiki/Olivopontocerebellar_atrophy" title="Olivopontocerebellar atrophy">OA</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Dyskinesia" title="Dyskinesia">Dyskinesia</a>
<ul>
<li><a href="/wiki/Dystonia" title="Dystonia">Dystonia</a>
<ul>
<li><a href="/wiki/Status_dystonicus" title="Status dystonicus">Status dystonicus</a></li>
<li><a href="/wiki/Spasmodic_torticollis" title="Spasmodic torticollis">Spasmodic torticollis</a></li>
<li><a href="/wiki/Meige%27s_syndrome" title="Meige's syndrome">Meige's</a></li>
<li><a href="/wiki/Blepharospasm" title="Blepharospasm">Blepharospasm</a></li>
</ul>
</li>
<li><a href="/wiki/Athetosis" title="Athetosis">Athetosis</a></li>
<li><a href="/wiki/Chorea" title="Chorea">Chorea</a>
<ul>
<li><a href="/wiki/Choreoathetosis" title="Choreoathetosis">Choreoathetosis</a></li>
</ul>
</li>
<li><a href="/wiki/Myoclonus" title="Myoclonus">Myoclonus</a>
<ul>
<li><a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></li>
</ul>
</li>
<li><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Tremor" title="Tremor">Tremor</a>
<ul>
<li><a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a></li>
<li><a href="/wiki/Intention_tremor" title="Intention tremor">Intention tremor</a></li>
</ul>
</li>
<li><a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs</a></li>
<li><a href="/wiki/Stiff_person_syndrome" title="Stiff person syndrome">Stiff person</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dementia" title="Dementia">Dementia</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul>
<li><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's</a>
<ul>
<li><a href="/wiki/Early-onset_Alzheimer%27s_disease" title="Early-onset Alzheimer's disease">Early-onset</a></li>
</ul>
</li>
<li><a href="/wiki/Primary_progressive_aphasia" title="Primary progressive aphasia">Primary progressive aphasia</a></li>
</ul>
</li>
<li><a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>/<a href="/wiki/Frontotemporal_lobar_degeneration" title="Frontotemporal lobar degeneration">Frontotemporal lobar degeneration</a>
<ul>
<li><a href="/wiki/Pick%27s_disease" title="Pick's disease">Pick's</a></li>
<li><a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">Dementia with Lewy bodies</a></li>
</ul>
</li>
<li><a href="/wiki/Posterior_cortical_atrophy" title="Posterior cortical atrophy">Posterior cortical atrophy</a></li>
</ul>
<ul>
<li><a href="/wiki/Vascular_dementia" title="Vascular dementia">Vascular dementia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Mitochondrial_disease" title="Mitochondrial disease">Mitochondrial disease</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Leigh%27s_disease" title="Leigh's disease">Leigh's disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">autoimmune</a></i>
<ul>
<li><a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a></li>
<li><a href="/wiki/Neuromyelitis_optica" title="Neuromyelitis optica">Neuromyelitis optica</a></li>
<li><a href="/wiki/Diffuse_myelinoclastic_sclerosis" title="Diffuse myelinoclastic sclerosis">Schilder's disease</a></li>
</ul>
</li>
<li><i><a href="/wiki/Hereditary_CNS_demyelinating_disease" title="Hereditary CNS demyelinating disease">hereditary</a></i>
<ul>
<li><a href="/wiki/Adrenoleukodystrophy" title="Adrenoleukodystrophy">Adrenoleukodystrophy</a></li>
<li><a href="/wiki/Alexander_disease" title="Alexander disease">Alexander</a></li>
<li><a href="/wiki/Canavan_disease" title="Canavan disease">Canavan</a></li>
<li><a href="/wiki/Krabbe_disease" title="Krabbe disease">Krabbe</a></li>
<li><a href="/wiki/Metachromatic_leukodystrophy" title="Metachromatic leukodystrophy">ML</a></li>
<li><a href="/wiki/Pelizaeus-Merzbacher_disease" title="Pelizaeus-Merzbacher disease" class="mw-redirect">PMD</a></li>
<li><a href="/wiki/Leukoencephalopathy_with_vanishing_white_matter" title="Leukoencephalopathy with vanishing white matter">VWM</a></li>
<li><a href="/wiki/Megalencephalic_leukoencephalopathy_with_subcortical_cysts" title="Megalencephalic leukoencephalopathy with subcortical cysts">MFC</a></li>
<li><a href="/wiki/CAMFAK_syndrome" title="CAMFAK syndrome">CAMFAK syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Central_pontine_myelinolysis" title="Central pontine myelinolysis">Central pontine myelinolysis</a></li>
<li><a href="/wiki/Marchiafava-Bignami_disease" title="Marchiafava-Bignami disease" class="mw-redirect">Marchiafava-Bignami disease</a></li>
<li><a href="/wiki/Alpers%27_disease" title="Alpers' disease">Alpers' disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;">Episodic/<br />
<a href="/wiki/Paroxysm" title="Paroxysm" class="mw-redirect">paroxysmal</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Epileptic_seizure" title="Epileptic seizure">Seizure</a>/<a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Focal_seizures" title="Focal seizures" class="mw-redirect">Focal</a></li>
<li><a href="/wiki/Generalised_epilepsy" title="Generalised epilepsy">Generalised</a></li>
<li><a href="/wiki/Status_epilepticus" title="Status epilepticus">Status epilepticus</a></li>
<li><a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Headache" title="Headache">Headache</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Migraine" title="Migraine">Migraine</a>
<ul>
<li><a href="/wiki/Familial_hemiplegic_migraine" title="Familial hemiplegic migraine">Familial hemiplegic</a></li>
</ul>
</li>
<li><a href="/wiki/Cluster_headache" title="Cluster headache">Cluster</a></li>
<li><a href="/wiki/Tension_headache" title="Tension headache">Tension</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Cerebrovascular_disease" title="Cerebrovascular disease">Cerebrovascular</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">TIA</a>
<ul>
<li><a href="/wiki/Amaurosis_fugax" title="Amaurosis fugax">Amaurosis fugax</a></li>
<li><a href="/wiki/Transient_global_amnesia" title="Transient global amnesia">Transient global amnesia</a></li>
<li><a href="/wiki/Aphasia" title="Aphasia">Acute aphasia</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Stroke" title="Stroke">Stroke</a>
<ul>
<li><a href="/wiki/Middle_cerebral_artery_syndrome" title="Middle cerebral artery syndrome">MCA</a></li>
<li><a href="/wiki/Anterior_cerebral_artery_syndrome" title="Anterior cerebral artery syndrome">ACA</a></li>
<li><a href="/wiki/Posterior_cerebral_artery_syndrome" title="Posterior cerebral artery syndrome">PCA</a></li>
<li><a href="/wiki/Foville%27s_syndrome" title="Foville's syndrome">Foville's</a></li>
<li><a href="/wiki/Millard-Gubler_syndrome" title="Millard-Gubler syndrome" class="mw-redirect">Millard-Gubler</a></li>
<li><a href="/wiki/Lateral_medullary_syndrome" title="Lateral medullary syndrome">Lateral medullary</a></li>
<li><a href="/wiki/Weber%27s_syndrome" title="Weber's syndrome">Weber's</a></li>
<li><a href="/wiki/Lacunar_stroke" title="Lacunar stroke">Lacunar stroke</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sleep_disorder" title="Sleep disorder">Sleep disorders</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Insomnia" title="Insomnia">Insomnia</a></li>
<li><a href="/wiki/Hypersomnia" title="Hypersomnia">Hypersomnia</a></li>
<li><a href="/wiki/Sleep_apnea" title="Sleep apnea">Sleep apnea</a>
<ul>
<li><a href="/wiki/Obstructive_sleep_apnea" title="Obstructive sleep apnea">Obstructive</a></li>
<li><a href="/wiki/Ondine%27s_curse" title="Ondine's curse">Ondine's curse</a></li>
</ul>
</li>
<li><a href="/wiki/Narcolepsy" title="Narcolepsy">Narcolepsy</a></li>
<li><a href="/wiki/Cataplexy" title="Cataplexy">Cataplexy</a></li>
<li><a href="/wiki/Kleine-Levin_syndrome" title="Kleine-Levin syndrome" class="mw-redirect">Kleine-Levin</a></li>
<li><a href="/wiki/Circadian_rhythm_sleep_disorder" title="Circadian rhythm sleep disorder">Circadian rhythm sleep disorder</a>
<ul>
<li><a href="/wiki/Advanced_sleep_phase_disorder" title="Advanced sleep phase disorder">Advanced sleep phase disorder</a></li>
<li><a href="/wiki/Delayed_sleep_phase_disorder" title="Delayed sleep phase disorder">Delayed sleep phase disorder</a></li>
<li><a href="/wiki/Non-24-hour_sleep%E2%80%93wake_disorder" title="Non-24-hour sleep–wake disorder">Non-24-hour sleep–wake disorder</a></li>
<li><a href="/wiki/Jet_lag" title="Jet lag">Jet lag</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">CSF</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Intracranial_hypertension" title="Intracranial hypertension" class="mw-redirect">Intracranial hypertension</a>
<ul>
<li><a href="/wiki/Hydrocephalus" title="Hydrocephalus">Hydrocephalus</a>/<a href="/wiki/Normal_pressure_hydrocephalus" title="Normal pressure hydrocephalus">NPH</a></li>
<li><a href="/wiki/Choroid_plexus_papilloma" title="Choroid plexus papilloma">Choroid plexus papilloma</a></li>
<li><a href="/wiki/Idiopathic_intracranial_hypertension" title="Idiopathic intracranial hypertension">Idiopathic intracranial hypertension</a></li>
</ul>
</li>
<li><a href="/wiki/Cerebral_edema" title="Cerebral edema">Cerebral edema</a></li>
<li><a href="/wiki/Intracranial_hypotension" title="Intracranial hypotension" class="mw-redirect">Intracranial hypotension</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Brain_herniation" title="Brain herniation">Brain herniation</a></li>
<li><a href="/wiki/Reye%27s_syndrome" title="Reye's syndrome" class="mw-redirect">Reye's</a></li>
<li><a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a></li>
<li><a href="/wiki/Toxic_encephalopathy" title="Toxic encephalopathy">Toxic encephalopathy</a></li>
<li><a href="/wiki/Hashimoto%27s_encephalopathy" title="Hashimoto's encephalopathy">Hashimoto's encephalopathy</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: LemonChiffon;"><a href="/wiki/Spinal_cord" title="Spinal cord">Spinal cord</a>/<br />
<a href="/wiki/Myelopathy" title="Myelopathy">myelopathy</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Syringomyelia" title="Syringomyelia">Syringomyelia</a></li>
<li><a href="/wiki/Syringobulbia" title="Syringobulbia">Syringobulbia</a></li>
<li><a href="/wiki/Morvan%27s_syndrome" title="Morvan's syndrome">Morvan's syndrome</a></li>
<li><a href="/wiki/Vascular_myelopathy" title="Vascular myelopathy">Vascular myelopathy</a>
<ul>
<li><a href="/wiki/Foix-Alajouanine_syndrome" title="Foix-Alajouanine syndrome" class="mw-redirect">Foix-Alajouanine syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Spinal_cord_compression" title="Spinal cord compression">Spinal cord compression</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: LemonChiffon;">Both/either</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease" class="mw-redirect">Degenerative</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Spinocerebellar_ataxia" title="Spinocerebellar ataxia">SA</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Friedreich%27s_ataxia" title="Friedreich's ataxia">Friedreich's ataxia</a></li>
<li><a href="/wiki/Ataxia_telangiectasia" title="Ataxia telangiectasia">Ataxia telangiectasia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Motor_neuron_disease" title="Motor neuron disease">MND</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i><a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">UMN</a> only:</i>
<ul>
<li><a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a></li>
<li><a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">Pseudobulbar palsy</a></li>
<li><a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">LMN</a> only:</i>
<ul>
<li><a href="/wiki/Distal_hereditary_motor_neuropathies" title="Distal hereditary motor neuropathies">Distal hereditary motor neuropathies</a></li>
<li><a href="/wiki/Spinal_muscular_atrophies" title="Spinal muscular atrophies">Spinal muscular atrophies</a>
<ul>
<li><a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">SMA</a></li>
<li><a href="/wiki/X-linked_spinal_muscular_atrophy_type_1" title="X-linked spinal muscular atrophy type 1" class="mw-redirect">SMAX1</a></li>
<li><a href="/wiki/X-linked_spinal_muscular_atrophy_type_2" title="X-linked spinal muscular atrophy type 2">SMAX2</a></li>
<li><a href="/wiki/Distal_spinal_muscular_atrophy_type_1" title="Distal spinal muscular atrophy type 1">DSMA1</a></li>
<li><a href="/wiki/Congenital_distal_spinal_muscular_atrophy" title="Congenital distal spinal muscular atrophy">Congenital DSMA</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_pontocerebellar_hypoplasia" title="Spinal muscular atrophy with pontocerebellar hypoplasia" class="mw-redirect">SMA-PCH</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance" title="Spinal muscular atrophy with lower extremity predominance">SMA-LED</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_progressive_myoclonic_epilepsy" title="Spinal muscular atrophy with progressive myoclonic epilepsy">SMA-PME</a></li>
</ul>
</li>
<li><a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">Progressive muscular atrophy</a></li>
<li><a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">Progressive bulbar palsy</a>
<ul>
<li><a href="/wiki/Fazio%E2%80%93Londe_disease" title="Fazio–Londe disease">Fazio–Londe</a></li>
<li><a href="/wiki/Infantile_progressive_bulbar_palsy" title="Infantile progressive bulbar palsy">Infantile progressive bulbar palsy</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li><i>both:</i>
<ul>
<li><a href="/wiki/Amyotrophic_lateral_sclerosis" title="Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:LemonChiffon;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Central_nervous_system" title="Central nervous system">CNS</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Nervous_system" title="Template:Nervous system">anat</a> (<a href="/wiki/Template:Meninges" title="Template:Meninges">n</a>/<a href="/wiki/Template:Spinal_cord" title="Template:Spinal cord">s</a>/<a href="/wiki/Template:Medulla" title="Template:Medulla">m</a>/<a href="/wiki/Template:Pons" title="Template:Pons">p</a>/<a href="/wiki/Template:Fourth_ventricle" title="Template:Fourth ventricle">4</a>/<a href="/wiki/Template:Mesencephalon" title="Template:Mesencephalon">e</a>/<a href="/wiki/Template:Cerebellum" title="Template:Cerebellum">b</a>/<a href="/wiki/Template:Diencephalon" title="Template:Diencephalon">d</a>/<a href="/wiki/Template:Cerebral_cortex" title="Template:Cerebral cortex">c</a>/<a href="/wiki/Template:Association_fibers" title="Template:Association fibers">a</a>/<a href="/wiki/Template:Commissural_fibers_and_septum" title="Template:Commissural fibers and septum">f</a>/<a href="/wiki/Template:Lateral_ventricles" title="Template:Lateral ventricles">l</a>/<a href="/wiki/Template:Rostral_basal_ganglia_and_associated_structures" title="Template:Rostral basal ganglia and associated structures">g</a>)/<a href="/wiki/Template:Nervous_system_physiology" title="Template:Nervous system physiology">phys</a>/<a href="/wiki/Template:Development_of_nervous_system" title="Template:Development of nervous system">devp</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver;;width:10em;">
<div>
<p><a href="/wiki/Template:CNS_diseases_of_the_nervous_system" title="Template:CNS diseases of the nervous system">noco</a> (<a href="/wiki/Template:Diseases_of_meninges" title="Template:Diseases of meninges">m</a>/<a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS">d</a>/<a href="/wiki/Template:Seizures_and_epilepsy" title="Template:Seizures and epilepsy">e</a>/<a href="/wiki/Template:Headache" title="Template:Headache">h</a>/<a href="/wiki/Template:Cerebrovascular_diseases" title="Template:Cerebrovascular diseases">v</a>/<a href="/wiki/Template:Sleep" title="Template:Sleep">s</a>)/<a href="/wiki/Template:Congenital_malformations_and_deformations_of_nervous_system" title="Template:Congenital malformations and deformations of nervous system">cong</a>/<a href="/wiki/Template:Nervous_system_tumors" title="Template:Nervous system tumors">tumr</a>, <a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_nervous_system" title="Template:Eponymous medical signs for nervous system">epon</a>, <a href="/wiki/Template:Neurotrauma" title="Template:Neurotrauma">injr</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Neuro_procedures" title="Template:Neuro procedures">proc</a>, <a href="/wiki/ATC_code_N" title="ATC code N">drug</a> (<a href="/wiki/Template:General_anesthetics" title="Template:General anesthetics">N1A</a>/<a href="/wiki/Template:Analgesics" title="Template:Analgesics">2AB</a>/<a href="/wiki/Template:Antimigraine_preparations" title="Template:Antimigraine preparations">C</a>/<a href="/wiki/Template:Anticonvulsants" title="Template:Anticonvulsants">3</a>/<a href="/wiki/Template:Antiparkinson" title="Template:Antiparkinson">4</a>/<a href="/wiki/Template:Cholinergics" title="Template:Cholinergics">7A</a>/<a href="/wiki/Template:Antiaddictives" title="Template:Antiaddictives">B</a>/<a href="/wiki/Template:Antivertigo_preparations" title="Template:Antivertigo preparations">C</a>/<a href="/wiki/Template:Other_nervous_system_drugs" title="Template:Other nervous system drugs">D</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Antiparkinson" title="Template:Antiparkinson"><span title="View this template" style=";;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Antiparkinson" title="Template talk:Antiparkinson"><span title="Discuss this template" style=";;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Antiparkinson&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Antiparkinson" title="Antiparkinson">Antiparkinson agents</a> (<a href="/wiki/ATC_code_N04" title="ATC code N04">N04</a>)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background: LemonChiffon;"><a href="/wiki/Dopaminergic" title="Dopaminergic">Dopaminergics</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine" title="Dopamine">DA</a> <a href="/wiki/Precursor_(chemistry)" title="Precursor (chemistry)">precursors</a>/<a href="/wiki/Prodrug" title="Prodrug">prodrugs</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Etilevodopa" title="Etilevodopa">Etilevodopa</a></li>
<li><a href="/wiki/Droxidopa" title="Droxidopa">Droxidopa</a></li>
<li><a href="/wiki/Levodopa" title="Levodopa" class="mw-redirect">Levodopa</a><sup>#</sup></li>
<li><a href="/wiki/Melevodopa" title="Melevodopa">Melevodopa</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_receptor" title="Dopamine receptor">DA receptor</a> <a href="/wiki/Dopamine_receptor_agonist" title="Dopamine receptor agonist" class="mw-redirect">agonists</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Aplindore" title="Aplindore">Aplindore</a></li>
<li><a href="/wiki/Apomorphine" title="Apomorphine">Apomorphine</a></li>
<li><a href="/wiki/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li>
<li><a href="/wiki/Cabergoline" title="Cabergoline">Cabergoline</a></li>
<li><a href="/wiki/Ciladopa" title="Ciladopa">Ciladopa</a></li>
<li><a href="/wiki/Dihydroergocryptine" title="Dihydroergocryptine">Dihydroergocryptine</a></li>
<li><a href="/wiki/Lisuride" title="Lisuride">Lisuride</a></li>
<li><a href="/wiki/Pardoprunox" title="Pardoprunox">Pardoprunox</a></li>
<li><a href="/wiki/Pergolide" title="Pergolide">Pergolide</a></li>
<li><a href="/wiki/Piribedil" title="Piribedil">Piribedil</a></li>
<li><a href="/wiki/Pramipexole" title="Pramipexole">Pramipexole</a></li>
<li><a href="/wiki/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li><a href="/wiki/Rotigotine" title="Rotigotine">Rotigotine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAO-B</a> <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">inhibitors</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Ladostigil" title="Ladostigil">Ladostigil</a></li>
<li><a href="/wiki/Lazabemide" title="Lazabemide">Lazabemide</a></li>
<li><a href="/wiki/Mofegiline" title="Mofegiline">Mofegiline</a></li>
<li><a href="/wiki/Pargyline" title="Pargyline">Pargyline</a></li>
<li><a href="/wiki/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li><a href="/wiki/Selegiline" title="Selegiline">Selegiline</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Catechol-O-methyl_transferase" title="Catechol-O-methyl transferase">COMT</a> <a href="/wiki/COMT_inhibitor" title="COMT inhibitor">inhibitors</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Entacapone" title="Entacapone">Entacapone</a></li>
<li><a href="/wiki/Nitecapone" title="Nitecapone">Nitecapone</a></li>
<li><a href="/wiki/Tolcapone" title="Tolcapone">Tolcapone</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background: LemonChiffon;">
<div style="padding:0em 0.75em;"><a href="/wiki/Aromatic_L-amino_acid_decarboxylase_inhibitor" title="Aromatic L-amino acid decarboxylase inhibitor">Aromatic L-amino acid decarboxylase inhibitors</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Benserazide" title="Benserazide">Benserazide</a></li>
<li><a href="/wiki/Carbidopa" title="Carbidopa">Carbidopa</a><sup>#</sup></li>
<li><a href="/wiki/Methyldopa" title="Methyldopa">Methyldopa</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background: LemonChiffon;"><a href="/wiki/Anticholinergic" title="Anticholinergic">Anticholinergics</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Benzatropine" title="Benzatropine">Benzatropine</a></li>
<li><a href="/wiki/Biperiden" title="Biperiden">Biperiden</a><sup>#</sup></li>
<li><a href="/wiki/Bornaprine" title="Bornaprine">Bornaprine</a></li>
<li><a href="/wiki/Chlorphenoxamine" title="Chlorphenoxamine">Chlorphenoxamine</a></li>
<li><a href="/wiki/Cycrimine" title="Cycrimine">Cycrimine</a></li>
<li><a href="/wiki/Dexetimide" title="Dexetimide">Dexetimide</a></li>
<li><a href="/wiki/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="/wiki/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="/wiki/Etanautine" title="Etanautine">Etanautine</a></li>
<li><a href="/wiki/Etybenzatropine" title="Etybenzatropine">Etybenzatropine</a></li>
<li><a href="/wiki/Mazaticol" title="Mazaticol">Mazaticol</a></li>
<li><a href="/wiki/Metixene" title="Metixene">Metixene</a></li>
<li><a href="/wiki/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><a href="/wiki/Phenglutarimide" title="Phenglutarimide">Phenglutarimide</a></li>
<li><a href="/wiki/Piroheptine" title="Piroheptine">Piroheptine</a></li>
<li><a href="/wiki/Procyclidine" title="Procyclidine">Procyclidine</a></li>
<li><a href="/wiki/Profenamine" title="Profenamine">Profenamine</a></li>
<li><a href="/wiki/Trihexyphenidyl" title="Trihexyphenidyl">Trihexyphenidyl</a></li>
<li><a href="/wiki/Tropatepine" title="Tropatepine">Tropatepine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background: LemonChiffon;">Others</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Amantadine" title="Amantadine">Amantadine</a></li>
<li><a href="/wiki/Budipine" title="Budipine">Budipine</a></li>
<li><a href="/wiki/3,4-Methylenedioxy-N-methylamphetamine" title="3,4-Methylenedioxy-N-methylamphetamine" class="mw-redirect">MDMA</a></li>
<li><a href="/wiki/Memantine" title="Memantine">Memantine</a></li>
<li><a href="/wiki/Methylxanthine" title="Methylxanthine" class="mw-redirect">Methylxanthines</a></li>
<li><a href="/wiki/Rimantadine" title="Rimantadine">Rimantadine</a></li>
<li><a href="/wiki/UWA-101" title="UWA-101">UWA-101</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<div class="hlist">
<ul>
<li><sup>#</sup><a href="/wiki/List_of_World_Health_Organization_Essential_Medicines" title="List of World Health Organization Essential Medicines" class="mw-redirect">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul>
<li><sup>†</sup><a href="/wiki/Clinical_trial#Phase_III" title="Clinical trial">Phase III</a></li>
<li><sup>§</sup><a href="/wiki/Clinical_trial#Phase_II" title="Clinical trial">Never to phase III</a></li>
</ul>
</li>
</ul>
</div>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:LemonChiffon;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Central_nervous_system" title="Central nervous system">CNS</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Nervous_system" title="Template:Nervous system">anat</a> (<a href="/wiki/Template:Meninges" title="Template:Meninges">n</a>/<a href="/wiki/Template:Spinal_cord" title="Template:Spinal cord">s</a>/<a href="/wiki/Template:Medulla" title="Template:Medulla">m</a>/<a href="/wiki/Template:Pons" title="Template:Pons">p</a>/<a href="/wiki/Template:Fourth_ventricle" title="Template:Fourth ventricle">4</a>/<a href="/wiki/Template:Mesencephalon" title="Template:Mesencephalon">e</a>/<a href="/wiki/Template:Cerebellum" title="Template:Cerebellum">b</a>/<a href="/wiki/Template:Diencephalon" title="Template:Diencephalon">d</a>/<a href="/wiki/Template:Cerebral_cortex" title="Template:Cerebral cortex">c</a>/<a href="/wiki/Template:Association_fibers" title="Template:Association fibers">a</a>/<a href="/wiki/Template:Commissural_fibers_and_septum" title="Template:Commissural fibers and septum">f</a>/<a href="/wiki/Template:Lateral_ventricles" title="Template:Lateral ventricles">l</a>/<a href="/wiki/Template:Rostral_basal_ganglia_and_associated_structures" title="Template:Rostral basal ganglia and associated structures">g</a>)/<a href="/wiki/Template:Nervous_system_physiology" title="Template:Nervous system physiology">phys</a>/<a href="/wiki/Template:Development_of_nervous_system" title="Template:Development of nervous system">devp</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver;;width:10em;">
<div>
<p><a href="/wiki/Template:CNS_diseases_of_the_nervous_system" title="Template:CNS diseases of the nervous system">noco</a> (<a href="/wiki/Template:Diseases_of_meninges" title="Template:Diseases of meninges">m</a>/<a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS">d</a>/<a href="/wiki/Template:Seizures_and_epilepsy" title="Template:Seizures and epilepsy">e</a>/<a href="/wiki/Template:Headache" title="Template:Headache">h</a>/<a href="/wiki/Template:Cerebrovascular_diseases" title="Template:Cerebrovascular diseases">v</a>/<a href="/wiki/Template:Sleep" title="Template:Sleep">s</a>)/<a href="/wiki/Template:Congenital_malformations_and_deformations_of_nervous_system" title="Template:Congenital malformations and deformations of nervous system">cong</a>/<a href="/wiki/Template:Nervous_system_tumors" title="Template:Nervous system tumors">tumr</a>, <a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_nervous_system" title="Template:Eponymous medical signs for nervous system">epon</a>, <a href="/wiki/Template:Neurotrauma" title="Template:Neurotrauma">injr</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Neuro_procedures" title="Template:Neuro procedures">proc</a>, <a href="/wiki/ATC_code_N" title="ATC code N">drug</a> (<a href="/wiki/Template:General_anesthetics" title="Template:General anesthetics">N1A</a>/<a href="/wiki/Template:Analgesics" title="Template:Analgesics">2AB</a>/<a href="/wiki/Template:Antimigraine_preparations" title="Template:Antimigraine preparations">C</a>/<a href="/wiki/Template:Anticonvulsants" title="Template:Anticonvulsants">3</a>/<a href="/wiki/Template:Antiparkinson" title="Template:Antiparkinson">4</a>/<a href="/wiki/Template:Cholinergics" title="Template:Cholinergics">7A</a>/<a href="/wiki/Template:Antiaddictives" title="Template:Antiaddictives">B</a>/<a href="/wiki/Template:Antivertigo_preparations" title="Template:Antivertigo preparations">C</a>/<a href="/wiki/Template:Other_nervous_system_drugs" title="Template:Other nervous system drugs">D</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<div style="display:none; right:10px;" class="metadata topicon nopopups" id="featured-star"><a href="/wiki/Wikipedia:Featured_articles" title="This is a featured article. Click here for more information."><img alt="This is a featured article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/e/e7/Cscr-featured.svg/15px-Cscr-featured.svg.png" width="15" height="14" srcset="//upload.wikimedia.org/wikipedia/en/thumb/e/e7/Cscr-featured.svg/23px-Cscr-featured.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/e/e7/Cscr-featured.svg/30px-Cscr-featured.svg.png 2x" /></a></div>
<p><span id="interwiki-it-fa"></span> <span id="interwiki-ru-fa"></span></p>


<!-- 
NewPP limit report
Parsed by mw1074
CPU time usage: 5.576 seconds
Real time usage: 5.796 seconds
Preprocessor visited node count: 16838/1000000
Preprocessor generated node count: 63025/1500000
Post‐expand include size: 581095/2048000 bytes
Template argument size: 45375/2048000 bytes
Highest expansion depth: 17/40
Expensive parser function count: 8/500
Lua time usage: 0.544/10.000 seconds
Lua memory usage: 3.1 MB/50 MB
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:22228064-0!*!0!!en!4!* and timestamp 20140325092418
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>								<div class="printfooter">
				Retrieved from "<a href="http://en.wikipedia.org/w/index.php?title=Parkinson%27s_disease&amp;oldid=601167669">http://en.wikipedia.org/w/index.php?title=Parkinson%27s_disease&amp;oldid=601167669</a>"				</div>
												<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Aging-associated_diseases" title="Category:Aging-associated diseases">Aging-associated diseases</a></li><li><a href="/wiki/Category:Geriatrics" title="Category:Geriatrics">Geriatrics</a></li><li><a href="/wiki/Category:Parkinson%27s_disease" title="Category:Parkinson's disease">Parkinson's disease</a></li><li><a href="/wiki/Category:Cytoskeletal_defects" title="Category:Cytoskeletal defects">Cytoskeletal defects</a></li><li><a href="/wiki/Category:Psychiatric_diagnosis" title="Category:Psychiatric diagnosis">Psychiatric diagnosis</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Use_dmy_dates_from_March_2014" title="Category:Use dmy dates from March 2014">Use dmy dates from March 2014</a></li><li><a href="/wiki/Category:Wikipedia_indefinitely_semi-protected_pages" title="Category:Wikipedia indefinitely semi-protected pages">Wikipedia indefinitely semi-protected pages</a></li><li><a href="/wiki/Category:Articles_with_Open_Directory_Project_links" title="Category:Articles with Open Directory Project links">Articles with Open Directory Project links</a></li><li><a href="/wiki/Category:Featured_articles" title="Category:Featured articles">Featured articles</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>
			<div id="mw-head">
				<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
	<h3 id="p-personal-label">Personal tools</h3>
	<ul>
<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Parkinson%27s+disease&amp;type=signup">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Parkinson%27s+disease" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>	</ul>
</div>
				<div id="left-navigation">
					<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
	<h3 id="p-namespaces-label">Namespaces</h3>
	<ul>
					<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Parkinson%27s_disease"  title="View the content page [c]" accesskey="c">Article</a></span></li>
					<li  id="ca-talk"><span><a href="/wiki/Talk:Parkinson%27s_disease"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
			</ul>
</div>
<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
	<h3 id="mw-vector-current-variant">
		</h3>
	<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
				</div>
				<div id="right-navigation">
					<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
	<h3 id="p-views-label">Views</h3>
	<ul>
					<li id="ca-view" class="selected"><span><a href="/wiki/Parkinson%27s_disease" >Read</a></span></li>
					<li id="ca-viewsource"><span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit"  title="This page is protected.&#10;You can view its source [e]" accesskey="e">View source</a></span></li>
					<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
			</ul>
</div>
<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
	<h3 id="p-cactions-label"><span>Actions</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
<div id="p-search" role="search">
	<h3><label for="searchInput">Search</label></h3>
	<form action="/w/index.php" id="searchform">
					<div id="simpleSearch">
					<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />		</div>
	</form>
</div>
				</div>
			</div>
			<div id="mw-panel">
					<div id="p-logo" role="banner"><a style="background-image: url(//upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
				<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
	<h3 id='p-navigation-label'>Navigation</h3>
	<div class="body">
		<ul>
			<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
			<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
			<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
			<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
			<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
			<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
	<h3 id='p-interaction-label'>Interaction</h3>
	<div class="body">
		<ul>
			<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
			<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
			<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
			<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
	<h3 id='p-tb-label'>Tools</h3>
	<div class="body">
		<ul>
			<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Parkinson%27s_disease" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
			<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Parkinson%27s_disease" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
			<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
			<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
			<li id="t-permalink"><a href="/w/index.php?title=Parkinson%27s_disease&amp;oldid=601167669" title="Permanent link to this revision of the page">Permanent link</a></li>
			<li id="t-info"><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=info">Page information</a></li>
			<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q11085" title="Link to connected data repository item [g]" accesskey="g">Data item</a></li>
<li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Parkinson%27s_disease&amp;id=601167669" title="Information on how to cite this page">Cite this page</a></li>		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
	<h3 id='p-coll-print_export-label'>Print/export</h3>
	<div class="body">
		<ul>
			<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Parkinson%27s+disease">Create a book</a></li>
			<li id="coll-download-as-rl"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Parkinson%27s+disease&amp;oldid=601167669&amp;writer=rl">Download as PDF</a></li>
			<li id="t-print"><a href="/w/index.php?title=Parkinson%27s_disease&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
	<h3 id='p-lang-label'>Languages</h3>
	<div class="body">
		<ul>
			<li class="interlanguage-link interwiki-als"><a href="//als.wikipedia.org/wiki/Parkinson-Krankheit" title="Parkinson-Krankheit – Alemannisch" lang="als" hreflang="als">Alemannisch</a></li>
			<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%85%D8%B1%D8%B6_%D8%A8%D8%A7%D8%B1%D9%83%D9%86%D8%B3%D9%88%D9%86" title="مرض باركنسون – Arabic" lang="ar" hreflang="ar">العربية</a></li>
			<li class="interlanguage-link interwiki-az"><a href="//az.wikipedia.org/wiki/Parkinson_x%C9%99st%C9%99liyi" title="Parkinson xəstəliyi – Azerbaijani" lang="az" hreflang="az">Azərbaycanca</a></li>
			<li class="interlanguage-link interwiki-bn"><a href="//bn.wikipedia.org/wiki/%E0%A6%AA%E0%A6%BE%E0%A6%B0%E0%A6%95%E0%A6%BF%E0%A6%A8%E0%A6%B8%E0%A6%A8_%E0%A6%B0%E0%A7%8B%E0%A6%97" title="পারকিনসন রোগ – Bengali" lang="bn" hreflang="bn">বাংলা</a></li>
			<li class="interlanguage-link interwiki-zh-min-nan"><a href="//zh-min-nan.wikipedia.org/wiki/Parkinson_%C3%AA_p%C4%93%E2%81%BF" title="Parkinson ê pēⁿ – Chinese (Min Nan)" lang="zh-min-nan" hreflang="zh-min-nan">Bân-lâm-gú</a></li>
			<li class="interlanguage-link interwiki-bg"><a href="//bg.wikipedia.org/wiki/%D0%91%D0%BE%D0%BB%D0%B5%D1%81%D1%82_%D0%BD%D0%B0_%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD" title="Болест на Паркинсон – Bulgarian" lang="bg" hreflang="bg">Български</a></li>
			<li class="interlanguage-link interwiki-bs"><a href="//bs.wikipedia.org/wiki/Parkinsonova_bolest" title="Parkinsonova bolest – Bosnian" lang="bs" hreflang="bs">Bosanski</a></li>
			<li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Malaltia_de_Parkinson" title="Malaltia de Parkinson – Catalan" lang="ca" hreflang="ca">Català</a></li>
			<li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Parkinsonova_nemoc" title="Parkinsonova nemoc – Czech" lang="cs" hreflang="cs">Čeština</a></li>
			<li class="interlanguage-link interwiki-co"><a href="//co.wikipedia.org/wiki/Malat%C3%ACa_di_Parkinson" title="Malatìa di Parkinson – Corsican" lang="co" hreflang="co">Corsu</a></li>
			<li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Parkinsons_sygdom" title="Parkinsons sygdom – Danish" lang="da" hreflang="da">Dansk</a></li>
			<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Parkinson-Krankheit" title="Parkinson-Krankheit – German" lang="de" hreflang="de">Deutsch</a></li>
			<li class="interlanguage-link interwiki-dv"><a href="//dv.wikipedia.org/wiki/%DE%8C%DE%AA%DE%83%DE%AA%DE%8C%DE%AA%DE%83%DE%AA%DE%87%DE%A6%DE%85%DE%A7_%DE%84%DE%A6%DE%8D%DE%A8" title="ތުރުތުރުއަޅާ ބަލި – Divehi" lang="dv" hreflang="dv">ދިވެހިބަސް</a></li>
			<li class="interlanguage-link interwiki-et"><a href="//et.wikipedia.org/wiki/Parkinsoni_t%C3%B5bi" title="Parkinsoni tõbi – Estonian" lang="et" hreflang="et">Eesti</a></li>
			<li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%9D%CF%8C%CF%83%CE%BF%CF%82_%CF%84%CE%BF%CF%85_%CE%A0%CE%AC%CF%81%CE%BA%CE%B9%CE%BD%CF%83%CE%BF%CE%BD" title="Νόσος του Πάρκινσον – Greek" lang="el" hreflang="el">Ελληνικά</a></li>
			<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Enfermedad_de_Parkinson" title="Enfermedad de Parkinson – Spanish" lang="es" hreflang="es">Español</a></li>
			<li class="interlanguage-link interwiki-eo"><a href="//eo.wikipedia.org/wiki/Parkinsona_malsano" title="Parkinsona malsano – Esperanto" lang="eo" hreflang="eo">Esperanto</a></li>
			<li class="interlanguage-link interwiki-eu"><a href="//eu.wikipedia.org/wiki/Parkinsonen_gaixotasun" title="Parkinsonen gaixotasun – Basque" lang="eu" hreflang="eu">Euskara</a></li>
			<li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%BE%D8%A7%D8%B1%DA%A9%DB%8C%D9%86%D8%B3%D9%88%D9%86" title="پارکینسون – Persian" lang="fa" hreflang="fa">فارسی</a></li>
			<li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Maladie_de_Parkinson" title="Maladie de Parkinson – French" lang="fr" hreflang="fr">Français</a></li>
			<li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Galar_Parkinson" title="Galar Parkinson – Irish" lang="ga" hreflang="ga">Gaeilge</a></li>
			<li class="interlanguage-link interwiki-gl"><a href="//gl.wikipedia.org/wiki/P%C3%A1rkinson" title="Párkinson – Galician" lang="gl" hreflang="gl">Galego</a></li>
			<li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%ED%8C%8C%ED%82%A8%EC%8A%A8%EB%B3%91" title="파킨슨병 – Korean" lang="ko" hreflang="ko">한국어</a></li>
			<li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%AA%E0%A4%BE%E0%A4%B0%E0%A5%8D%E0%A4%95%E0%A4%BF%E0%A4%82%E0%A4%B8%E0%A4%A8_%E0%A4%B0%E0%A5%8B%E0%A4%97" title="पार्किंसन रोग – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li>
			<li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Parkinsonova_bolest" title="Parkinsonova bolest – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li>
			<li class="interlanguage-link interwiki-ig"><a href="//ig.wikipedia.org/wiki/%E1%BB%8Cri%C3%A0_Parkinson" title="Ọrià Parkinson – Igbo" lang="ig" hreflang="ig">Igbo</a></li>
			<li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Penyakit_Parkinson" title="Penyakit Parkinson – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li>
			<li class="interlanguage-link interwiki-is"><a href="//is.wikipedia.org/wiki/Parkinsonsveiki" title="Parkinsonsveiki – Icelandic" lang="is" hreflang="is">Íslenska</a></li>
			<li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Malattia_di_Parkinson" title="Malattia di Parkinson – Italian" lang="it" hreflang="it">Italiano</a></li>
			<li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%9E%D7%97%D7%9C%D7%AA_%D7%A4%D7%A8%D7%A7%D7%99%D7%A0%D7%A1%D7%95%D7%9F" title="מחלת פרקינסון – Hebrew" lang="he" hreflang="he">עברית</a></li>
			<li class="interlanguage-link interwiki-jv"><a href="//jv.wikipedia.org/wiki/Buyuten" title="Buyuten – Javanese" lang="jv" hreflang="jv">Basa Jawa</a></li>
			<li class="interlanguage-link interwiki-ka"><a href="//ka.wikipedia.org/wiki/%E1%83%9E%E1%83%90%E1%83%A0%E1%83%99%E1%83%98%E1%83%9C%E1%83%A1%E1%83%9D%E1%83%9C%E1%83%98%E1%83%A1_%E1%83%93%E1%83%90%E1%83%90%E1%83%95%E1%83%90%E1%83%93%E1%83%94%E1%83%91%E1%83%90" title="პარკინსონის დაავადება – Georgian" lang="ka" hreflang="ka">ქართული</a></li>
			<li class="interlanguage-link interwiki-kk"><a href="//kk.wikipedia.org/wiki/%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD_%D0%B0%D1%83%D1%80%D1%83%D1%8B" title="Паркинсон ауруы – Kazakh" lang="kk" hreflang="kk">Қазақша</a></li>
			<li class="interlanguage-link interwiki-ku"><a href="//ku.wikipedia.org/wiki/Nexwe%C5%9Fiya_parkinson%C3%AA" title="Nexweşiya parkinsonê – Kurdish" lang="ku" hreflang="ku">Kurdî</a></li>
			<li class="interlanguage-link interwiki-la"><a href="//la.wikipedia.org/wiki/Morbus_Parkinson" title="Morbus Parkinson – Latin" lang="la" hreflang="la">Latina</a></li>
			<li class="interlanguage-link interwiki-lv"><a href="//lv.wikipedia.org/wiki/P%C4%81rkinsona_slim%C4%ABba" title="Pārkinsona slimība – Latvian" lang="lv" hreflang="lv">Latviešu</a></li>
			<li class="interlanguage-link interwiki-lb"><a href="//lb.wikipedia.org/wiki/Parkinson-Krankheet" title="Parkinson-Krankheet – Luxembourgish" lang="lb" hreflang="lb">Lëtzebuergesch</a></li>
			<li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Parkinson-k%C3%B3r" title="Parkinson-kór – Hungarian" lang="hu" hreflang="hu">Magyar</a></li>
			<li class="interlanguage-link interwiki-mk"><a href="//mk.wikipedia.org/wiki/%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%BE%D0%B2%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82" title="Паркинсонова болест – Macedonian" lang="mk" hreflang="mk">Македонски</a></li>
			<li class="interlanguage-link interwiki-ml"><a href="//ml.wikipedia.org/wiki/%E0%B4%AA%E0%B4%BE%E0%B4%B0%E0%B5%8D%E2%80%8D%E0%B4%95%E0%B5%8D%E0%B4%95%E0%B4%BF%E0%B4%A8%E0%B5%8D%E2%80%8D%E0%B4%B8%E0%B4%A3%E0%B5%8D%E2%80%8D%E0%B4%B8%E0%B5%8D_%E0%B4%B0%E0%B5%8B%E0%B4%97%E0%B4%82" title="പാര്‍ക്കിന്‍സണ്‍സ് രോഗം – Malayalam" lang="ml" hreflang="ml">മലയാളം</a></li>
			<li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Penyakit_Parkinson" title="Penyakit Parkinson – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li>
			<li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Ziekte_van_Parkinson" title="Ziekte van Parkinson – Dutch" lang="nl" hreflang="nl">Nederlands</a></li>
			<li class="interlanguage-link interwiki-ne"><a href="//ne.wikipedia.org/wiki/%E0%A4%AA%E0%A4%BE%E0%A4%B0%E0%A5%8D%E0%A4%95%E0%A4%BF%E0%A4%A8%E0%A4%B8%E0%A4%A8" title="पार्किनसन – Nepali" lang="ne" hreflang="ne">नेपाली</a></li>
			<li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%91%E3%83%BC%E3%82%AD%E3%83%B3%E3%82%BD%E3%83%B3%E7%97%85" title="パーキンソン病 – Japanese" lang="ja" hreflang="ja">日本語</a></li>
			<li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Parkinsons_sykdom" title="Parkinsons sykdom – Norwegian (bokmål)" lang="no" hreflang="no">Norsk bokmål</a></li>
			<li class="interlanguage-link interwiki-or"><a href="//or.wikipedia.org/wiki/%E0%AC%AA%E0%AC%BE%E0%AC%B0%E0%AD%8D%E0%AC%95%E0%AC%BF%E0%AC%A8%E0%AD%8D%E2%80%8C%E0%AC%B8%E0%AC%A8%E0%AD%8D_%E0%AC%B0%E0%AD%8B%E0%AC%97" title="ପାର୍କିନ୍‌ସନ୍ ରୋଗ – Oriya" lang="or" hreflang="or">ଓଡ଼ିଆ</a></li>
			<li class="interlanguage-link interwiki-pa"><a href="//pa.wikipedia.org/wiki/%E0%A8%AA%E0%A8%BE%E0%A8%B0%E0%A8%95%E0%A8%BF%E0%A9%B0%E0%A8%B8%E0%A8%A8_%E0%A8%B0%E0%A9%8B%E0%A8%97" title="ਪਾਰਕਿੰਸਨ ਰੋਗ – Punjabi" lang="pa" hreflang="pa">ਪੰਜਾਬੀ</a></li>
			<li class="interlanguage-link interwiki-ps"><a href="//ps.wikipedia.org/wiki/%D8%AF_%D9%BE%D8%A7%D8%B1%DA%A9%DB%90%D9%86%D8%B3%D9%88%D9%86_%D9%86%D8%A7%D8%B1%D9%88%D8%BA%D9%8A" title="د پارکېنسون ناروغي – Pashto" lang="ps" hreflang="ps">پښتو</a></li>
			<li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Choroba_Parkinsona" title="Choroba Parkinsona – Polish" lang="pl" hreflang="pl">Polski</a></li>
			<li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Doen%C3%A7a_de_Parkinson" title="Doença de Parkinson – Portuguese" lang="pt" hreflang="pt">Português</a></li>
			<li class="interlanguage-link interwiki-ro"><a href="//ro.wikipedia.org/wiki/Boala_Parkinson" title="Boala Parkinson – Romanian" lang="ro" hreflang="ro">Română</a></li>
			<li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B0" title="Болезнь Паркинсона – Russian" lang="ru" hreflang="ru">Русский</a></li>
			<li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Parkinson%27s_disease" title="Parkinson's disease – Simple English" lang="simple" hreflang="simple">Simple English</a></li>
			<li class="interlanguage-link interwiki-sk"><a href="//sk.wikipedia.org/wiki/Parkinsonova_choroba" title="Parkinsonova choroba – Slovak" lang="sk" hreflang="sk">Slovenčina</a></li>
			<li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Parkinsonova_bolezen" title="Parkinsonova bolezen – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li>
			<li class="interlanguage-link interwiki-ckb"><a href="//ckb.wikipedia.org/wiki/%D9%BE%D8%A7%D8%B1%DA%A9%DB%8C%D9%86%D8%B3%DB%86%D9%86" title="پارکینسۆن – Sorani Kurdish" lang="ckb" hreflang="ckb">کوردی</a></li>
			<li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%BE%D0%B2%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82" title="Паркинсонова болест – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li>
			<li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Parkinsonova_bolest" title="Parkinsonova bolest – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li>
			<li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Parkinsonin_tauti" title="Parkinsonin tauti – Finnish" lang="fi" hreflang="fi">Suomi</a></li>
			<li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Parkinsons_sjukdom" title="Parkinsons sjukdom – Swedish" lang="sv" hreflang="sv">Svenska</a></li>
			<li class="interlanguage-link interwiki-tl"><a href="//tl.wikipedia.org/wiki/Karamdaman_ni_Parkinson" title="Karamdaman ni Parkinson – Tagalog" lang="tl" hreflang="tl">Tagalog</a></li>
			<li class="interlanguage-link interwiki-ta"><a href="//ta.wikipedia.org/wiki/%E0%AE%A8%E0%AE%9F%E0%AF%81%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AF%81%E0%AE%B5%E0%AE%BE%E0%AE%A4%E0%AE%AE%E0%AF%8D" title="நடுக்குவாதம் – Tamil" lang="ta" hreflang="ta">தமிழ்</a></li>
			<li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%9E%E0%B8%B2%E0%B8%A3%E0%B9%8C%E0%B8%81%E0%B8%B4%E0%B8%99%E0%B8%AA%E0%B8%B1%E0%B8%99" title="โรคพาร์กินสัน – Thai" lang="th" hreflang="th">ไทย</a></li>
			<li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Parkinson_hastal%C4%B1%C4%9F%C4%B1" title="Parkinson hastalığı – Turkish" lang="tr" hreflang="tr">Türkçe</a></li>
			<li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A5%D0%B2%D0%BE%D1%80%D0%BE%D0%B1%D0%B0_%D0%9F%D0%B0%D1%80%D0%BA%D1%96%D0%BD%D1%81%D0%BE%D0%BD%D0%B0" title="Хвороба Паркінсона – Ukrainian" lang="uk" hreflang="uk">Українська</a></li>
			<li class="interlanguage-link interwiki-ur"><a href="//ur.wikipedia.org/wiki/%D9%BE%D8%A7%D8%B1%DA%A9%D9%86%D8%B3%D9%86_%DA%A9%DB%8C_%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C" title="پارکنسن کی بیماری – Urdu" lang="ur" hreflang="ur">اردو</a></li>
			<li class="interlanguage-link interwiki-vi"><a href="//vi.wikipedia.org/wiki/B%E1%BB%87nh_Parkinson" title="Bệnh Parkinson – Vietnamese" lang="vi" hreflang="vi">Tiếng Việt</a></li>
			<li class="interlanguage-link interwiki-yi"><a href="//yi.wikipedia.org/wiki/%D7%A4%D7%90%D7%A8%D7%A7%D7%99%D7%A0%D7%A1%D7%90%D7%9F_%D7%A7%D7%A8%D7%A2%D7%A0%D7%A7" title="פארקינסאן קרענק – Yiddish" lang="yi" hreflang="yi">ייִדיש</a></li>
			<li class="interlanguage-link interwiki-yo"><a href="//yo.wikipedia.org/wiki/%C3%80r%C3%B9n_Parkinson" title="Àrùn Parkinson – Yoruba" lang="yo" hreflang="yo">Yorùbá</a></li>
			<li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E5%B8%95%E9%87%91%E6%A3%AE%E6%B0%8F%E7%97%87" title="帕金森氏症 – Chinese" lang="zh" hreflang="zh">中文</a></li>
			<li class="uls-p-lang-dummy"><a href="#"></a></li>
			<li class="wbc-editpage"><a href="//www.wikidata.org/wiki/Q11085#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></li>
		</ul>
	</div>
</div>
			</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 25 March 2014 at 09:24.<br /></li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy.</a> <br/>
Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a class="external" href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/wiki/Parkinson%27s_disease" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
					<li id="footer-copyrightico">
						<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" width="88" height="31" alt="Wikimedia Foundation"/></a>
					</li>
					<li id="footer-poweredbyico">
						<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" width="88" height="31" /></a>
					</li>
				</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mediawiki.action.view.postEdit","mobile.desktop","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","mw.MwEmbedSupport.style","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","skins.vector.collapsibleNav"],null,true);
}</script>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=scripts&amp;skin=vector&amp;*"></script>
<!-- Served by mw1041 in 0.548 secs. -->
	</body>
</html>
